UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
FORM N-PX
ANNUAL REPORT OF PROXY VOTING RECORD OF REGISTERED MANAGEMENT INVESTMENT COMPANY
Investment Company Act file number 811-22021
The Gabelli Healthcare & WellnessRx Trust
(Exact name of registrant as specified in charter)
One Corporate Center
Rye, New York 10580-1422
(Address of principal executive offices) (Zip code)
John C. Ball
Gabelli Funds, LLC
One Corporate Center
Rye, New York 10580-1422
(Name and address of agent for service)
Registrant’s telephone number, including area code: 1-800-422-3554
Date of fiscal year end: December 31
Date of reporting period: July 1, 2022 – June 30, 2023
Form N-PX is to be used by a registered management investment company, other than a small business investment company registered on Form N-5 (17 CFR 239.24 and 274.5), to file reports with the Commission, not later than August 31 of each year, containing the registrant’s proxy voting record for the most recent twelve-month period ended June 30, pursuant to section 30 of the Investment Company Act of 1940 and rule 30b1-4 thereunder (17 CFR 270.30b1-4). The Commission may use the information provided on Form N-PX in its regulatory, disclosure review, inspection, and policymaking roles.
A registrant is required to disclose the information specified by Form N-PX, and the Commission will make this information public. A registrant is not required to respond to the collection of information contained in Form N-PX unless the Form displays a currently valid Office of Management and Budget (“OMB”) control number. Please direct comments concerning the accuracy of the information collection burden estimate and any suggestions for reducing the burden to the Secretary, Securities and Exchange Commission, 450 Fifth Street, NW, Washington, DC 20549-0609. The OMB has reviewed this collection of information under the clearance requirements of 44 U.S.C. § 3507.
PROXY VOTING RECORD
FOR PERIOD JULY 1, 2022 TO JUNE 30, 2023
ProxyEdge Meeting Date Range: 07/01/2022 - 06/30/2023 The Gabelli Healthcare and Wellness RX Trust |
Report Date: 07/01/2023 1 |
Investment Company Report
| NOMAD FOODS LIMITED | ||||||||||||||
| Security | G6564A105 | Meeting Type | Annual | |||||||||||
| Ticker Symbol | NOMD | Meeting Date | 01-Jul-2022 | |||||||||||
| ISIN | VGG6564A1057 | Agenda | 935650855 - Management | |||||||||||
| Item | Proposal | Proposed by |
Vote | For/Against Management |
||||||||||
| 1a. | Election of Director for a one-year term expiring at the 2023 Annual Meeting: Sir Martin Ellis Franklin, KGCN | Management | For | For | ||||||||||
| 1b. | Election of Director for a one-year term expiring at the 2023 Annual Meeting: Noam Gottesman | Management | For | For | ||||||||||
| 1c. | Election of Director for a one-year term expiring at the 2023 Annual Meeting: Ian G.H. Ashken | Management | For | For | ||||||||||
| 1d. | Election of Director for a one-year term expiring at the 2023 Annual Meeting: Stéfan Descheemaeker | Management | For | For | ||||||||||
| 1e. | Election of Director for a one-year term expiring at the 2023 Annual Meeting: James E. Lillie | Management | For | For | ||||||||||
| 1f. | Election of Director for a one-year term expiring at the 2023 Annual Meeting: Stuart M. MacFarlane | Management | For | For | ||||||||||
| 1g. | Election of Director for a one-year term expiring at the 2023 Annual Meeting: Victoria Parry | Management | For | For | ||||||||||
| 1h. | Election of Director for a one-year term expiring at the 2023 Annual Meeting: Amit Pilowsky | Management | For | For | ||||||||||
| 1i. | Election of Director for a one-year term expiring at the 2023 Annual Meeting: Melanie Stack | Management | For | For | ||||||||||
| 1j. | Election of Director for a one-year term expiring at the 2023 Annual Meeting: Samy Zekhout | Management | For | For | ||||||||||
| 2. | Ratify the selection of PricewaterhouseCoopers LLP as our independent registered public accounting firm for the 2022 fiscal year. | Management | For | For | ||||||||||
| PETS AT HOME GROUP PLC | ||||||||||||||
| Security | G7041J107 | Meeting Type | Annual General Meeting | |||||||||||
| Ticker Symbol | Meeting Date | 07-Jul-2022 | ||||||||||||
| ISIN | GB00BJ62K685 | Agenda | 715764848 - Management | |||||||||||
| Item | Proposal | Proposed by |
Vote | For/Against Management |
||||||||||
| 1 | TO RECEIVE THE COMPANY'S AUDITED FINANCIAL STATEMENTS FOR THE FINANCIAL YEAR ENDED 31 MARCH 2022 | Management | For | For | ||||||||||
| 2 | TO APPROVE THE DIRECTORS' REMUNERATION REPORT FOR THE YEAR ENDED 31 MARCH 2022 | Management | For | For | ||||||||||
| 3 | TO DECLARE A FINAL DIVIDEND RECOMMENDED BY THE DIRECTORS OF 7.5 PENCE PER ORDINARY SHARE FOR THE YEAR ENDED 31 MARCH 2022 | Management | For | For | ||||||||||
| 4.A | TO RE-ELECT MIKE IDDON AS A DIRECTOR OF THE COMPANY | Management | For | For | ||||||||||
| 4.B | TO RE-ELECT DENNIS MILLARD AS A DIRECTOR OF THE COMPANY | Management | For | For | ||||||||||
| 4.C | TO RE-ELECT SHARON FLOOD AS A DIRECTOR OF THE COMPANY | Management | For | For | ||||||||||
| 4.D | TO RE-ELECT STANISLAS LAURENT AS A DIRECTOR OF THE COMPANY | Management | For | For | ||||||||||
| 4.E | TO RE-ELECT SUSAN DAWSON AS A DIRECTOR OF THE COMPANY | Management | For | For | ||||||||||
| 4.F | TO RE-ELECT IAN BURKE AS A DIRECTOR OF THE COMPANY | Management | For | For | ||||||||||
| 4.G | TO RE-ELECT ZARIN PATEL AS A DIRECTOR OF THE COMPANY | Management | For | For | ||||||||||
| 5 | TO ELECT LYSSA MCGOWAN AS DIRECTOR OF THE COMPANY | Management | For | For | ||||||||||
| 6 | TO RE-APPOINT KPMG LLP AS AUDITOR OF THE COMPANY | Management | For | For | ||||||||||
| 7 | TO AUTHORISE THE DIRECTORS TO SET THE FEES PAID TO THE AUDITOR OF THE COMPANY | Management | For | For | ||||||||||
| 8 | AUTHORITY TO ALLOT SHARES | Management | For | For | ||||||||||
| 9 | AUTHORITY TO MAKE POLITICAL DONATIONS AND EXPENDITURE | Management | For | For | ||||||||||
| 10 | PARTIAL DISAPPLICATION OF PRE-EMPTION RIGHTS | Management | Abstain | Against | ||||||||||
| 11 | ADDITIONAL PARTIAL DISAPPLICATION OF PRE- EMPTION RIGHTS | Management | For | For | ||||||||||
| 12 | AUTHORITY TO PURCHASE OWN SHARES | Management | For | For | ||||||||||
| 13 | THAT A GENERAL MEETING OTHER THAN AN ANNUAL GENERAL MEETING MAY BE CALLED ON NOT LESS THAN 14 CLEAR DAYS' NOTICE | Management | For | For | ||||||||||
| CMMT | 09 JUN 2022: PLEASE NOTE THAT THIS IS A REVISION DUE TO MODIFICATION OF THE-TEXT OF RESOLUTION 1. IF YOU HAVE ALREADY SENT IN YOUR VOTES, PLEASE DO NOT-VOTE AGAIN UNLESS YOU DECIDE TO AMEND YOUR ORIGINAL INSTRUCTIONS. THANK YOU | Non-Voting | ||||||||||||
| CLOVIS ONCOLOGY, INC. | ||||||||||||||
| Security | 189464100 | Meeting Type | Annual | |||||||||||
| Ticker Symbol | CLVS | Meeting Date | 07-Jul-2022 | |||||||||||
| ISIN | US1894641000 | Agenda | 935632326 - Management | |||||||||||
| Item | Proposal | Proposed by |
Vote | For/Against Management |
||||||||||
| 1. | DIRECTOR | Management | ||||||||||||
| 1 | Brian G. Atwood | For | For | |||||||||||
| 2 | James C. Blair | For | For | |||||||||||
| 3 | Richard A. Fair | For | For | |||||||||||
| 4 | Paul H. Klingenstein | For | For | |||||||||||
| 2. | Approval of an amendment to our Amended and Restated Certificate of Incorporation to effect a reverse stock split of our common stock at a ratio of 1-for-7 (the "Reverse Stock Split"). | Management | For | For | ||||||||||
| 3. | Approval of an amendment to our Amended and Restated Certificate of Incorporation to decrease, concurrent with and conditioned upon the implementation of the Reverse Stock Split, the number of authorized shares of common stock from 200,000,000 to 57,142,000 shares. | Management | For | For | ||||||||||
| 4. | Approval of an amendment and restatement of our Amended and Restated 2020 Stock Incentive Plan to increase the number of shares available for issuance under the plan by 4,000,000 shares (prior to giving effect to the Reverse Stock Split), concurrent with and conditioned upon the implementation of the Reverse Stock Split. | Management | Against | Against | ||||||||||
| 5. | Approval of an advisory proposal on compensation of the Company's named executive officers, as disclosed in the attached proxy statement. | Management | For | For | ||||||||||
| 6. | Ratification of the appointment of Ernst & Young LLP as the independent registered public accounting firm of the Company for the fiscal year ending December 31, 2022. | Management | For | For | ||||||||||
| 7. | Approval of an adjournment of the Annual Meeting, if necessary or appropriate, to solicit additional proxies. | Management | For | For | ||||||||||
| OPKO HEALTH, INC. | ||||||||||||||
| Security | 68375N103 | Meeting Type | Annual | |||||||||||
| Ticker Symbol | OPK | Meeting Date | 14-Jul-2022 | |||||||||||
| ISIN | US68375N1037 | Agenda | 935671405 - Management | |||||||||||
| Item | Proposal | Proposed by |
Vote | For/Against Management |
||||||||||
| 1a. | Election of Director: Phillip Frost, M.D. | Management | For | For | ||||||||||
| 1b. | Election of Director: Jane H. Hsiao, Ph.D., MBA | Management | For | For | ||||||||||
| 1c. | Election of Director: Steven D. Rubin | Management | For | For | ||||||||||
| 1d. | Election of Director: Elias A. Zerhouni, M.D. | Management | For | For | ||||||||||
| 1e. | Election of Director: Jon R. Cohen, M.D. | Management | For | For | ||||||||||
| 1f. | Election of Director: Gary J. Nabel, M.D., Ph.D. | Management | For | For | ||||||||||
| 1g. | Election of Director: Alexis Borisy | Management | For | For | ||||||||||
| 1h. | Election of Director: Richard M. Krasno, Ph.D. | Management | For | For | ||||||||||
| 1i. | Election of Director: Prem A. Lachman, M.D. | Management | For | For | ||||||||||
| 1j. | Election of Director: Roger J. Medel, M.D. | Management | For | For | ||||||||||
| 1k. | Election of Director: John A. Paganelli | Management | For | For | ||||||||||
| 1l. | Election of Director: Richard C. Pfenniger, Jr. | Management | For | For | ||||||||||
| 1m. | Election of Director: Alice Lin-Tsing Yu, M.D., Ph.D. | Management | For | For | ||||||||||
| 2. | To approve a non-binding advisory resolution regarding the compensation paid to the Company's named executive officers. | Management | For | For | ||||||||||
| 3. | To amend the OPKO Health, Inc. 2016 Equity Incentive Plan to increase the number of shares issuable thereunder from 30,000,000 to 60,000,000. | Management | Against | Against | ||||||||||
| 4. | To ratify the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2022. | Management | For | For | ||||||||||
| MCKESSON CORPORATION | ||||||||||||||
| Security | 58155Q103 | Meeting Type | Annual | |||||||||||
| Ticker Symbol | MCK | Meeting Date | 22-Jul-2022 | |||||||||||
| ISIN | US58155Q1031 | Agenda | 935672027 - Management | |||||||||||
| Item | Proposal | Proposed by |
Vote | For/Against Management |
||||||||||
| 1a. | Election of Director for a one-year term: Richard H. Carmona, M.D. | Management | For | For | ||||||||||
| 1b. | Election of Director for a one-year term: Dominic J. Caruso | Management | For | For | ||||||||||
| 1c. | Election of Director for a one-year term: W. Roy Dunbar | Management | For | For | ||||||||||
| 1d. | Election of Director for a one-year term: James H. Hinton | Management | For | For | ||||||||||
| 1e. | Election of Director for a one-year term: Donald R. Knauss | Management | For | For | ||||||||||
| 1f. | Election of Director for a one-year term: Bradley E. Lerman | Management | For | For | ||||||||||
| 1g. | Election of Director for a one-year term: Linda P. Mantia | Management | For | For | ||||||||||
| 1h. | Election of Director for a one-year term: Maria Martinez | Management | For | For | ||||||||||
| 1i. | Election of Director for a one-year term: Susan R. Salka | Management | For | For | ||||||||||
| 1j. | Election of Director for a one-year term: Brian S. Tyler | Management | For | For | ||||||||||
| 1k. | Election of Director for a one-year term: Kathleen Wilson- Thompson | Management | For | For | ||||||||||
| 2. | Ratification of Appointment of Deloitte & Touche LLP as the Company's Independent Registered Public Accounting Firm for Fiscal Year 2023. | Management | For | For | ||||||||||
| 3. | Advisory vote on executive compensation. | Management | For | For | ||||||||||
| 4. | Approval of our 2022 Stock Plan. | Management | For | For | ||||||||||
| 5. | Approval of Amendment to our 2000 Employee Stock Purchase Plan. | Management | For | For | ||||||||||
| 6. | Shareholder Proposal on Special Shareholder Meeting Improvement. | Shareholder | Against | For | ||||||||||
| 7. | Shareholder Proposal on Transparency in Rule 10b5-1 Trading Policy. | Shareholder | Against | For | ||||||||||
| ITO EN,LTD. | ||||||||||||||
| Security | J25027103 | Meeting Type | Annual General Meeting | |||||||||||
| Ticker Symbol | Meeting Date | 28-Jul-2022 | ||||||||||||
| ISIN | JP3143000002 | Agenda | 715860450 - Management | |||||||||||
| Item | Proposal | Proposed by |
Vote | For/Against Management |
||||||||||
| Please reference meeting materials. | Non-Voting | |||||||||||||
| 1 | Approve Appropriation of Surplus | Management | For | For | ||||||||||
| 2 | Amend Articles to: Approve Minor Revisions Related to Change of Laws and Regulations, Reduce the Board of Directors Size, Reduce Term of Office of Directors to One Year | Management | For | For | ||||||||||
| 3.1 | Appoint a Director Honjo, Hachiro | Management | For | For | ||||||||||
| 3.2 | Appoint a Director Honjo, Daisuke | Management | For | For | ||||||||||
| 3.3 | Appoint a Director Honjo, Shusuke | Management | For | For | ||||||||||
| 3.4 | Appoint a Director Watanabe, Minoru | Management | For | For | ||||||||||
| 3.5 | Appoint a Director Nakano, Yoshihisa | Management | For | For | ||||||||||
| 3.6 | Appoint a Director Kamiya, Shigeru | Management | For | For | ||||||||||
| 3.7 | Appoint a Director Yosuke Jay Oceanbright Honjo | Management | For | For | ||||||||||
| 3.8 | Appoint a Director Hirata, Atsushi | Management | For | For | ||||||||||
| 3.9 | Appoint a Director Taguchi, Morikazu | Management | For | For | ||||||||||
| 3.10 | Appoint a Director Usui, Yuichi | Management | For | For | ||||||||||
| 3.11 | Appoint a Director Tanaka, Yutaka | Management | For | For | ||||||||||
| 3.12 | Appoint a Director Takano, Hideo | Management | For | For | ||||||||||
| 3.13 | Appoint a Director Abe, Keiko | Management | For | For | ||||||||||
| HAEMONETICS CORPORATION | ||||||||||||||
| Security | 405024100 | Meeting Type | Annual | |||||||||||
| Ticker Symbol | HAE | Meeting Date | 05-Aug-2022 | |||||||||||
| ISIN | US4050241003 | Agenda | 935677178 - Management | |||||||||||
| Item | Proposal | Proposed by |
Vote | For/Against Management |
||||||||||
| 1.1 | Election of Director: Robert E. Abernathy | Management | For | For | ||||||||||
| 1.2 | Election of Director: Catherine M. Burzik | Management | For | For | ||||||||||
| 1.3 | Election of Director: Michael J. Coyle | Management | For | For | ||||||||||
| 1.4 | Election of Director: Charles J. Dockendorff | Management | For | For | ||||||||||
| 1.5 | Election of Director: Lloyd E. Johnson | Management | For | For | ||||||||||
| 1.6 | Election of Director: Mark W. Kroll | Management | For | For | ||||||||||
| 1.7 | Election of Director: Claire Pomeroy | Management | For | For | ||||||||||
| 1.8 | Election of Director: Christopher A. Simon | Management | For | For | ||||||||||
| 1.9 | Election of Director: Ellen M. Zane | Management | For | For | ||||||||||
| 2. | To approve, on an advisory basis, the compensation of our named executive officers | Management | For | For | ||||||||||
| 3. | To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending April 1, 2023 | Management | For | For | ||||||||||
| THE J. M. SMUCKER COMPANY | ||||||||||||||
| Security | 832696405 | Meeting Type | Annual | |||||||||||
| Ticker Symbol | SJM | Meeting Date | 17-Aug-2022 | |||||||||||
| ISIN | US8326964058 | Agenda | 935684351 - Management | |||||||||||
| Item | Proposal | Proposed by |
Vote | For/Against Management |
||||||||||
| 1a. | Election of Directors whose term of office will expire in 2023: Susan E. Chapman-Hughes | Management | For | For | ||||||||||
| 1b. | Election of Directors whose term of office will expire in 2023: Paul J. Dolan | Management | For | For | ||||||||||
| 1c. | Election of Directors whose term of office will expire in 2023: Jay L. Henderson | Management | For | For | ||||||||||
| 1d. | Election of Directors whose term of office will expire in 2023: Jonathan E. Johnson III | Management | For | For | ||||||||||
| 1e. | Election of Directors whose term of office will expire in 2023: Kirk L. Perry | Management | For | For | ||||||||||
| 1f. | Election of Directors whose term of office will expire in 2023: Sandra Pianalto | Management | For | For | ||||||||||
| 1g. | Election of Directors whose term of office will expire in 2023: Alex Shumate | Management | For | For | ||||||||||
| 1h. | Election of Directors whose term of office will expire in 2023: Mark T. Smucker | Management | For | For | ||||||||||
| 1i. | Election of Directors whose term of office will expire in 2023: Richard K. Smucker | Management | For | For | ||||||||||
| 1j. | Election of Directors whose term of office will expire in 2023: Jodi L. Taylor | Management | For | For | ||||||||||
| 1k. | Election of Directors whose term of office will expire in 2023: Dawn C. Willoughby | Management | For | For | ||||||||||
| 2. | Ratification of appointment of Ernst & Young LLP as the Company's Independent Registered Public Accounting Firm for the 2023 fiscal year. | Management | For | For | ||||||||||
| 3. | Advisory approval of the Company's executive compensation. | Management | For | For | ||||||||||
| 4. | Adoption of amendments to the Company's Amended Articles of Incorporation to eliminate the time phased voting provisions. | Management | Against | Against | ||||||||||
| NEOGEN CORPORATION | ||||||||||||||
| Security | 640491106 | Meeting Type | Special | |||||||||||
| Ticker Symbol | NEOG | Meeting Date | 17-Aug-2022 | |||||||||||
| ISIN | US6404911066 | Agenda | 935691914 - Management | |||||||||||
| Item | Proposal | Proposed by |
Vote | For/Against Management |
||||||||||
| 1. | To approve the issuance of shares of Neogen common stock (the "Share Issuance") in connection with the Merger contemplated by the Agreement and Plan of Merger (as it may be amended from time to time, the "Merger Agreement"), dated as of December 13, 2021, by and among 3M Company, Garden SpinCo Corporation, Neogen Corporation ("Neogen") and Nova RMT Sub, Inc. (the "Share Issuance Proposal"). | Management | For | For | ||||||||||
| 2. | To approve the amendment of Neogen's Restated Articles of Incorporation, as amended, to (a) increase the number of authorized shares of Neogen common stock from 240,000,000 shares of Neogen common stock to 315,000,000 shares of Neogen common stock and (b) increase the maximum number of directors on the Neogen board of directors (the "Board") from nine directors to eleven directors (the "Charter Amendment Proposal"). | Management | For | For | ||||||||||
| 3. | To approve the amendment of Neogen's bylaws to increase the maximum number of directors that may comprise the Board from nine directors to eleven directors (the "Bylaw Board Size Proposal"). | Management | For | For | ||||||||||
| 4. | To approve the amendment of Neogen's bylaws in order to authorize the Board to amend the bylaws without obtaining the prior approval of Neogen's shareholders. | Management | Against | Against | ||||||||||
| 5. | To approve the adjournment of the special meeting, if necessary, to solicit additional proxies in the event there are not sufficient votes at the time of the special meeting to approve the Share Issuance Proposal, the Charter Amendment Proposal or the Bylaw Board Size Proposal. | Management | For | For | ||||||||||
| VITASOY INTERNATIONAL HOLDINGS LTD | ||||||||||||||
| Security | Y93794108 | Meeting Type | Annual General Meeting | |||||||||||
| Ticker Symbol | Meeting Date | 30-Aug-2022 | ||||||||||||
| ISIN | HK0345001611 | Agenda | 715944066 - Management | |||||||||||
| Item | Proposal | Proposed by |
Vote | For/Against Management |
||||||||||
| CMMT | PLEASE NOTE THAT THE COMPANY NOTICE AND PROXY FORM ARE AVAILABLE BY CLICKING-ON THE URL LINKS:- https://www1.hkexnews.hk/listedco/listconews/sehk/2022/ 0725/2022072500345.pdf-AND- https://www1.hkexnews.hk/listedco/listconews/sehk/2022/ 0725/2022072500365.pdf | Non-Voting | ||||||||||||
| CMMT | IN THE HONG KONG MARKET A VOTE OF ABSTAIN WILL BE TREATED THE SAME AS A VOTE-OF TAKE NO ACTION. | Non-Voting | ||||||||||||
| 1 | TO RECEIVE AND ADOPT THE AUDITED FINANCIAL STATEMENTS AND THE REPORTS OF THE DIRECTORS AND AUDITORS FOR THE YEAR ENDED 31ST MARCH, 2022 | Management | For | For | ||||||||||
| 2.A.I | TO RE-ELECT MR. WINSTON YAU-LAI LO AS AN EXECUTIVE DIRECTOR | Management | Against | Against | ||||||||||
| 2.AII | TO RE-ELECT MR. PAUL JEREMY BROUGH AS AN INDEPENDENT NON-EXECUTIVE DIRECTOR | Management | Against | Against | ||||||||||
| 2AIII | TO RE-ELECT MR. ROBERTO GUIDETTI AS AN EXECUTIVE DIRECTOR | Management | For | For | ||||||||||
| 2.B | TO DETERMINE THE REMUNERATION OF THE DIRECTORS | Management | For | For | ||||||||||
| 3 | TO APPOINT AUDITORS AND AUTHORISE THE DIRECTORS TO FIX THEIR REMUNERATION | Management | For | For | ||||||||||
| 4.A | TO GRANT A GENERAL MANDATE TO THE DIRECTORS TO ISSUE, ALLOT AND DEAL WITH ADDITIONAL SHARES OF THE COMPANY, NOT EXCEEDING 10% OF THE NUMBER OF ISSUED SHARES OF THE COMPANY AS AT THE DATE OF THIS RESOLUTION | Management | Against | Against | ||||||||||
| 4.B | TO GRANT A GENERAL MANDATE TO THE DIRECTORS TO BUY-BACK SHARES OF THE COMPANY, NOT EXCEEDING 10% OF THE NUMBER OF ISSUED SHARES OF THE COMPANY AS AT THE DATE OF THIS RESOLUTION | Management | For | For | ||||||||||
| 4.C | TO ADD THE NUMBER OF SHARES BOUGHT-BACK PURSUANT TO RESOLUTION 4B TO THE NUMBER OF SHARES AVAILABLE PURSUANT TO RESOLUTION 4A | Management | Against | Against | ||||||||||
| 4.D | TO APPROVE AND ADOPT THE NEW SHARE OPTION SCHEME | Management | Against | Against | ||||||||||
| PATTERSON COMPANIES, INC. | ||||||||||||||
| Security | 703395103 | Meeting Type | Annual | |||||||||||
| Ticker Symbol | PDCO | Meeting Date | 12-Sep-2022 | |||||||||||
| ISIN | US7033951036 | Agenda | 935691471 - Management | |||||||||||
| Item | Proposal | Proposed by |
Vote | For/Against Management |
||||||||||
| 1a. | Election of Director to have terms expiring in 2023: John D. Buck | Management | For | For | ||||||||||
| 1b. | Election of Director to have terms expiring in 2023: Alex N. Blanco | Management | For | For | ||||||||||
| 1c. | Election of Director to have terms expiring in 2023: Jody H. Feragen | Management | For | For | ||||||||||
| 1d. | Election of Director to have terms expiring in 2023: Robert C. Frenzel | Management | For | For | ||||||||||
| 1e. | Election of Director to have terms expiring in 2023: Philip G. McKoy | Management | For | For | ||||||||||
| 1f. | Election of Director to have terms expiring in 2023: Ellen A. Rudnick | Management | For | For | ||||||||||
| 1g. | Election of Director to have terms expiring in 2023: Neil A. Schrimsher | Management | For | For | ||||||||||
| 1h. | Election of Director to have terms expiring in 2023: Mark S. Walchirk | Management | For | For | ||||||||||
| 2. | Advisory approval of executive compensation. | Management | For | For | ||||||||||
| 3. | To ratify the selection of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending April 29, 2023. | Management | For | For | ||||||||||
| CONAGRA BRANDS, INC. | ||||||||||||||
| Security | 205887102 | Meeting Type | Annual | |||||||||||
| Ticker Symbol | CAG | Meeting Date | 21-Sep-2022 | |||||||||||
| ISIN | US2058871029 | Agenda | 935696736 - Management | |||||||||||
| Item | Proposal | Proposed by |
Vote | For/Against Management |
||||||||||
| 1a. | Election of Director: Anil Arora | Management | For | For | ||||||||||
| 1b. | Election of Director: Thomas K. Brown | Management | For | For | ||||||||||
| 1c. | Election of Director: Emanuel Chirico | Management | For | For | ||||||||||
| 1d. | Election of Director: Sean M. Connolly | Management | For | For | ||||||||||
| 1e. | Election of Director: George Dowdie | Management | For | For | ||||||||||
| 1f. | Election of Director: Fran Horowitz | Management | For | For | ||||||||||
| 1g. | Election of Director: Richard H. Lenny | Management | For | For | ||||||||||
| 1h. | Election of Director: Melissa Lora | Management | For | For | ||||||||||
| 1i. | Election of Director: Ruth Ann Marshall | Management | For | For | ||||||||||
| 1j. | Election of Director: Denise A. Paulonis | Management | For | For | ||||||||||
| 2. | Ratification of the appointment of KPMG LLP as our independent auditor for fiscal 2023 | Management | For | For | ||||||||||
| 3. | Advisory approval of our named executive officer compensation | Management | For | For | ||||||||||
| 4. | A Board resolution to amend the Certificate of Incorporation to allow shareholders to act by written consent | Management | For | For | ||||||||||
| 5. | A shareholder proposal regarding the office of the Chair and the office of the Chief Executive Officer | Shareholder | Against | For | ||||||||||
| 1LIFE HEALTHCARE, INC. | ||||||||||||||
| Security | 68269G107 | Meeting Type | Special | |||||||||||
| Ticker Symbol | ONEM | Meeting Date | 22-Sep-2022 | |||||||||||
| ISIN | US68269G1076 | Agenda | 935704432 - Management | |||||||||||
| Item | Proposal | Proposed by |
Vote | For/Against Management |
||||||||||
| 1. | To adopt the Agreement and Plan of Merger, dated July 20, 2022 (such agreement, as it may be amended, modified or supplemented from time to time, the "Merger Agreement"), by and among 1Life Healthcare, Inc. ("1Life"), a Delaware corporation, Amazon.com, Inc. ("Amazon"), a Delaware corporation, and Negroni Merger Sub, Inc. ("Merger Sub"), a Delaware corporation. Upon the terms and subject to the conditions of the Merger Agreement, Amazon will acquire 1Life via a merger of Merger Sub with and into 1Life, with 1Life continuing as the surviving corporation. | Management | For | For | ||||||||||
| 2. | To approve, on an advisory (non-binding) basis, the compensation that may be paid or become payable to 1Life's named executive officers that is based on or otherwise relates to the Merger Agreement and the transactions contemplated by the Merger Agreement. | Management | For | For | ||||||||||
| 3. | To adjourn the special meeting of the 1Life stockholders (the "Special Meeting") to a later date or dates, if necessary or appropriate, including to solicit additional proxies to approve the proposal to adopt the Merger Agreement if there are insufficient votes to adopt the Merger Agreement at the time of the Special Meeting. | Management | For | For | ||||||||||
| GENERAL MILLS, INC. | ||||||||||||||
| Security | 370334104 | Meeting Type | Annual | |||||||||||
| Ticker Symbol | GIS | Meeting Date | 27-Sep-2022 | |||||||||||
| ISIN | US3703341046 | Agenda | 935697877 - Management | |||||||||||
| Item | Proposal | Proposed by |
Vote | For/Against Management |
||||||||||
| 1a. | Election of Director: R. Kerry Clark | Management | For | For | ||||||||||
| 1b. | Election of Director: David M. Cordani | Management | For | For | ||||||||||
| 1c. | Election of Director: C. Kim Goodwin | Management | For | For | ||||||||||
| 1d. | Election of Director: Jeffrey L. Harmening | Management | For | For | ||||||||||
| 1e. | Election of Director: Maria G. Henry | Management | For | For | ||||||||||
| 1f. | Election of Director: Jo Ann Jenkins | Management | For | For | ||||||||||
| 1g. | Election of Director: Elizabeth C. Lempres | Management | For | For | ||||||||||
| 1h. | Election of Director: Diane L. Neal | Management | For | For | ||||||||||
| 1i. | Election of Director: Steve Odland | Management | For | For | ||||||||||
| 1j. | Election of Director: Maria A. Sastre | Management | For | For | ||||||||||
| 1k. | Election of Director: Eric D. Sprunk | Management | For | For | ||||||||||
| 1l. | Election of Director: Jorge A. Uribe | Management | For | For | ||||||||||
| 2. | Approval of the 2022 Stock Compensation Plan. | Management | For | For | ||||||||||
| 3. | Advisory Vote on Executive Compensation. | Management | For | For | ||||||||||
| 4. | Ratify Appointment of the Independent Registered Public Accounting Firm. | Management | For | For | ||||||||||
| 5. | Shareholder Proposal - Independent Board Chairman. | Shareholder | Against | For | ||||||||||
| 6. | Shareholder Proposal Regarding a Plastic Packaging Report. | Shareholder | Abstain | Against | ||||||||||
| LAMB WESTON HOLDINGS, INC. | ||||||||||||||
| Security | 513272104 | Meeting Type | Annual | |||||||||||
| Ticker Symbol | LW | Meeting Date | 29-Sep-2022 | |||||||||||
| ISIN | US5132721045 | Agenda | 935697889 - Management | |||||||||||
| Item | Proposal | Proposed by |
Vote | For/Against Management |
||||||||||
| 1a. | Election of Director: Peter J. Bensen | Management | For | For | ||||||||||
| 1b. | Election of Director: Charles A. Blixt | Management | For | For | ||||||||||
| 1c. | Election of Director: Robert J. Coviello | Management | For | For | ||||||||||
| 1d. | Election of Director: André J. Hawaux | Management | For | For | ||||||||||
| 1e. | Election of Director: W.G. Jurgensen | Management | For | For | ||||||||||
| 1f. | Election of Director: Thomas P. Maurer | Management | For | For | ||||||||||
| 1g. | Election of Director: Hala G. Moddelmog | Management | For | For | ||||||||||
| 1h. | Election of Director: Robert A. Niblock | Management | For | For | ||||||||||
| 1i. | Election of Director: Maria Renna Sharpe | Management | For | For | ||||||||||
| 1j. | Election of Director: Thomas P. Werner | Management | For | For | ||||||||||
| 2. | Advisory Vote to Approve Executive Compensation. | Management | For | For | ||||||||||
| 3. | Ratification of the Selection of KPMG LLP as Independent Auditors for Fiscal Year 2023. | Management | For | For | ||||||||||
| BIOHAVEN PHARMACEUTICAL HLDG CO LTD | ||||||||||||||
| Security | G11196105 | Meeting Type | Special | |||||||||||
| Ticker Symbol | BHVN | Meeting Date | 29-Sep-2022 | |||||||||||
| ISIN | VGG111961055 | Agenda | 935707298 - Management | |||||||||||
| Item | Proposal | Proposed by |
Vote | For/Against Management |
||||||||||
| 1. | To adopt (i) the Agreement and Plan of Merger, dated as of May 9, 2022 (the "Merger Agreement"), by and among Biohaven Pharmaceutical Holding Company Ltd. ("Biohaven"), Pfizer Inc. & Bulldog (BVI) Ltd., (ii) the form of Plan of Reverse Triangular Merger & form of Plan of Forward Triangular Merger (together, the "Plan of Merger") & (iii) Separation & Distribution Agreement, dated as of May 9, 2022 ("Distribution Agreement"), by and between Biohaven & Biohaven Research Ltd. ("SpinCo"), in each case, as they may be amended from time to time. | Management | For | For | ||||||||||
| 2. | To approve, by non-binding, advisory vote, certain compensatory arrangements for Biohaven's named executive officers in connection with the acquisition by Pfizer of Biohaven and the distribution to Biohaven's shareholders of all of the issued and outstanding common shares of SpinCo. | Management | For | For | ||||||||||
| 3. | To adjourn the Special Meeting, if necessary, desirable or appropriate, to solicit additional proxies if, at the time of the Special Meeting, there are an insufficient number of votes to adopt the Merger Agreement, the Plan of Merger and the Distribution Agreement. | Management | For | For | ||||||||||
| GLOBAL BLOOD THERAPEUTICS, INC. | ||||||||||||||
| Security | 37890U108 | Meeting Type | Special | |||||||||||
| Ticker Symbol | GBT | Meeting Date | 30-Sep-2022 | |||||||||||
| ISIN | US37890U1088 | Agenda | 935705662 - Management | |||||||||||
| Item | Proposal | Proposed by |
Vote | For/Against Management |
||||||||||
| 1. | To adopt the Agreement and Plan of Merger, dated as of August 7, 2022, by and among Pfizer Inc., Ribeye Acquisition Corp. and Global Blood Therapeutics, Inc., as it may be amended from time to time (the "Merger Agreement"). | Management | For | For | ||||||||||
| 2. | To approve, on an advisory (nonbinding) basis, the compensation that may be paid or become payable to Global Blood Therapeutics, Inc.'s named executive officers that is based on or otherwise related to the Merger Agreement and the transactions contemplated by the Merger Agreement. | Management | For | For | ||||||||||
| 3. | To adjourn the special meeting of stockholders of Global Blood Therapeutics, Inc. (the "Special Meeting"), if necessary or appropriate, to solicit additional proxies if there are insufficient votes to adopt the Merger Agreement at the time of the Special Meeting. | Management | For | For | ||||||||||
| NEOGEN CORPORATION | ||||||||||||||
| Security | 640491106 | Meeting Type | Annual | |||||||||||
| Ticker Symbol | NEOG | Meeting Date | 06-Oct-2022 | |||||||||||
| ISIN | US6404911066 | Agenda | 935707628 - Management | |||||||||||
| Item | Proposal | Proposed by |
Vote | For/Against Management |
||||||||||
| 1. | DIRECTOR | Management | ||||||||||||
| 1 | JOHN E. ADENT | For | For | |||||||||||
| 2 | WILLIAM T. BOEHM, PH.D. | For | For | |||||||||||
| 3 | JAMES P. TOBIN | For | For | |||||||||||
| 2. | TO APPROVE, BY NON-BINDING ADVISORY VOTE, THE COMPENSATION OF EXECUTIVES. | Management | For | For | ||||||||||
| 3. | RATIFICATION OF APPOINTMENT OF BDO USA LLP AS THE COMPANY'S INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM. | Management | For | For | ||||||||||
| MERIDIAN BIOSCIENCE, INC. | ||||||||||||||
| Security | 589584101 | Meeting Type | Special | |||||||||||
| Ticker Symbol | VIVO | Meeting Date | 10-Oct-2022 | |||||||||||
| ISIN | US5895841014 | Agenda | 935710702 - Management | |||||||||||
| Item | Proposal | Proposed by |
Vote | For/Against Management |
||||||||||
| 1. | Adoption of the Agreement and Plan of Merger, (as may be amended from time to time, the "merger agreement"), by and among Meridian Bioscience, Inc. ("Meridian"), SD Biosensor, Inc., Columbus Holding Company ("Columbus Holding") and Madeira Acquisition Corp., a directly wholly owned subsidiary of Columbus Holding ("Merger Sub"). The merger agreement provides for acquisition of Meridian by Columbus Holding through a merger of Merger Sub with and into Meridian, with Meridian surviving merger as a wholly owned subsidiary of Columbus Holding. | Management | For | For | ||||||||||
| 2. | Approval, on an advisory (non-binding) basis, of the compensation that may be paid or become payable to Meridian's named executive officers that is based on or otherwise relates to the merger agreement and the transactions contemplated by the merger agreement. | Management | For | For | ||||||||||
| 3. | Approval of the adjournment of the special meeting to a later date or dates if necessary or appropriate to solicit additional proxies if there are insufficient votes to adopt the merger agreement at the time of the special meeting. | Management | For | For | ||||||||||
| THE PROCTER & GAMBLE COMPANY | ||||||||||||||
| Security | 742718109 | Meeting Type | Annual | |||||||||||
| Ticker Symbol | PG | Meeting Date | 11-Oct-2022 | |||||||||||
| ISIN | US7427181091 | Agenda | 935703149 - Management | |||||||||||
| Item | Proposal | Proposed by |
Vote | For/Against Management |
||||||||||
| 1a. | ELECTION OF DIRECTOR: B. Marc Allen | Management | For | For | ||||||||||
| 1b. | ELECTION OF DIRECTOR: Angela F. Braly | Management | For | For | ||||||||||
| 1c. | ELECTION OF DIRECTOR: Amy L. Chang | Management | For | For | ||||||||||
| 1d. | ELECTION OF DIRECTOR: Joseph Jimenez | Management | For | For | ||||||||||
| 1e. | ELECTION OF DIRECTOR: Christopher Kempczinski | Management | For | For | ||||||||||
| 1f. | ELECTION OF DIRECTOR: Debra L. Lee | Management | For | For | ||||||||||
| 1g. | ELECTION OF DIRECTOR: Terry J. Lundgren | Management | For | For | ||||||||||
| 1h. | ELECTION OF DIRECTOR: Christine M. McCarthy | Management | For | For | ||||||||||
| 1i. | ELECTION OF DIRECTOR: Jon R. Moeller | Management | For | For | ||||||||||
| 1j. | ELECTION OF DIRECTOR: Rajesh Subramaniam | Management | For | For | ||||||||||
| 1k. | ELECTION OF DIRECTOR: Patricia A. Woertz | Management | For | For | ||||||||||
| 2. | Ratify Appointment of the Independent Registered Public Accounting Firm | Management | For | For | ||||||||||
| 3. | Advisory Vote to Approve the Company's Executive Compensation (the "Say on Pay" vote) | Management | For | For | ||||||||||
| EARGO, INC. | ||||||||||||||
| Security | 270087109 | Meeting Type | Annual | |||||||||||
| Ticker Symbol | EAR | Meeting Date | 12-Oct-2022 | |||||||||||
| ISIN | US2700871096 | Agenda | 935711754 - Management | |||||||||||
| Item | Proposal | Proposed by |
Vote | For/Against Management |
||||||||||
| 1a. | Election of Class II Director to hold office until the 2025 annual meeting of stockholder: A. Brooke Seawell | Management | For | For | ||||||||||
| 2. | To ratify the appointment of Deloitte & Touche LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2022. | Management | For | For | ||||||||||
| 3. | To approve, on a non-binding, advisory basis, the frequency of future advisory votes on the compensation of the Company's named executive officers. | Management | 1 Year | For | ||||||||||
| 4. | To adopt an amendment to the Company's Amended and Restated Certificate of Incorporation to effect a reverse stock split of the Company's common stock, at a ratio in the range of 1-for-5 to 1-for-50, such ratio to be determined by the Board of Directors and included in a public announcement. | Management | For | For | ||||||||||
| 5. | To adopt an amendment to the Company's Amended and Restated Certificate of Incorporation to increase the number of authorized shares of common stock of the Company from 300,000,000 to 450,000,000. | Management | For | For | ||||||||||
| 6. | To approve, for purposes of complying with Nasdaq Listing Rule 5635, the issuance of shares of the Company's common stock issuable upon conversion of the Company's 2022 senior secured convertible notes. | Management | For | For | ||||||||||
| SEMLER SCIENTIFIC, INC. | ||||||||||||||
| Security | 81684M104 | Meeting Type | Annual | |||||||||||
| Ticker Symbol | SMLR | Meeting Date | 20-Oct-2022 | |||||||||||
| ISIN | US81684M1045 | Agenda | 935710928 - Management | |||||||||||
| Item | Proposal | Proposed by |
Vote | For/Against Management |
||||||||||
| 1.1 | Election of Class l Director: Wayne T. Pan, M.D., Ph.D. | Management | For | For | ||||||||||
| 2. | Approve, on an advisory basis, the compensation of the Company's named executive officers as disclosed in the proxy statement. | Management | For | For | ||||||||||
| 3. | To ratify the selection by the Audit Committee of the board of directors of BDO USA, LLP as the independent registered public accounting firm of the Company for its year ending December 31, 2022. | Management | For | For | ||||||||||
| CONFORMIS, INC. | ||||||||||||||
| Security | 20717E101 | Meeting Type | Special | |||||||||||
| Ticker Symbol | CFMS | Meeting Date | 26-Oct-2022 | |||||||||||
| ISIN | US20717E1010 | Agenda | 935710663 - Management | |||||||||||
| Item | Proposal | Proposed by |
Vote | For/Against Management |
||||||||||
| 1. | Updated Reverse Stock Split Proposal: To approve and adopt an amendment to the Company's restated certificate of incorporation to effect a reverse stock split of our common stock and adjust the number of shares authorized by the restated certificate of incorporation. | Management | For | For | ||||||||||
| 2. | Adjournment Proposal: To approve one or more adjournments of the Special Meeting, if necessary or appropriate, to solicit additional proxies in favor of the Updated Reverse Stock Split Proposal if there are not sufficient votes at the Special Meeting to approve and adopt the Updated Reverse Stock Split Proposal. | Management | For | For | ||||||||||
| CATALENT, INC. | ||||||||||||||
| Security | 148806102 | Meeting Type | Annual | |||||||||||
| Ticker Symbol | CTLT | Meeting Date | 27-Oct-2022 | |||||||||||
| ISIN | US1488061029 | Agenda | 935709975 - Management | |||||||||||
| Item | Proposal | Proposed by |
Vote | For/Against Management |
||||||||||
| 1a. | Election of Director: Madhavan Balachandran | Management | For | For | ||||||||||
| 1b. | Election of Director: Michael J. Barber | Management | For | For | ||||||||||
| 1c. | Election of Director: J. Martin Carroll | Management | For | For | ||||||||||
| 1d. | Election of Director: John Chiminski | Management | For | For | ||||||||||
| 1e. | Election of Director: Rolf Classon | Management | For | For | ||||||||||
| 1f. | Election of Director: Rosemary A. Crane | Management | For | For | ||||||||||
| 1g. | Election of Director: Karen Flynn | Management | For | For | ||||||||||
| 1h. | Election of Director: John J. Greisch | Management | For | For | ||||||||||
| 1i. | Election of Director: Christa Kreuzburg | Management | For | For | ||||||||||
| 1j. | Election of Director: Gregory T. Lucier | Management | For | For | ||||||||||
| 1k. | Election of Director: Donald E. Morel, Jr. | Management | For | For | ||||||||||
| 1l. | Election of Director: Alessandro Maselli | Management | For | For | ||||||||||
| 1m. | Election of Director: Jack Stahl | Management | For | For | ||||||||||
| 1n. | Election of Director: Peter Zippelius | Management | For | For | ||||||||||
| 2. | Ratification of Appointment of Ernst & Young LLP as Independent Auditor for Fiscal 2023 | Management | For | For | ||||||||||
| 3. | Advisory Vote to Approve Our Executive Compensation (Say-on-Pay) | Management | For | For | ||||||||||
| CARDIOVASCULAR SYSTEMS, INC. | ||||||||||||||
| Security | 141619106 | Meeting Type | Annual | |||||||||||
| Ticker Symbol | CSII | Meeting Date | 08-Nov-2022 | |||||||||||
| ISIN | US1416191062 | Agenda | 935713708 - Management | |||||||||||
| Item | Proposal | Proposed by |
Vote | For/Against Management |
||||||||||
| 1a. | Election of Class II Director to hold office until the 2025 Annual Meeting: Scott R. Ward | Management | For | For | ||||||||||
| 1b. | Election of Class II Director to hold office until the 2025 Annual Meeting: Kelvin Womack | Management | For | For | ||||||||||
| 2. | To ratify the appointment of PricewaterhouseCoopers LLP as the independent registered public accounting firm of the Company for its fiscal year ending June 30, 2023. | Management | For | For | ||||||||||
| 3. | To approve, on an advisory basis, the compensation paid to our named executive officers as disclosed in the proxy statement. | Management | For | For | ||||||||||
| ELECTROMED, INC. | ||||||||||||||
| Security | 285409108 | Meeting Type | Annual | |||||||||||
| Ticker Symbol | ELMD | Meeting Date | 11-Nov-2022 | |||||||||||
| ISIN | US2854091087 | Agenda | 935713152 - Management | |||||||||||
| Item | Proposal | Proposed by |
Vote | For/Against Management |
||||||||||
| 1. | DIRECTOR | Management | ||||||||||||
| 1 | Stan K. Erickson | For | For | |||||||||||
| 2 | Gregory J. Fluet | For | For | |||||||||||
| 3 | Joseph L. Galatowitsch | For | For | |||||||||||
| 4 | Lee A. Jones | For | For | |||||||||||
| 5 | Kathleen S. Skarvan | For | For | |||||||||||
| 6 | Andrew J. Summers | For | For | |||||||||||
| 7 | Kathleen A. Tune | For | For | |||||||||||
| 8 | Andrea M. Walsh | For | For | |||||||||||
| 2. | To ratify appointment of RSM US LLP as our independent registered public accounting firm. | Management | For | For | ||||||||||
| 3. | To approve, on a non-binding and advisory basis, our executive compensation. | Management | For | For | ||||||||||
| BARK, INC. | ||||||||||||||
| Security | 68622E104 | Meeting Type | Annual | |||||||||||
| Ticker Symbol | BARK | Meeting Date | 15-Nov-2022 | |||||||||||
| ISIN | US68622E1047 | Agenda | 935717516 - Management | |||||||||||
| Item | Proposal | Proposed by |
Vote | For/Against Management |
||||||||||
| 1a. | Election of Class A Director: Betsy McLaughlin | Management | For | For | ||||||||||
| 1b. | Election of Class A Director: Henrik Werdelin | Management | For | For | ||||||||||
| 2. | Ratify the appointment of Deloitte & Touche LLP as the company's independent registered public accounting firm for the fiscal year ending March 31, 2023 | Management | For | For | ||||||||||
| 3. | Approve, on an advisory basis, the frequency with which future advisory votes to approve the compensation of the company's named executive officers should be held | Management | 1 Year | For | ||||||||||
| THE HAIN CELESTIAL GROUP, INC. | ||||||||||||||
| Security | 405217100 | Meeting Type | Annual | |||||||||||
| Ticker Symbol | HAIN | Meeting Date | 17-Nov-2022 | |||||||||||
| ISIN | US4052171000 | Agenda | 935716261 - Management | |||||||||||
| Item | Proposal | Proposed by |
Vote | For/Against Management |
||||||||||
| 1a. | Election of Director: Richard A. Beck | Management | For | For | ||||||||||
| 1b. | Election of Director: Celeste A. Clark | Management | For | For | ||||||||||
| 1c. | Election of Director: Dean Hollis | Management | For | For | ||||||||||
| 1d. | Election of Director: Shervin J. Korangy | Management | For | For | ||||||||||
| 1e. | Election of Director: Mark L. Schiller | Management | For | For | ||||||||||
| 1f. | Election of Director: Michael B. Sims | Management | For | For | ||||||||||
| 1g. | Election of Director: Carlyn R. Taylor | Management | For | For | ||||||||||
| 1h. | Election of Director: Dawn M. Zier | Management | For | For | ||||||||||
| 2. | Proposal to approve, on an advisory basis, named executive officer compensation. | Management | For | For | ||||||||||
| 3. | Proposal to ratify the appointment of Ernst & Young LLP to act as registered independent accountants of the Company for the fiscal year ending June 30, 2023. | Management | For | For | ||||||||||
| 4. | Proposal to approve the 2022 Long Term Incentive and Stock Award Plan. | Management | Against | Against | ||||||||||
| CHR. HANSEN HOLDING A/S | ||||||||||||||
| Security | K1830B107 | Meeting Type | Annual General Meeting | |||||||||||
| Ticker Symbol | CHYHY | Meeting Date | 23-Nov-2022 | |||||||||||
| ISIN | DK0060227585 | Agenda | 716293129 - Management | |||||||||||
| Item | Proposal | Proposed by |
Vote | For/Against Management |
||||||||||
| CMMT | VOTING INSTRUCTIONS FOR MOST MEETINGS ARE CAST BY THE REGISTRAR IN ACCORDANCE-WITH YOUR VOTING INSTRUCTIONS. FOR THE SMALL NUMBER OF MEETINGS WHERE THERE-IS NO REGISTRAR, YOUR VOTING INSTRUCTIONS WILL BE CAST BY THE CHAIRMAN OF THE-BOARD (OR A BOARD MEMBER) AS PROXY. THE CHAIRMAN (OR A BOARD MEMBER) MAY-CHOOSE TO ONLY CAST PRO-MANAGEMENT VOTING INSTRUCTIONS. TO GUARANTEE YOUR-VOTING INSTRUCTIONS AGAINST MANAGEMENT ARE CAST, YOU MAY SUBMIT A REQUEST TO-ATTEND THE MEETING IN PERSON. THE SUB CUSTODIAN BANKS OFFER REPRESENTATION-SERVICES FOR AN ADDED FEE, IF REQUESTED | Non-Voting | ||||||||||||
| CMMT | SPLIT AND PARTIAL VOTING IS NOT AUTHORIZED FOR A BENEFICIAL OWNER IN THE-DANISH MARKET | Non-Voting | ||||||||||||
| CMMT | VOTING MUST BE LODGED WITH SHAREHOLDER DETAILS AS PROVIDED BY YOUR CUSTODIAN- BANK. IF NO SHAREHOLDER DETAILS ARE PROVIDED, YOUR INSTRUCTIONS MAY BE- REJECTED | Non-Voting | ||||||||||||
| CMMT | PLEASE NOTE THAT SHAREHOLDERS ARE ALLOWED TO VOTE 'IN FAVOR' OR 'ABSTAIN'-ONLY FOR RESOLUTION NUMBERS 7.A.A, 7.B.A TO 7.B.E AND 8.A. THANK YOU | Non-Voting | ||||||||||||
| 1 | REPORT ON THE COMPANY'S ACTIVITIES | Non-Voting | ||||||||||||
| 2 | APPROVAL OF THE 2021/22 ANNUAL REPORT | Management | No Action | |||||||||||
| 3 | RESOLUTION ON THE APPROPRIATION OF PROFIT | Management | No Action | |||||||||||
| 4 | PRESENTATION OF THE COMPANY'S 2021/22 REMUNERATION REPORT FOR AN ADVISORY VOTE | Management | No Action | |||||||||||
| 5 | RESOLUTION ON REMUNERATION OF MEMBERS OF THE BOARD OF DIRECTORS | Management | No Action | |||||||||||
| 6.A | PROPOSALS FROM THE BOARD OF DIRECTORS: AUTHORIZATION TO THE BOARD OF DIRECTORS TO INCREASE THE COMPANY'S SHARE CAPITAL WITH OR WITHOUT PRE-EMPTIVE SUBSCRIPTION RIGHTS FOR THE EXISTING SHAREHOLDERS | Management | No Action | |||||||||||
| 6.B | PROPOSALS FROM THE BOARD OF DIRECTORS: AUTHORIZATION TO THE BOARD OF DIRECTORS FOR THE COMPANY TO ACQUIRE OWN SHARES | Management | No Action | |||||||||||
| 6.C | PROPOSALS FROM THE BOARD OF DIRECTORS: PROPOSED AMENDMENTS TO THE COMPANY'S ARTICLES OF ASSOCIATION (USE OF BOTH MALE AND FEMALE PRONOUNS) | Management | No Action | |||||||||||
| 7.A.A | ELECTION OF A CHAIR OF THE BOARD OF DIRECTORS: DOMINIQUE REINICHE (RE-ELECTION) | Management | No Action | |||||||||||
| 7.B.A | ELECTION OF OTHER MEMBER TO THE BOARD OF DIRECTORS: JESPER BRANDGAARD (RE-ELECTION) | Management | No Action | |||||||||||
| 7.B.B | ELECTION OF OTHER MEMBER TO THE BOARD OF DIRECTORS: LUIS CANTARELL (RE-ELECTION) | Management | No Action | |||||||||||
| 7.B.C | ELECTION OF OTHER MEMBER TO THE BOARD OF DIRECTORS: LISE KAAE (RE-ELECTION) | Management | No Action | |||||||||||
| 7.B.D | ELECTION OF OTHER MEMBER TO THE BOARD OF DIRECTORS: HEIDI KLEINBACH-SAUTER (RE- ELECTION) | Management | No Action | |||||||||||
| 7.B.E | ELECTION OF OTHER MEMBER TO THE BOARD OF DIRECTORS: KEVIN LANE (RE-ELECTION) | Management | No Action | |||||||||||
| 8.A | ELECTION OF A COMPANY AUDITOR: RE-ELECTION OF PWC STATSAUTORISERET REVISIONSPARTNERSELSKAB | Management | No Action | |||||||||||
| 9 | AUTHORISATION OF THE CHAIR OF THE ANNUAL GENERAL MEETING | Management | No Action | |||||||||||
| CMMT | INTERMEDIARY CLIENTS ONLY - PLEASE NOTE THAT IF YOU ARE CLASSIFIED AS AN- INTERMEDIARY CLIENT UNDER THE SHAREHOLDER RIGHTS DIRECTIVE II, YOU SHOULD BE-PROVIDING THE UNDERLYING SHAREHOLDER INFORMATION AT THE VOTE INSTRUCTION-LEVEL. IF YOU ARE UNSURE ON HOW TO PROVIDE THIS LEVEL OF DATA TO BROADRIDGE-OUTSIDE OF PROXYEDGE, PLEASE SPEAK TO YOUR DEDICATED CLIENT SERVICE-REPRESENTATIVE FOR ASSISTANCE | Non-Voting | ||||||||||||
| CMMT | PLEASE NOTE THAT IF YOU HOLD CREST DEPOSITORY INTERESTS (CDIS) AND-PARTICIPATE AT THIS MEETING, YOU (OR YOUR CREST SPONSORED MEMBER/CUSTODIAN)-WILL BE REQUIRED TO INSTRUCT A TRANSFER OF THE RELEVANT CDIS TO THE ESCROW-ACCOUNT SPECIFIED IN THE ASSOCIATED CORPORATE EVENT IN THE CREST SYSTEM. THIS-TRANSFER WILL NEED TO BE COMPLETED BY THE SPECIFIED CREST SYSTEM DEADLINE.-ONCE THIS TRANSFER HAS SETTLED, THE CDIS WILL BE BLOCKED IN THE CREST SYSTEM.-THE CDIS WILL TYPICALLY BE RELEASED FROM ESCROW AS SOON AS PRACTICABLE ON-RECORD DATE +1 DAY (OR ON MEETING DATE +1 DAY IF NO RECORD DATE APPLIES)-UNLESS OTHERWISE SPECIFIED, AND ONLY AFTER THE AGENT HAS CONFIRMED- AVAILABILITY OF THE POSITION. IN ORDER FOR A VOTE TO BE ACCEPTED, THE VOTED-POSITION MUST BE BLOCKED IN THE REQUIRED ESCROW ACCOUNT IN THE CREST SYSTEM.-BY VOTING ON | Non-Voting | ||||||||||||
| THIS MEETING, YOUR CREST SPONSORED MEMBER/CUSTODIAN MAY USE YOUR-VOTE INSTRUCTION AS THE AUTHORIZATION TO TAKE THE NECESSARY ACTION WHICH WILL-INCLUDE TRANSFERRING YOUR INSTRUCTED POSITION TO ESCROW. PLEASE CONTACT YOUR-CREST SPONSORED MEMBER/CUSTODIAN DIRECTLY FOR FURTHER INFORMATION ON THE-CUSTODY PROCESS AND WHETHER OR NOT THEY REQUIRE SEPARATE INSTRUCTIONS FROM-YOU | ||||||||||||||
| CMMT | PLEASE NOTE SHARE BLOCKING WILL APPLY FOR ANY VOTED POSITIONS SETTLING-THROUGH EUROCLEAR BANK. | Non-Voting | ||||||||||||
| CMMT | 02 NOV 2022: PLEASE NOTE THAT THIS IS A REVISION DUE TO MODIFICATION OF THE-TEXT OF RESOLUTION 6.C. IF YOU HAVE ALREADY SENT IN YOUR VOTES, PLEASE DO NOT-VOTE AGAIN UNLESS YOU DECIDE TO AMEND YOUR ORIGINAL INSTRUCTIONS. THANK YOU | Non-Voting | ||||||||||||
| CAMPBELL SOUP COMPANY | ||||||||||||||
| Security | 134429109 | Meeting Type | Annual | |||||||||||
| Ticker Symbol | CPB | Meeting Date | 30-Nov-2022 | |||||||||||
| ISIN | US1344291091 | Agenda | 935719130 - Management | |||||||||||
| Item | Proposal | Proposed by |
Vote | For/Against Management |
||||||||||
| 1a. | Election of Director for a one-year term expiring at the 2023 Annual Meeting: Fabiola R. Arredondo | Management | For | For | ||||||||||
| 1b. | Election of Director for a one-year term expiring at the 2023 Annual Meeting: Howard M. Averill | Management | For | For | ||||||||||
| 1c. | Election of Director for a one-year term expiring at the 2023 Annual Meeting: John P. (JP) Bilbrey | Management | For | For | ||||||||||
| 1d. | Election of Director for a one-year term expiring at the 2023 Annual Meeting: Mark A. Clouse | Management | For | For | ||||||||||
| 1e. | Election of Director for a one-year term expiring at the 2023 Annual Meeting: Bennett Dorrance, Jr. | Management | For | For | ||||||||||
| 1f. | Election of Director for a one-year term expiring at the 2023 Annual Meeting: Maria Teresa (Tessa) Hilado | Management | For | For | ||||||||||
| 1g. | Election of Director for a one-year term expiring at the 2023 Annual Meeting: Grant H. Hill | Management | For | For | ||||||||||
| 1h. | Election of Director for a one-year term expiring at the 2023 Annual Meeting: Sarah Hofstetter | Management | For | For | ||||||||||
| 1i. | Election of Director for a one-year term expiring at the 2023 Annual Meeting: Marc B. Lautenbach | Management | For | For | ||||||||||
| 1j. | Election of Director for a one-year term expiring at the 2023 Annual Meeting: Mary Alice D. Malone | Management | For | For | ||||||||||
| 1k. | Election of Director for a one-year term expiring at the 2023 Annual Meeting: Keith R. McLoughlin | Management | For | For | ||||||||||
| 1l. | Election of Director for a one-year term expiring at the 2023 Annual Meeting: Kurt T. Schmidt | Management | For | For | ||||||||||
| 1m. | Election of Director for a one-year term expiring at the 2023 Annual Meeting: Archbold D. van Beuren | Management | For | For | ||||||||||
| 2. | To ratify the appointment of PricewaterhouseCoopers LLP as our independent registered public accounting firm for fiscal 2023. | Management | For | For | ||||||||||
| 3. | To vote on an advisory resolution to approve the fiscal 2022 compensation of our named executive officers, commonly referred to as a "say on pay" vote. | Management | For | For | ||||||||||
| 4. | To approve the Campbell Soup Company 2022 Long- Term Incentive Plan. | Management | For | For | ||||||||||
| 5. | To vote on a shareholder proposal regarding a report on certain supply chain practices. | Shareholder | Abstain | Against | ||||||||||
| 6. | To vote on a shareholder proposal regarding a report on how the company's 401(k) retirement fund investments contribute to climate change. | Shareholder | Against | For | ||||||||||
| ELECTROCORE, INC | ||||||||||||||
| Security | 28531P103 | Meeting Type | Annual | |||||||||||
| Ticker Symbol | ECOR | Meeting Date | 02-Dec-2022 | |||||||||||
| ISIN | US28531P1030 | Agenda | 935722884 - Management | |||||||||||
| Item | Proposal | Proposed by |
Vote | For/Against Management |
||||||||||
| 1a. | Election of Director until the 2025 Annual Meeting: Daniel S. Goldberger | Management | For | For | ||||||||||
| 1b. | Election of Director until the 2025 Annual Meeting: Julie A. Goldstein | Management | For | For | ||||||||||
| 1c. | Election of Director until the 2025 Annual Meeting: Patricia Wilber | Management | For | For | ||||||||||
| 2. | Ratification of appointment of Marcum LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2022. | Management | For | For | ||||||||||
| 3. | Approval of an amendment to the Company's Certificate of Incorporation to effect a reverse stock split of the outstanding shares of common stock of the Company by a ratio within a range of one-for-5 to one-for-50 (or any whole number in between), the implementation and timing of which shall be subject to the discretion of the Board of Directors. | Management | For | For | ||||||||||
| MEDTRONIC PLC | ||||||||||||||
| Security | G5960L103 | Meeting Type | Annual | |||||||||||
| Ticker Symbol | MDT | Meeting Date | 08-Dec-2022 | |||||||||||
| ISIN | IE00BTN1Y115 | Agenda | 935723610 - Management | |||||||||||
| Item | Proposal | Proposed by |
Vote | For/Against Management |
||||||||||
| 1a. | Election of Director to hold office until the 2023 Annual General Meeting: Richard H. Anderson | Management | For | For | ||||||||||
| 1b. | Election of Director to hold office until the 2023 Annual General Meeting: Craig Arnold | Management | For | For | ||||||||||
| 1c. | Election of Director to hold office until the 2023 Annual General Meeting: Scott C. Donnelly | Management | For | For | ||||||||||
| 1d. | Election of Director to hold office until the 2023 Annual General Meeting: Lidia L. Fonseca | Management | For | For | ||||||||||
| 1e. | Election of Director to hold office until the 2023 Annual General Meeting: Andrea J. Goldsmith, Ph.D. | Management | For | For | ||||||||||
| 1f. | Election of Director to hold office until the 2023 Annual General Meeting: Randall J. Hogan, III | Management | For | For | ||||||||||
| 1g. | Election of Director to hold office until the 2023 Annual General Meeting: Kevin E. Lofton | Management | For | For | ||||||||||
| 1h. | Election of Director to hold office until the 2023 Annual General Meeting: Geoffrey S. Martha | Management | For | For | ||||||||||
| 1i. | Election of Director to hold office until the 2023 Annual General Meeting: Elizabeth G. Nabel, M.D. | Management | For | For | ||||||||||
| 1j. | Election of Director to hold office until the 2023 Annual General Meeting: Denise M. O'Leary | Management | For | For | ||||||||||
| 1k. | Election of Director to hold office until the 2023 Annual General Meeting: Kendall J. Powell | Management | For | For | ||||||||||
| 2. | Ratifying, in a non-binding vote, the appointment of PricewaterhouseCoopers LLP as the Company's independent auditor for fiscal year 2023 and authorizing, in a binding vote, the Board of Directors, acting through the Audit Committee, to set the auditor's remuneration. | Management | For | For | ||||||||||
| 3. | Approving, on an advisory basis, the Company's executive compensation. | Management | For | For | ||||||||||
| 4. | Renewing the Board of Directors' authority to issue shares under Irish law. | Management | For | For | ||||||||||
| 5. | Renewing the Board of Directors' authority to opt out of pre-emption rights under Irish law. | Management | Against | Against | ||||||||||
| 6. | Authorizing the Company and any subsidiary of the Company to make overseas market purchases of Medtronic ordinary shares. | Management | For | For | ||||||||||
| VIATRIS INC. | ||||||||||||||
| Security | 92556V106 | Meeting Type | Annual | |||||||||||
| Ticker Symbol | VTRS | Meeting Date | 09-Dec-2022 | |||||||||||
| ISIN | US92556V1061 | Agenda | 935725880 - Management | |||||||||||
| Item | Proposal | Proposed by |
Vote | For/Against Management |
||||||||||
| 1A. | Election of Class II Director to hold office until the 2023 annual meeting: W. Don Cornwell | Management | For | For | ||||||||||
| 1B. | Election of Class II Director to hold office until the 2023 annual meeting: Harry A. Korman | Management | For | For | ||||||||||
| 1C. | Election of Class II Director to hold office until the 2023 annual meeting: Rajiv Malik | Management | For | For | ||||||||||
| 1D. | Election of Class II Director to hold office until the 2023 annual meeting: Richard A. Mark, C.P.A. | Management | For | For | ||||||||||
| 2. | Approval of, on a non-binding advisory basis, the 2021 compensation of the named executive officers of the Company. | Management | For | For | ||||||||||
| 3. | Ratification of the selection of Deloitte & Touche LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2022. | Management | For | For | ||||||||||
| 4. | Shareholder proposal regarding independent board chairman. | Shareholder | Against | For | ||||||||||
| ORTHOFIX MEDICAL INC. | ||||||||||||||
| Security | 68752M108 | Meeting Type | Special | |||||||||||
| Ticker Symbol | OFIX | Meeting Date | 04-Jan-2023 | |||||||||||
| ISIN | US68752M1080 | Agenda | 935744397 - Management | |||||||||||
| Item | Proposal | Proposed by |
Vote | For/Against Management |
||||||||||
| 1. | To approve the issuance of Orthofix common stock, par value $0.10 per share, to SeaSpine stockholders in connection with the merger contemplated by the Agreement and Plan of Merger, dated as of October 10, 2022, by and among Orthofix Medical Inc., Orca Merger Sub Inc. and SeaSpine Holdings Corporation (the "Orthofix share issuance proposal"). | Management | For | For | ||||||||||
| 2. | To approve the adjournment of the Orthofix special meeting to a later date or dates, if necessary or appropriate, to solicit additional proxies in the event there are not sufficient votes at the time of the Orthofix special meeting to approve the Orthofix share issuance proposal. | Management | For | For | ||||||||||
| UNITED NATURAL FOODS, INC. | ||||||||||||||
| Security | 911163103 | Meeting Type | Annual | |||||||||||
| Ticker Symbol | UNFI | Meeting Date | 10-Jan-2023 | |||||||||||
| ISIN | US9111631035 | Agenda | 935739574 - Management | |||||||||||
| Item | Proposal | Proposed by |
Vote | For/Against Management |
||||||||||
| 1a. | Election of Director: Eric F. Artz | Management | For | For | ||||||||||
| 1b. | Election of Director: Ann Torre Bates | Management | For | For | ||||||||||
| 1c. | Election of Director: Gloria R. Boyland | Management | For | For | ||||||||||
| 1d. | Election of Director: Denise M. Clark | Management | For | For | ||||||||||
| 1e. | Election of Director: J. Alexander Douglas | Management | For | For | ||||||||||
| 1f. | Election of Director: Daphne J. Dufresne | Management | For | For | ||||||||||
| 1g. | Election of Director: Michael S. Funk | Management | For | For | ||||||||||
| 1h. | Election of Director: Shamim Mohammad | Management | For | For | ||||||||||
| 1i. | Election of Director: James L. Muehlbauer | Management | For | For | ||||||||||
| 1j. | Election of Director: Peter A. Roy | Management | For | For | ||||||||||
| 1k. | Election of Director: Jack Stahl | Management | For | For | ||||||||||
| 2. | The ratification of the selection of KPMG LLP as our independent registered public accounting firm for the fiscal year ending July 29, 2023. | Management | For | For | ||||||||||
| 3. | To approve, on an advisory basis, our executive compensation. | Management | For | For | ||||||||||
| 4. | The approval of the Second Amended and Restated 2020 Equity Incentive Plan. | Management | Against | Against | ||||||||||
| BECTON, DICKINSON AND COMPANY | ||||||||||||||
| Security | 075887109 | Meeting Type | Annual | |||||||||||
| Ticker Symbol | BDX | Meeting Date | 24-Jan-2023 | |||||||||||
| ISIN | US0758871091 | Agenda | 935749789 - Management | |||||||||||
| Item | Proposal | Proposed by |
Vote | For/Against Management |
||||||||||
| 1A. | Election of Director: William M. Brown | Management | For | For | ||||||||||
| 1B. | Election of Director: Catherine M. Burzik | Management | For | For | ||||||||||
| 1C. | Election of Director: Carrie L. Byington | Management | For | For | ||||||||||
| 1D. | Election of Director: R Andrew Eckert | Management | For | For | ||||||||||
| 1E. | Election of Director: Claire M. Fraser | Management | For | For | ||||||||||
| 1F. | Election of Director: Jeffrey W. Henderson | Management | For | For | ||||||||||
| 1G. | Election of Director: Christopher Jones | Management | For | For | ||||||||||
| 1H. | Election of Director: Marshall O. Larsen | Management | For | For | ||||||||||
| 1I. | Election of Director: Thomas E. Polen | Management | For | For | ||||||||||
| 1J. | Election of Director: Timothy M. Ring | Management | For | For | ||||||||||
| 1K. | Election of Director: Bertram L. Scott | Management | For | For | ||||||||||
| 2. | Ratification of the selection of the independent registered public accounting firm. | Management | For | For | ||||||||||
| 3. | Advisory vote to approve named executive officer compensation. | Management | For | For | ||||||||||
| 4. | Advisory vote to approve the frequency of named executive officer compensation advisory votes. | Management | 1 Year | For | ||||||||||
| 5. | Approval of amendments to the 2004 Employee and Director Equity-Based Compensation Plan. | Management | For | For | ||||||||||
| 6. | A shareholder proposal to require prior shareholder approval of certain termination payments, if properly presented at the meeting. | Shareholder | Against | For | ||||||||||
| POST HOLDINGS, INC. | ||||||||||||||
| Security | 737446104 | Meeting Type | Annual | |||||||||||
| Ticker Symbol | POST | Meeting Date | 26-Jan-2023 | |||||||||||
| ISIN | US7374461041 | Agenda | 935742711 - Management | |||||||||||
| Item | Proposal | Proposed by |
Vote | For/Against Management |
||||||||||
| 1.1 | Election of Director: Dorothy M. Burwell | Management | For | For | ||||||||||
| 1.2 | Election of Director: Robert E. Grote | Management | For | For | ||||||||||
| 1.3 | Election of Director: David W. Kemper | Management | For | For | ||||||||||
| 1.4 | Election of Director: Robert V. Vitale | Management | For | For | ||||||||||
| 2. | Ratification of PricewaterhouseCoopers LLP as the Company's Independent Registered Public Accounting Firm for the fiscal year ending September 30, 2023. | Management | For | For | ||||||||||
| 3. | Advisory approval of the Company's executive compensation. | Management | For | For | ||||||||||
| WALGREENS BOOTS ALLIANCE, INC. | ||||||||||||||
| Security | 931427108 | Meeting Type | Annual | |||||||||||
| Ticker Symbol | WBA | Meeting Date | 26-Jan-2023 | |||||||||||
| ISIN | US9314271084 | Agenda | 935747280 - Management | |||||||||||
| Item | Proposal | Proposed by |
Vote | For/Against Management |
||||||||||
| 1a. | Election of Director: Janice M. Babiak | Management | For | For | ||||||||||
| 1b. | Election of Director: Inderpal S. Bhandari | Management | For | For | ||||||||||
| 1c. | Election of Director: Rosalind G. Brewer | Management | For | For | ||||||||||
| 1d. | Election of Director: Ginger L. Graham | Management | For | For | ||||||||||
| 1e. | Election of Director: Bryan C. Hanson | Management | For | For | ||||||||||
| 1f. | Election of Director: Valerie B. Jarrett | Management | For | For | ||||||||||
| 1g. | Election of Director: John A. Lederer | Management | For | For | ||||||||||
| 1h. | Election of Director: Dominic P. Murphy | Management | For | For | ||||||||||
| 1i. | Election of Director: Stefano Pessina | Management | For | For | ||||||||||
| 1j. | Election of Director: Nancy M. Schlichting | Management | For | For | ||||||||||
| 2. | Advisory vote to approve named executive officer compensation. | Management | For | For | ||||||||||
| 3. | Ratification of the appointment of Deloitte & Touche LLP as the independent registered public accounting firm for fiscal year 2023. | Management | For | For | ||||||||||
| 4. | Stockholder proposal requesting report on public health costs due to tobacco product sales and the impact on overall market returns. | Shareholder | Abstain | Against | ||||||||||
| 5. | Stockholder proposal requesting an independent board chairman. | Shareholder | Against | For | ||||||||||
| EDGEWELL PERSONAL CARE COMPANY | ||||||||||||||
| Security | 28035Q102 | Meeting Type | Annual | |||||||||||
| Ticker Symbol | EPC | Meeting Date | 03-Feb-2023 | |||||||||||
| ISIN | US28035Q1022 | Agenda | 935748989 - Management | |||||||||||
| Item | Proposal | Proposed by |
Vote | For/Against Management |
||||||||||
| 1a. | Election of Director: Robert W. Black | Management | For | For | ||||||||||
| 1b. | Election of Director: George R. Corbin | Management | For | For | ||||||||||
| 1c. | Election of Director: Carla C. Hendra | Management | For | For | ||||||||||
| 1d. | Election of Director: John C. Hunter, III | Management | For | For | ||||||||||
| 1e. | Election of Director: James C. Johnson | Management | For | For | ||||||||||
| 1f. | Election of Director: Rod R. Little | Management | For | For | ||||||||||
| 1g. | Election of Director: Joseph D. O'Leary | Management | For | For | ||||||||||
| 1h. | Election of Director: Rakesh Sachdev | Management | For | For | ||||||||||
| 1i. | Election of Director: Swan Sit | Management | For | For | ||||||||||
| 1j. | Election of Director: Gary K. Waring | Management | For | For | ||||||||||
| 2. | To ratify the appointment of PricewaterhouseCoopers LLP as the independent registered public accounting firm for fiscal 2023. | Management | For | For | ||||||||||
| 3. | To cast a non-binding advisory vote on executive compensation. | Management | For | For | ||||||||||
| 4. | Approval of the Company's 2nd Amended and Restated 2018 Stock Incentive Plan. | Management | Abstain | Against | ||||||||||
| BELLRING BRANDS, INC. | ||||||||||||||
| Security | 07831C103 | Meeting Type | Annual | |||||||||||
| Ticker Symbol | BRBR | Meeting Date | 06-Feb-2023 | |||||||||||
| ISIN | US07831C1036 | Agenda | 935751924 - Management | |||||||||||
| Item | Proposal | Proposed by |
Vote | For/Against Management |
||||||||||
| 1.1 | Election of Director: Darcy H. Davenport | Management | For | For | ||||||||||
| 1.2 | Election of Director: Elliot H. Stein, Jr. | Management | For | For | ||||||||||
| 2. | The ratification of the appointment of PricewaterhouseCoopers LLP as our independent registered public accounting firm for the fiscal year ending September 30, 2023. | Management | For | For | ||||||||||
| 3. | To consider and vote upon a proposal to increase the number of authorized shares under the Company's 2019 Long-Term Incentive Plan by 6,000,000 shares from 2,000,000 shares to 8,000,000 shares. | Management | For | For | ||||||||||
| 4. | To consider and vote, on an advisory basis, for the adoption of a resolution approving the compensation of our named executive officers, as such compensation is described under the "Compensation Discussion and Analysis" and "Executive Compensation" sections of this proxy statement. | Management | For | For | ||||||||||
| SURMODICS, INC. | ||||||||||||||
| Security | 868873100 | Meeting Type | Annual | |||||||||||
| Ticker Symbol | SRDX | Meeting Date | 09-Feb-2023 | |||||||||||
| ISIN | US8688731004 | Agenda | 935751227 - Management | |||||||||||
| Item | Proposal | Proposed by |
Vote | For/Against Management |
||||||||||
| 1. | DIRECTOR | Management | ||||||||||||
| 1 | Susan E. Knight | For | For | |||||||||||
| 2 | José H. Bedoya | For | For | |||||||||||
| 2. | Set the number of directors at six (6). | Management | For | For | ||||||||||
| 3. | Ratify the appointment of Deloitte & Touche LLP as Surmodics' independent registered public accounting firm for fiscal year 2023. | Management | For | For | ||||||||||
| 4. | Approve, in a non-binding advisory vote, the Company's executive compensation. | Management | For | For | ||||||||||
| 5. | Approve, in a non-binding advisory vote, the frequency of the non-binding shareholder advisory vote on executive compensation. | Management | 1 Year | For | ||||||||||
| 6. | Approve an amendment to the Surmodics, Inc. 2019 Equity Incentive Plan. | Management | Against | Against | ||||||||||
| EMBECTA CORP | ||||||||||||||
| Security | 29082K105 | Meeting Type | Annual | |||||||||||
| Ticker Symbol | EMBC | Meeting Date | 09-Feb-2023 | |||||||||||
| ISIN | US29082K1051 | Agenda | 935752673 - Management | |||||||||||
| Item | Proposal | Proposed by |
Vote | For/Against Management |
||||||||||
| 1a. | Election of Director: Mr. David J. Albritton | Management | For | For | ||||||||||
| 1b. | Election of Director: Ms. Carrie L. Anderson | Management | For | For | ||||||||||
| 1c. | Election of Director: Mr. Christopher R. Reidy | Management | For | For | ||||||||||
| 2. | Ratification of selection of independent registered public accounting firm. | Management | For | For | ||||||||||
| 3. | Advisory vote to approve named executive officer compensation. | Management | For | For | ||||||||||
| 4. | Advisory vote on the frequency of future advisory votes to approve named executive officer compensation. | Management | 1 Year | For | ||||||||||
| INGLES MARKETS, INCORPORATED | ||||||||||||||
| Security | 457030104 | Meeting Type | Annual | |||||||||||
| Ticker Symbol | IMKTA | Meeting Date | 14-Feb-2023 | |||||||||||
| ISIN | US4570301048 | Agenda | 935754449 - Management | |||||||||||
| Item | Proposal | Proposed by |
Vote | For/Against Management |
||||||||||
| 1. | DIRECTOR | Management | ||||||||||||
| 1 | Ernest E. Ferguson | For | For | |||||||||||
| 2 | John R. Lowden | For | For | |||||||||||
| 2. | To approve, by non-binding vote, executive compensation, as disclosed in the Proxy Statement. | Management | For | For | ||||||||||
| 3. | Stockholder proposal concerning equal voting rights for each share. | Shareholder | Against | For | ||||||||||
| HOLOGIC, INC. | ||||||||||||||
| Security | 436440101 | Meeting Type | Annual | |||||||||||
| Ticker Symbol | HOLX | Meeting Date | 09-Mar-2023 | |||||||||||
| ISIN | US4364401012 | Agenda | 935758132 - Management | |||||||||||
| Item | Proposal | Proposed by |
Vote | For/Against Management |
||||||||||
| 1a. | Election of Director: Stephen P. MacMillan | Management | For | For | ||||||||||
| 1b. | Election of Director: Sally W. Crawford | Management | For | For | ||||||||||
| 1c. | Election of Director: Charles J. Dockendorff | Management | For | For | ||||||||||
| 1d. | Election of Director: Scott T. Garrett | Management | For | For | ||||||||||
| 1e. | Election of Director: Ludwig N. Hantson | Management | For | For | ||||||||||
| 1f. | Election of Director: Namal Nawana | Management | For | For | ||||||||||
| 1g. | Election of Director: Christiana Stamoulis | Management | For | For | ||||||||||
| 1h. | Election of Director: Stacey D. Stewart | Management | For | For | ||||||||||
| 1i. | Election of Director: Amy M. Wendell | Management | For | For | ||||||||||
| 2. | A non-binding advisory resolution to approve executive compensation. | Management | For | For | ||||||||||
| 3. | A non-binding advisory vote on the frequency of future advisory votes to approve executive compensation. | Management | 1 Year | For | ||||||||||
| 4. | Approval of the Hologic, Inc. Amended and Restated 2008 Equity Incentive Plan. | Management | For | For | ||||||||||
| 5. | Approval of the Hologic, Inc. Amended and Restated 2012 Employee Stock Purchase Plan. | Management | For | For | ||||||||||
| 6. | Ratification of the appointment of Ernst & Young LLP as our independent registered public accounting firm for fiscal 2023. | Management | For | For | ||||||||||
| DLH HOLDINGS CORP. | ||||||||||||||
| Security | 23335Q100 | Meeting Type | Annual | |||||||||||
| Ticker Symbol | DLHC | Meeting Date | 09-Mar-2023 | |||||||||||
| ISIN | US23335Q1004 | Agenda | 935760187 - Management | |||||||||||
| Item | Proposal | Proposed by |
Vote | For/Against Management |
||||||||||
| 1. | DIRECTOR | Management | ||||||||||||
| 1 | Judith L. Bjornaas | For | For | |||||||||||
| 2 | Martin J. Delaney | For | For | |||||||||||
| 3 | Dr. Elder Granger | For | For | |||||||||||
| 4 | Dr. Frances M. Murphy | For | For | |||||||||||
| 5 | Zachary C. Parker | For | For | |||||||||||
| 6 | Frederick G. Wasserman | For | For | |||||||||||
| 7 | Austin J. Yerks III | For | For | |||||||||||
| 8 | Stephen J. Zelkowicz | For | For | |||||||||||
| 2. | An Advisory Vote regarding the approval of compensation paid to our named Executive Officers. | Management | For | For | ||||||||||
| 3. | Ratification of Independent Registered Public Accounting Firm. | Management | For | For | ||||||||||
| AMERISOURCEBERGEN CORPORATION | ||||||||||||||
| Security | 03073E105 | Meeting Type | Annual | |||||||||||
| Ticker Symbol | ABC | Meeting Date | 09-Mar-2023 | |||||||||||
| ISIN | US03073E1055 | Agenda | 935761242 - Management | |||||||||||
| Item | Proposal | Proposed by |
Vote | For/Against Management |
||||||||||
| 1a. | Election of Director: Ornella Barra | Management | For | For | ||||||||||
| 1b. | Election of Director: Steven H. Collis | Management | For | For | ||||||||||
| 1c. | Election of Director: D. Mark Durcan | Management | For | For | ||||||||||
| 1d. | Election of Director: Richard W. Gochnauer | Management | For | For | ||||||||||
| 1e. | Election of Director: Lon R. Greenberg | Management | For | For | ||||||||||
| 1f. | Election of Director: Kathleen W. Hyle | Management | For | For | ||||||||||
| 1g. | Election of Director: Lorence H. Kim, M.D. | Management | For | For | ||||||||||
| 1h. | Election of Director: Henry W. McGee | Management | For | For | ||||||||||
| 1i. | Election of Director: Redonda G. Miller, M.D. | Management | For | For | ||||||||||
| 1j. | Election of Director: Dennis M. Nally | Management | For | For | ||||||||||
| 2. | Ratification of Ernst & Young LLP as the Company's independent registered public accounting firm for fiscal year 2023. | Management | For | For | ||||||||||
| 3. | Advisory vote to approve the compensation of the Company's named executive officers. | Management | For | For | ||||||||||
| 4. | Advisory vote on the frequency of a shareholder vote on the compensation of the Company's named executive officers. | Management | 1 Year | For | ||||||||||
| 5. | Shareholder proposal regarding shareholder ratification of termination pay. | Shareholder | Against | For | ||||||||||
| AGILENT TECHNOLOGIES, INC. | ||||||||||||||
| Security | 00846U101 | Meeting Type | Annual | |||||||||||
| Ticker Symbol | A | Meeting Date | 15-Mar-2023 | |||||||||||
| ISIN | US00846U1016 | Agenda | 935762218 - Management | |||||||||||
| Item | Proposal | Proposed by |
Vote | For/Against Management |
||||||||||
| 1.1 | Election of Director for a three-year term: Heidi K. Kunz | Management | For | For | ||||||||||
| 1.2 | Election of Director for a three-year term: Susan H. Rataj | Management | For | For | ||||||||||
| 1.3 | Election of Director for a three-year term: George A. Scangos, Ph.D. | Management | For | For | ||||||||||
| 1.4 | Election of Director for a three-year term: Dow R. Wilson | Management | For | For | ||||||||||
| 2. | To approve, on a non-binding advisory basis, the compensation of our named executive officers. | Management | For | For | ||||||||||
| 3. | To ratify the Audit and Finance Committee's appointment of PricewaterhouseCoopers LLP as our independent registered public accounting firm. | Management | For | For | ||||||||||
| 4. | To approve amendments to the Certificate of Incorporation to create a new stockholder right to call a special meeting. | Management | For | For | ||||||||||
| 5. | An advisory vote on the frequency of the stockholder vote to approve the compensation of our named executive officers. | Management | 1 Year | For | ||||||||||
| THE COOPER COMPANIES, INC. | ||||||||||||||
| Security | 216648402 | Meeting Type | Annual | |||||||||||
| Ticker Symbol | COO | Meeting Date | 15-Mar-2023 | |||||||||||
| ISIN | US2166484020 | Agenda | 935764010 - Management | |||||||||||
| Item | Proposal | Proposed by |
Vote | For/Against Management |
||||||||||
| 1a. | Election of Director: Colleen E. Jay | Management | For | For | ||||||||||
| 1b. | Election of Director: William A. Kozy | Management | For | For | ||||||||||
| 1c. | Election of Director: Cynthia L. Lucchese | Management | For | For | ||||||||||
| 1d. | Election of Director: Teresa S. Madden | Management | For | For | ||||||||||
| 1e. | Election of Director: Gary S. Petersmeyer | Management | For | For | ||||||||||
| 1f. | Election of Director: Maria Rivas, M.D. | Management | For | For | ||||||||||
| 1g. | Election of Director: Robert S. Weiss | Management | For | For | ||||||||||
| 1h. | Election of Director: Albert G. White III | Management | For | For | ||||||||||
| 2. | Ratification of the appointment of KPMG LLP as the independent registered public accounting firm for The Cooper Companies, Inc. for the fiscal year ending October 31, 2023. | Management | For | For | ||||||||||
| 3. | Approval of the 2023 Long Term Incentive Plan for Employees. | Management | For | For | ||||||||||
| 4. | An advisory vote on the compensation of our named executive officers as presented in the Proxy Statement. | Management | For | For | ||||||||||
| 5. | Advisory vote on the frequency with which executive compensation will be subject to a stockholder advisory vote. | Management | 1 Year | For | ||||||||||
| PHENOMEX INC. | ||||||||||||||
| Security | 084310101 | Meeting Type | Special | |||||||||||
| Ticker Symbol | BLI | Meeting Date | 16-Mar-2023 | |||||||||||
| ISIN | US0843101017 | Agenda | 935768133 - Management | |||||||||||
| Item | Proposal | Proposed by |
Vote | For/Against Management |
||||||||||
| 1. | Approve the issuance of shares of common stock of Berkeley Lights, Inc. ("Berkeley Lights") to the stockholders of IsoPlexis Corporation ("IsoPlexis") in connection with the merger contemplated by the Agreement and Plan of Merger, dated as of December 21, 2022, by and among Berkeley Lights, Iceland Merger Sub Inc. and IsoPlexis (the "share issuance proposal"). | Management | For | For | ||||||||||
| 2. | Approve the adjournment of the special meeting, if necessary or appropriate, to solicit additional proxies if there are insufficient votes at the time of the Berkeley Lights special meeting to approve the share issuance proposal. | Management | For | For | ||||||||||
| SUNTORY BEVERAGE & FOOD LIMITED | ||||||||||||||
| Security | J78186103 | Meeting Type | Annual General Meeting | |||||||||||
| Ticker Symbol | Meeting Date | 24-Mar-2023 | ||||||||||||
| ISIN | JP3336560002 | Agenda | 716729908 - Management | |||||||||||
| Item | Proposal | Proposed by |
Vote | For/Against Management |
||||||||||
| Please reference meeting materials. | Non-Voting | |||||||||||||
| 1 | Approve Appropriation of Surplus | Management | For | For | ||||||||||
| 2.1 | Appoint a Director who is not Audit and Supervisory Committee Member Ono, Makiko | Management | For | For | ||||||||||
| 2.2 | Appoint a Director who is not Audit and Supervisory Committee Member Shekhar Mundlay | Management | For | For | ||||||||||
| 2.3 | Appoint a Director who is not Audit and Supervisory Committee Member Naiki, Hachiro | Management | For | For | ||||||||||
| 2.4 | Appoint a Director who is not Audit and Supervisory Committee Member Peter Harding | Management | For | For | ||||||||||
| 2.5 | Appoint a Director who is not Audit and Supervisory Committee Member Miyamori, Hiroshi | Management | Against | Against | ||||||||||
| 2.6 | Appoint a Director who is not Audit and Supervisory Committee Member Inoue, Yukari | Management | For | For | ||||||||||
| 3.1 | Appoint a Director who is Audit and Supervisory Committee Member Yamazaki, Yuji | Management | Against | Against | ||||||||||
| 3.2 | Appoint a Director who is Audit and Supervisory Committee Member Masuyama, Mika | Management | For | For | ||||||||||
| 3.3 | Appoint a Director who is Audit and Supervisory Committee Member Mimura, Mariko | Management | For | For | ||||||||||
| 4 | Appoint a Substitute Director who is Audit and Supervisory Committee Member Amitani, Mitsuhiro | Management | For | For | ||||||||||
| CHR. HANSEN HOLDING A/S | ||||||||||||||
| Security | K1830B107 | Meeting Type | ExtraOrdinary General Meeting | |||||||||||
| Ticker Symbol | CHYHY | Meeting Date | 30-Mar-2023 | |||||||||||
| ISIN | DK0060227585 | Agenda | 716757820 - Management | |||||||||||
| Item | Proposal | Proposed by |
Vote | For/Against Management |
||||||||||
| CMMT | VOTING INSTRUCTIONS FOR MOST MEETINGS ARE CAST BY THE REGISTRAR IN ACCORDANCE-WITH YOUR VOTING INSTRUCTIONS. FOR THE SMALL NUMBER OF MEETINGS WHERE THERE-IS NO REGISTRAR, YOUR VOTING INSTRUCTIONS WILL BE CAST BY THE CHAIRMAN OF THE-BOARD (OR A BOARD MEMBER) AS PROXY. THE CHAIRMAN (OR A BOARD MEMBER) MAY-CHOOSE TO ONLY CAST PRO-MANAGEMENT VOTING INSTRUCTIONS. TO GUARANTEE YOUR-VOTING INSTRUCTIONS AGAINST MANAGEMENT ARE CAST, YOU MAY SUBMIT A REQUEST TO-ATTEND THE MEETING IN PERSON. THE SUB CUSTODIAN BANKS OFFER REPRESENTATION-SERVICES FOR AN ADDED FEE, IF REQUESTED. | Non-Voting | ||||||||||||
| CMMT | SPLIT AND PARTIAL VOTING IS NOT AUTHORIZED FOR A BENEFICIAL OWNER IN THE-DANISH MARKET. | Non-Voting | ||||||||||||
| CMMT | VOTING MUST BE LODGED WITH SHAREHOLDER DETAILS AS PROVIDED BY YOUR CUSTODIAN- BANK. IF NO SHAREHOLDER DETAILS ARE PROVIDED, YOUR INSTRUCTIONS MAY BE- REJECTED. | Non-Voting | ||||||||||||
| 1 | RESOLUTION TO ADOPT THE IMPLEMENTATION OF A STATUTORY MERGER OF CHR. HANSEN AND NOVOZYMES A/S IN ACCORDANCE WITH THE MERGER PLAN OF DECEMBER 12, 2022 | Management | No Action | |||||||||||
| 2 | RESOLUTION TO APPROVE TRANSACTION SPECIFIC INDEMNIFICATION OF MANAGEMENT AND RELEVANT EMPLOYEES | Management | No Action | |||||||||||
| 3 | CHANGE OF THE FINANCIAL YEAR OF CHR. HANSEN | Management | No Action | |||||||||||
| 4 | ADJUSTMENT OF BOARD REMUNERATION DUE TO PROPOSED MERGER AND CHANGE OF THE FINANCIAL YEAR | Management | No Action | |||||||||||
| 5 | AUTHORISATION TO THE CHAIR OF THE EXTRAORDINARY GENERAL MEETING | Management | No Action | |||||||||||
| CMMT | PLEASE NOTE THAT IF YOU HOLD CREST DEPOSITORY INTERESTS (CDIS) AND-PARTICIPATE AT THIS MEETING, YOU (OR YOUR CREST SPONSORED MEMBER/CUSTODIAN)-WILL BE REQUIRED TO INSTRUCT A TRANSFER OF THE RELEVANT CDIS TO THE ESCROW-ACCOUNT SPECIFIED IN THE ASSOCIATED CORPORATE | Non-Voting | ||||||||||||
| EVENT IN THE CREST SYSTEM. THIS-TRANSFER WILL NEED TO BE COMPLETED BY THE SPECIFIED CREST SYSTEM DEADLINE.-ONCE THIS TRANSFER HAS SETTLED, THE CDIS WILL BE BLOCKED IN THE CREST SYSTEM.-THE CDIS WILL TYPICALLY BE RELEASED FROM ESCROW AS SOON AS PRACTICABLE ON-RECORD DATE +1 DAY (OR ON MEETING DATE +1 DAY IF NO RECORD DATE APPLIES)-UNLESS OTHERWISE SPECIFIED, AND ONLY AFTER THE AGENT HAS CONFIRMED- AVAILABILITY OF THE POSITION. IN ORDER FOR A VOTE TO BE ACCEPTED, THE VOTED-POSITION MUST BE BLOCKED IN THE REQUIRED ESCROW ACCOUNT IN THE CREST SYSTEM.-BY VOTING ON THIS MEETING, YOUR CREST SPONSORED MEMBER/CUSTODIAN MAY USE YOUR-VOTE INSTRUCTION AS THE AUTHORIZATION TO TAKE THE NECESSARY ACTION WHICH WILL-INCLUDE TRANSFERRING YOUR INSTRUCTED POSITION TO ESCROW. PLEASE CONTACT YOUR-CREST SPONSORED MEMBER/CUSTODIAN DIRECTLY FOR FURTHER INFORMATION ON THE-CUSTODY PROCESS AND WHETHER OR NOT THEY REQUIRE SEPARATE INSTRUCTIONS FROM-YOU | ||||||||||||||
| CMMT | PLEASE NOTE SHARE BLOCKING WILL APPLY FOR ANY VOTED POSITIONS SETTLING-THROUGH EUROCLEAR BANK. | Non-Voting | ||||||||||||
| CMMT | 09 MAR 2023: PLEASE NOTE THAT THIS IS A REVISION DUE TO ADDITION OF COMMENT.-IF YOU HAVE ALREADY SENT IN YOUR VOTES, PLEASE DO NOT VOTE AGAIN UNLESS YOU-DECIDE TO AMEND YOUR ORIGINAL INSTRUCTIONS. THANK YOU | Non-Voting | ||||||||||||
| CMMT | 09 MAR 2023: INTERMEDIARY CLIENTS ONLY - PLEASE NOTE THAT IF YOU ARE-CLASSIFIED AS AN INTERMEDIARY CLIENT UNDER THE SHAREHOLDER RIGHTS DIRECTIVE-II, YOU SHOULD BE PROVIDING THE UNDERLYING SHAREHOLDER INFORMATION AT THE-VOTE INSTRUCTION LEVEL. IF YOU ARE UNSURE ON HOW TO PROVIDE THIS LEVEL OF- DATA TO BROADRIDGE OUTSIDE OF PROXYEDGE, PLEASE SPEAK TO YOUR DEDICATED-CLIENT SERVICE REPRESENTATIVE FOR ASSISTANCE | Non-Voting | ||||||||||||
| IQVIA HOLDINGS INC. | ||||||||||||||
| Security | 46266C105 | Meeting Type | Annual | |||||||||||
| Ticker Symbol | IQV | Meeting Date | 18-Apr-2023 | |||||||||||
| ISIN | US46266C1053 | Agenda | 935769628 - Management | |||||||||||
| Item | Proposal | Proposed by |
Vote | For/Against Management |
||||||||||
| 1a. | Election of Director: Carol J. Burt | Management | For | For | ||||||||||
| 1b. | Election of Director: Colleen A. Goggins | Management | For | For | ||||||||||
| 1c. | Election of Director: Sheila A. Stamps | Management | For | For | ||||||||||
| 2. | Approve an advisory (non-binding) resolution to approve IQVIA's executive compensation (say-on-pay). | Management | For | For | ||||||||||
| 3. | Approve a Company proposal to amend IQVIA's Certificate of Incorporation to adopt a stockholders' right to request a special stockholders' meeting. | Management | For | For | ||||||||||
| 4. | If properly presented, a stockholder proposal concerning special stockholder meetings. | Shareholder | Against | For | ||||||||||
| 5. | If properly presented, a stockholder proposal for separate Chairman and Chief Executive Officer roles. | Shareholder | Against | For | ||||||||||
| 6. | Ratification of the appointment of PricewaterhouseCoopers LLP as IQVIA's independent registered public accounting firm for 2023. | Management | For | For | ||||||||||
| HCA HEALTHCARE, INC. | ||||||||||||||
| Security | 40412C101 | Meeting Type | Annual | |||||||||||
| Ticker Symbol | HCA | Meeting Date | 19-Apr-2023 | |||||||||||
| ISIN | US40412C1018 | Agenda | 935776902 - Management | |||||||||||
| Item | Proposal | Proposed by |
Vote | For/Against Management |
||||||||||
| 1a. | Election of Director: Thomas F. Frist III | Management | For | For | ||||||||||
| 1b. | Election of Director: Samuel N. Hazen | Management | For | For | ||||||||||
| 1c. | Election of Director: Meg G. Crofton | Management | For | For | ||||||||||
| 1d. | Election of Director: Robert J. Dennis | Management | For | For | ||||||||||
| 1e. | Election of Director: Nancy-Ann DeParle | Management | For | For | ||||||||||
| 1f. | Election of Director: William R. Frist | Management | For | For | ||||||||||
| 1g. | Election of Director: Hugh F. Johnston | Management | For | For | ||||||||||
| 1h. | Election of Director: Michael W. Michelson | Management | For | For | ||||||||||
| 1i. | Election of Director: Wayne J. Riley, M.D. | Management | For | For | ||||||||||
| 1j. | Election of Director: Andrea B. Smith | Management | For | For | ||||||||||
| 2. | To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for the year ending December 31, 2023. | Management | For | For | ||||||||||
| 3. | To approve the HCA Healthcare, Inc. 2023 Employee Stock Purchase Plan. | Management | For | For | ||||||||||
| 4. | Advisory vote to approve named executive officer compensation. | Management | For | For | ||||||||||
| 5. | Stockholder proposal, if properly presented at the meeting, regarding political spending disclosure. | Shareholder | Abstain | Against | ||||||||||
| 6. | Stockholder proposal, if properly presented at the meeting, regarding amendment to Patient Safety and Quality of Care Committee charter. | Shareholder | Against | For | ||||||||||
| NESTLE S.A. | ||||||||||||||
| Security | H57312649 | Meeting Type | Annual General Meeting | |||||||||||
| Ticker Symbol | NSRGY | Meeting Date | 20-Apr-2023 | |||||||||||
| ISIN | CH0038863350 | Agenda | 716817068 - Management | |||||||||||
| Item | Proposal | Proposed by |
Vote | For/Against Management |
||||||||||
| CMMT | VOTING MUST BE LODGED WITH BENEFICIAL OWNER DETAILS AS PROVIDED BY YOUR- CUSTODIAN BANK. IF NO BENEFICIAL OWNER DETAILS ARE PROVIDED, YOUR INSTRUCTION-MAY BE REJECTED | Non-Voting | ||||||||||||
| CMMT | PART 2 OF THIS MEETING IS FOR VOTING ON AGENDA AND MEETING ATTENDANCE-REQUESTS ONLY. PLEASE ENSURE THAT YOU HAVE FIRST VOTED IN FAVOUR OF THE-REGISTRATION OF SHARES IN PART 1 OF THE MEETING. IT IS A MARKET REQUIREMENT-FOR MEETINGS OF THIS TYPE THAT THE SHARES ARE REGISTERED AND MOVED TO A-REGISTERED LOCATION AT THE CSD, AND SPECIFIC POLICIES AT THE INDIVIDUAL-SUB- CUSTODIANS MAY VARY. UPON RECEIPT OF THE VOTE INSTRUCTION, IT IS POSSIBLE-THAT A MARKER MAY BE PLACED ON YOUR SHARES TO ALLOW FOR RECONCILIATION AND-RE- REGISTRATION FOLLOWING A TRADE.THEREFORE WHILST THIS DOES NOT PREVENT THE-TRADING OF SHARES, ANY THAT ARE REGISTERED MUST BE FIRST DEREGISTERED IF-REQUIRED FOR SETTLEMENT. DEREGISTRATION CAN AFFECT THE VOTING RIGHTS OF THOSE-SHARES. IF YOU HAVE CONCERNS REGARDING YOUR ACCOUNTS, PLEASE CONTACT YOUR-CLIENT REPRESENTATIVE. | Non-Voting | ||||||||||||
| 1.1 | APPROVAL OF THE ANNUAL REVIEW, THE FINANCIAL STATEMENTS OF NESTLE S.A. AND THE CONSOLIDATED FINANCIAL STATEMENTS OF THE NESTLE GROUP FOR 2022 | Management | No Action | |||||||||||
| 1.2 | ACCEPTANCE OF THE COMPENSATION REPORT 2022 (ADVISORY VOTE) | Management | No Action | |||||||||||
| 2 | DISCHARGE TO THE MEMBERS OF THE BOARD OF DIRECTORS AND OF THE MANAGEMENT FOR 2022 | Management | No Action | |||||||||||
| 3 | APPROPRIATION OF PROFIT RESULTING FROM THE BALANCE SHEET OF NESTLE S.A. (PROPOSED DIVIDEND) FOR THE FINANCIAL YEAR 2022 | Management | No Action | |||||||||||
| 4.1.1 | RE-ELECTION AS MEMBER AND CHAIRMAN OF THE BOARD OF DIRECTORS: PAUL BULCKE | Management | No Action | |||||||||||
| 4.1.2 | RE-ELECTION AS MEMBER OF THE BOARD OF DIRECTORS: ULF MARK SCHNEIDER | Management | No Action | |||||||||||
| 4.1.3 | RE-ELECTION AS MEMBER OF THE BOARD OF DIRECTORS: HENRI DE CASTRIES | Management | No Action | |||||||||||
| 4.1.4 | RE-ELECTION AS MEMBER OF THE BOARD OF DIRECTORS: RENATO FASSBIND | Management | No Action | |||||||||||
| 4.1.5 | RE-ELECTION AS MEMBER OF THE BOARD OF DIRECTORS: PABLO ISLA | Management | No Action | |||||||||||
| 4.1.6 | RE-ELECTION AS MEMBER OF THE BOARD OF DIRECTORS: PATRICK AEBISCHER | Management | No Action | |||||||||||
| 4.1.7 | RE-ELECTION AS MEMBER OF THE BOARD OF DIRECTORS: KIMBERLY A. ROSS | Management | No Action | |||||||||||
| 4.1.8 | RE-ELECTION AS MEMBER OF THE BOARD OF DIRECTORS: DICK BOER | Management | No Action | |||||||||||
| 4.1.9 | RE-ELECTION AS MEMBER OF THE BOARD OF DIRECTORS: DINESH PALIWAL | Management | No Action | |||||||||||
| 4.110 | RE-ELECTION AS MEMBER OF THE BOARD OF DIRECTORS: HANNE JIMENEZ DE MORA | Management | No Action | |||||||||||
| 4.111 | RE-ELECTION AS MEMBER OF THE BOARD OF DIRECTORS: LINDIWE MAJELE SIBANDA | Management | No Action | |||||||||||
| 4.112 | RE-ELECTION AS MEMBER OF THE BOARD OF DIRECTORS: CHRIS LEONG | Management | No Action | |||||||||||
| 4.113 | RE-ELECTION AS MEMBER OF THE BOARD OF DIRECTORS: LUCA MAESTRI | Management | No Action | |||||||||||
| 4.2.1 | ELECTION TO THE BOARD OF DIRECTORS: RAINER BLAIR | Management | No Action | |||||||||||
| 4.2.2 | ELECTION TO THE BOARD OF DIRECTORS: MARIE- GABRIELLE INEICHEN-FLEISCH | Management | No Action | |||||||||||
| 4.3.1 | ELECTION AS MEMBER OF THE COMPENSATION COMMITTEE: PABLO ISLA | Management | No Action | |||||||||||
| 4.3.2 | ELECTION AS MEMBER OF THE COMPENSATION COMMITTEE: PATRICK AEBISCHER | Management | No Action | |||||||||||
| 4.3.3 | ELECTION AS MEMBER OF THE COMPENSATION COMMITTEE: DICK BOER | Management | No Action | |||||||||||
| 4.3.4 | ELECTION AS MEMBER OF THE COMPENSATION COMMITTEE: DINESH PALIWAL | Management | No Action | |||||||||||
| 4.4 | ELECTION OF THE STATUTORY AUDITORS: ERNST AND YOUNG LTD, LAUSANNE BRANCH | Management | No Action | |||||||||||
| 4.5 | ELECTION OF THE INDEPENDENT REPRESENTATIVE: HARTMANN DREYER, ATTORNEYS-AT-LAW | Management | No Action | |||||||||||
| 5.1 | APPROVAL OF THE COMPENSATION OF THE BOARD OF DIRECTORS | Management | No Action | |||||||||||
| 5.2 | APPROVAL OF THE COMPENSATION OF THE EXECUTIVE BOARD | Management | No Action | |||||||||||
| 6 | CAPITAL REDUCTION (BY CANCELLATION OF SHARES) | Management | No Action | |||||||||||
| 7.1 | AMENDMENTS OF PROVISIONS OF THE ARTICLES OF ASSOCIATION PERTAINING TO THE GENERAL MEETING | Management | No Action | |||||||||||
| 7.2 | AMENDMENTS OF PROVISIONS OF THE ARTICLES OF ASSOCIATION PERTAINING TO THE BOARD OF DIRECTORS, COMPENSATION, CONTRACTS AND MANDATES AND MISCELLANEOUS PROVISIONS | Management | No Action | |||||||||||
| 8 | IN THE EVENT OF ANY YET UNKNOWN NEW OR MODIFIED PROPOSAL BY A SHAREHOLDER DURING THE GENERAL MEETING, I INSTRUCT THE INDEPENDENT REPRESENTATIVE TO VOTE AS FOLLOWS: (YES = VOTE IN FAVOR OF ANY SUCH YET UNKNOWN PROPOSAL, NO = VOTE AGAINST ANY SUCH YET UNKNOWN PROPOSAL, ABSTAIN = ABSTAIN FROM VOTING) - THE BOARD OF DIRECTORS RECOMMENDS TO VOTE NO ON ANY SUCH YET UNKNOWN PROPOSAL | Shareholder | No Action | |||||||||||
| BAUSCH + LOMB CORPORATION | ||||||||||||||
| Security | 071705107 | Meeting Type | Annual | |||||||||||
| Ticker Symbol | BLCO | Meeting Date | 24-Apr-2023 | |||||||||||
| ISIN | CA0717051076 | Agenda | 935776510 - Management | |||||||||||
| Item | Proposal | Proposed by |
Vote | For/Against Management |
||||||||||
| 1a. | Election of Director: Nathalie Bernier | Management | For | For | ||||||||||
| 1b. | Election of Director: Richard U. De Schutter | Management | For | For | ||||||||||
| 1c. | Election of Director: Gary Hu | Management | For | For | ||||||||||
| 1d. | Election of Director: Brett Icahn | Management | For | For | ||||||||||
| 1e. | Election of Director: Sarah B. Kavanagh | Management | For | For | ||||||||||
| 1f. | Election of Director: John A. Paulson | Management | For | For | ||||||||||
| 1g. | Election of Director: Russel C. Robertson | Management | For | For | ||||||||||
| 1h. | Election of Director: Thomas W. Ross, Sr. | Management | For | For | ||||||||||
| 1i. | Election of Director: Brenton L. Saunders | Management | For | For | ||||||||||
| 1j. | Election of Director: Andrew C. von Eschenbach | Management | For | For | ||||||||||
| 2. | The approval, in an advisory vote, of the compensation of our Named Executive Officers. | Management | For | For | ||||||||||
| 3. | The approval, in an advisory vote, of the frequency of future advisory votes on named executive officer compensation. | Management | 1 Year | For | ||||||||||
| 4. | The approval of an amendment and restatement of the Bausch + Lomb Corporation 2022 Omnibus Incentive Plan. | Management | Against | Against | ||||||||||
| 5. | The appointment of PricewaterhouseCoopers LLP to serve as the Company's auditor until the close of the 2024 Annual Meeting of Shareholders and to authorize the Board to fix the auditor's remuneration. | Management | For | For | ||||||||||
| PERKINELMER, INC. | ||||||||||||||
| Security | 714046109 | Meeting Type | Annual | |||||||||||
| Ticker Symbol | PKI | Meeting Date | 25-Apr-2023 | |||||||||||
| ISIN | US7140461093 | Agenda | 935776623 - Management | |||||||||||
| Item | Proposal | Proposed by |
Vote | For/Against Management |
||||||||||
| 1a. | Election of Director for a term of one year: Peter Barrett, PhD | Management | For | For | ||||||||||
| 1b. | Election of Director for a term of one year: Samuel R. Chapin | Management | For | For | ||||||||||
| 1c. | Election of Director for a term of one year: Sylvie Grégoire, PharmD | Management | For | For | ||||||||||
| 1d. | Election of Director for a term of one year: Michelle McMurry-Heath, MD, PhD | Management | For | For | ||||||||||
| 1e. | Election of Director for a term of one year: Alexis P. Michas | Management | For | For | ||||||||||
| 1f. | Election of Director for a term of one year: Prahlad R. Singh, PhD | Management | For | For | ||||||||||
| 1g. | Election of Director for a term of one year: Michel Vounatsos | Management | For | For | ||||||||||
| 1h. | Election of Director for a term of one year: Frank Witney, PhD | Management | For | For | ||||||||||
| 1i. | Election of Director for a term of one year: Pascale Witz | Management | For | For | ||||||||||
| 2. | To ratify the selection of Deloitte & Touche LLP as PerkinElmer's independent registered public accounting firm for the current fiscal year. | Management | For | For | ||||||||||
| 3. | To approve, by non-binding advisory vote, our executive compensation. | Management | For | For | ||||||||||
| 4. | To recommend, by non-binding advisory vote, the frequency of future executive compensation advisory votes. | Management | 1 Year | For | ||||||||||
| 5. | To approve the amendment of the company's restated articles of organization, as amended, to change the name of the Company from PerkinElmer, Inc. to Revvity, Inc. | Management | For | For | ||||||||||
| GALAPAGOS N V | ||||||||||||||
| Security | 36315X101 | Meeting Type | Annual | |||||||||||
| Ticker Symbol | GLPG | Meeting Date | 25-Apr-2023 | |||||||||||
| ISIN | US36315X1019 | Agenda | 935800866 - Management | |||||||||||
| Item | Proposal | Proposed by |
Vote | For/Against Management |
||||||||||
| 2. | Acknowledgement and approval of the non-consolidated annual accounts of the Company for the financial year ended on 31 December 2022, and approval of the allocation of the annual result as proposed by the Board of Directors. | Management | For | For | ||||||||||
| 5. | Acknowledgement and approval of the remuneration report. | Management | Against | Against | ||||||||||
| 6. | Release from liability to be granted to the members of the Board of Directors, the members of the former Supervisory Board, and the statutory auditor for the performance of their respective mandates during the financial year ended on 31 December 2022. | Management | For | For | ||||||||||
| 7. | Remuneration of the statutory auditor for the financial year ended on 31 December 2022. | Management | For | For | ||||||||||
| 8. | Appointment of statutory auditor. | Management | For | For | ||||||||||
| 9. | Re-appointment of Mr. Peter Guenter as independent director. | Management | For | For | ||||||||||
| 10. | Re-appointment of Mr. Daniel O'Day as director. | Management | For | For | ||||||||||
| 11. | Re-appointment of Dr. Linda Higgins as director. | Management | For | For | ||||||||||
| BIO-RAD LABORATORIES, INC. | ||||||||||||||
| Security | 090572207 | Meeting Type | Annual | |||||||||||
| Ticker Symbol | BIO | Meeting Date | 25-Apr-2023 | |||||||||||
| ISIN | US0905722072 | Agenda | 935806224 - Management | |||||||||||
| Item | Proposal | Proposed by |
Vote | For/Against Management |
||||||||||
| 1.1 | Election of Director: Melinda Litherland | Management | For | For | ||||||||||
| 1.2 | Election of Director: Arnold A. Pinkston | Management | For | For | ||||||||||
| 2. | Proposal to ratify the selection of KPMG LLP to serve as the Company's independent auditors. | Management | For | For | ||||||||||
| 3. | Advisory vote to approve executive compensation. | Management | For | For | ||||||||||
| 4. | Advisory vote on the frequency of future advisory votes to approve executive compensation. | Management | 3 Years | For | ||||||||||
| 5. | Stockholder proposal regarding political disclosure. | Shareholder | Abstain | Against | ||||||||||
| GALAPAGOS N V | ||||||||||||||
| Security | 36315X101 | Meeting Type | Annual | |||||||||||
| Ticker Symbol | GLPG | Meeting Date | 25-Apr-2023 | |||||||||||
| ISIN | US36315X1019 | Agenda | 935830631 - Management | |||||||||||
| Item | Proposal | Proposed by |
Vote | For/Against Management |
||||||||||
| 2. | Acknowledgement and approval of the non-consolidated annual accounts of the Company for the financial year ended on 31 December 2022, and approval of the allocation of the annual result as proposed by the Board of Directors. | Management | For | For | ||||||||||
| 5. | Acknowledgement and approval of the remuneration report. | Management | Against | Against | ||||||||||
| 6. | Release from liability to be granted to the members of the Board of Directors, the members of the former Supervisory Board, and the statutory auditor for the performance of their respective mandates during the financial year ended on 31 December 2022. | Management | For | For | ||||||||||
| 7. | Remuneration of the statutory auditor for the financial year ended on 31 December 2022. | Management | For | For | ||||||||||
| 8. | Appointment of statutory auditor. | Management | For | For | ||||||||||
| 9. | Re-appointment of Mr. Peter Guenter as independent director. | Management | For | For | ||||||||||
| 10. | Re-appointment of Mr. Daniel O'Day as director. | Management | For | For | ||||||||||
| 11. | Re-appointment of Dr. Linda Higgins as director. | Management | For | For | ||||||||||
| CALAVO GROWERS, INC. | ||||||||||||||
| Security | 128246105 | Meeting Type | Annual | |||||||||||
| Ticker Symbol | CVGW | Meeting Date | 26-Apr-2023 | |||||||||||
| ISIN | US1282461052 | Agenda | 935772928 - Management | |||||||||||
| Item | Proposal | Proposed by |
Vote | For/Against Management |
||||||||||
| 1. | DIRECTOR | Management | ||||||||||||
| 1 | Farha Aslam | For | For | |||||||||||
| 2 | Marc L. Brown | For | For | |||||||||||
| 3 | Michael A. DiGregorio | For | For | |||||||||||
| 4 | James D. Helin | For | For | |||||||||||
| 5 | Steven Hollister | For | For | |||||||||||
| 6 | Kathleen M. Holmgren | For | For | |||||||||||
| 7 | Brian Kocher | Withheld | Against | |||||||||||
| 8 | J. Link Leavens | For | For | |||||||||||
| 9 | Adriana G. Mendizabal | For | For | |||||||||||
| 2. | RATIFICATION OF APPOINTMENT OF DELOITTE & TOUCHE LLP AS INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM OF CALAVO GROWERS, INC. FOR THE YEAR ENDING OCTOBER 31, 2023 | Management | For | For | ||||||||||
| 3. | ADVISORY VOTE APPROVING THE EXECUTIVE COMPENSATION DISCLOSED IN THE ACCOMPANYING PROXY STATEMENT | Management | For | For | ||||||||||
| SMITH & NEPHEW PLC | ||||||||||||||
| Security | 83175M205 | Meeting Type | Annual | |||||||||||
| Ticker Symbol | SNN | Meeting Date | 26-Apr-2023 | |||||||||||
| ISIN | US83175M2052 | Agenda | 935775063 - Management | |||||||||||
| Item | Proposal | Proposed by |
Vote | For/Against Management |
||||||||||
| O1 | To receive the audited accounts for the financial year ended 31 December 2022. | Management | For | For | ||||||||||
| O2 | To approve the Directors' Remuneration Policy. | Management | For | For | ||||||||||
| O3 | To approve the Directors' Remuneration Report. | Management | For | For | ||||||||||
| O4 | To declare a final dividend. | Management | For | For | ||||||||||
| O5 | ELECTION OF DIRECTOR: Rupert Soames OBE | Management | For | For | ||||||||||
| O6 | ELECTION OF DIRECTOR: Erik Engstrom | Management | For | For | ||||||||||
| O7 | ELECTION OF DIRECTOR: Jo Hallas | Management | For | For | ||||||||||
| O8 | ELECTION OF DIRECTOR: John Ma | Management | For | For | ||||||||||
| O9 | ELECTION OF DIRECTOR: Katarzyna Mazur-Hofsaess | Management | For | For | ||||||||||
| O10 | ELECTION OF DIRECTOR: Rick Medlock | Management | For | For | ||||||||||
| O11 | ELECTION OF DIRECTOR: Deepak Nath | Management | For | For | ||||||||||
| O12 | ELECTION OF DIRECTOR: Anne-Françoise Nesmes | Management | For | For | ||||||||||
| O13 | ELECTION OF DIRECTOR: Marc Owen | Management | For | For | ||||||||||
| O14 | ELECTION OF DIRECTOR: Roberto Quarta | Management | For | For | ||||||||||
| O15 | ELECTION OF DIRECTOR: Angie Risley | Management | For | For | ||||||||||
| O16 | ELECTION OF DIRECTOR: Bob White | Management | For | For | ||||||||||
| O17 | To re-appoint KPMG LLP as the Auditor. | Management | For | For | ||||||||||
| O18 | To authorise the Directors to determine the remuneration of the Auditor. | Management | For | For | ||||||||||
| O19 | To renew the authorisation of the Directors to allot shares. | Management | For | For | ||||||||||
| S20 | Directors given power to allot equity securities in the Company for cash through the sale of treasury shares. | Management | For | For | ||||||||||
| S21 | Directors given power to allot equity securities in the Company for cash through the sale of ordinary shares held by the Company as treasury shares. | Management | For | For | ||||||||||
| S22 | That the Company be generally and unconditionally authorised to make market purchases of the Company's own shares. | Management | For | For | ||||||||||
| S23 | To authorise general meetings to be held on 14 clear days' notice. | Management | For | For | ||||||||||
| THE CIGNA GROUP | ||||||||||||||
| Security | 125523100 | Meeting Type | Annual | |||||||||||
| Ticker Symbol | CI | Meeting Date | 26-Apr-2023 | |||||||||||
| ISIN | US1255231003 | Agenda | 935779073 - Management | |||||||||||
| Item | Proposal | Proposed by |
Vote | For/Against Management |
||||||||||
| 1a. | Election of Director: David M. Cordani | Management | For | For | ||||||||||
| 1b. | Election of Director: William J. DeLaney | Management | For | For | ||||||||||
| 1c. | Election of Director: Eric J. Foss | Management | For | For | ||||||||||
| 1d. | Election of Director: Retired Maj. Gen. Elder Granger, M.D. | Management | For | For | ||||||||||
| 1e. | Election of Director: Neesha Hathi | Management | For | For | ||||||||||
| 1f. | Election of Director: George Kurian | Management | For | For | ||||||||||
| 1g. | Election of Director: Kathleen M. Mazzarella | Management | For | For | ||||||||||
| 1h. | Election of Director: Mark B. McClellan, M.D., Ph.D. | Management | For | For | ||||||||||
| 1i. | Election of Director: Kimberly A. Ross | Management | For | For | ||||||||||
| 1j. | Election of Director: Eric C. Wiseman | Management | For | For | ||||||||||
| 1k. | Election of Director: Donna F. Zarcone | Management | For | For | ||||||||||
| 2. | Advisory approval of The Cigna Group's executive compensation | Management | For | For | ||||||||||
| 3. | Advisory approval of the frequency of future advisory votes on executive compensation | Management | 1 Year | For | ||||||||||
| 4. | Ratification of the appointment of PricewaterhouseCoopers LLP as The Cigna Group's independent registered public accounting firm for 2023 | Management | For | For | ||||||||||
| 5. | Approval of an amendment to our Restated Certificate of Incorporation to limit the liability of certain officers of the Company as permitted pursuant to recent amendments to the Delaware General Corporation Law | Management | For | For | ||||||||||
| 6. | Shareholder proposal - Special shareholder meeting improvement | Shareholder | Against | For | ||||||||||
| 7. | Shareholder proposal - Political contributions report | Shareholder | Abstain | Against | ||||||||||
| KERRY GROUP PLC | ||||||||||||||
| Security | G52416107 | Meeting Type | Annual General Meeting | |||||||||||
| Ticker Symbol | Meeting Date | 27-Apr-2023 | ||||||||||||
| ISIN | IE0004906560 | Agenda | 716822918 - Management | |||||||||||
| Item | Proposal | Proposed by |
Vote | For/Against Management |
||||||||||
| CMMT | VOTING MUST BE LODGED WITH SHAREHOLDER DETAILS AS PROVIDED BY YOUR CUSTODIAN- BANK. IF NO SHAREHOLDER DETAILS ARE PROVIDED, YOUR INSTRUCTIONS MAY BE- REJECTED | Non-Voting | ||||||||||||
| 1 | TO REVIEW THE COMPANY'S AFFAIRS AND TO RECEIVE AND CONSIDER THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2022, TOGETHER WITH THE REPORTS OF THE DIRECTORS AND THE AUDITORS THEREON | Management | No Action | |||||||||||
| 2 | TO DECLARE A FINAL DIVIDEND: THIS IS A RESOLUTION TO DECLARE A FINAL DIVIDEND OF 73.4 CENT PER A ORDINARY SHARE FOR THE YEAR ENDED 31 DECEMBER 2022. IF APPROVED, THE FINAL DIVIDEND WILL BE PAID ON 12 MAY 2023 TO SHAREHOLDERS REGISTERED ON THE RECORD DATE 14 APRIL 2023. THIS DIVIDEND IS IN ADDITION TO THE INTERIM DIVIDEND OF 31.4 CENT PER SHARE PAID TO SHAREHOLDERS ON 11 NOVEMBER 2022. | Management | No Action | |||||||||||
| 3.A | TO ELECT THE FOLLOWING DIRECTOR: MR PATRICK ROHAN | Management | No Action | |||||||||||
| 4.A | TO RE-ELECT THE FOLLOWING DIRECTOR: MR GERRY BEHAN | Management | No Action | |||||||||||
| 4.B | TO RE-ELECT THE FOLLOWING DIRECTOR: DR HUGH BRADY | Management | No Action | |||||||||||
| 4.C | TO RE-ELECT THE FOLLOWING DIRECTOR: MS FIONA DAWSON | Management | No Action | |||||||||||
| 4.D | TO RE-ELECT THE FOLLOWING DIRECTOR: DR KARIN DORREPAAL | Management | No Action | |||||||||||
| 4.E | TO RE-ELECT THE FOLLOWING DIRECTOR: MS EMER GILVARRY | Management | No Action | |||||||||||
| 4.F | TO RE-ELECT THE FOLLOWING DIRECTOR: MR MICHAEL KERR | Management | No Action | |||||||||||
| 4.G | TO RE-ELECT THE FOLLOWING DIRECTOR: MS MARGUERITE LARKIN | Management | No Action | |||||||||||
| 4.H | TO RE-ELECT THE FOLLOWING DIRECTOR: MR TOM MORAN | Management | No Action | |||||||||||
| 4.I | TO RE-ELECT THE FOLLOWING DIRECTOR: MR CHRISTOPHER ROGERS | Management | No Action | |||||||||||
| 4.J | TO RE-ELECT THE FOLLOWING DIRECTOR: MR EDMOND SCANLON | Management | No Action | |||||||||||
| 4.K | TO RE-ELECT THE FOLLOWING DIRECTOR: MR JINLONG WANG | Management | No Action | |||||||||||
| 5 | AUTHORITY TO DETERMINE THE AUDITORS REMUNERATION | Management | No Action | |||||||||||
| 6 | AUTHORITY TO CONVENE AN EXTRAORDINARY GENERAL MEETING ON 14 DAYS NOTICE FOR THE PASSING OF AN ORDINARY RESOLUTION | Management | No Action | |||||||||||
| 7 | TO RECEIVE AND CONSIDER THE DIRECTORS' REMUNERATION REPORT (EXCLUDING SECTION C) | Management | No Action | |||||||||||
| 8 | AUTHORITY TO ISSUE ORDINARY SHARES | Management | No Action | |||||||||||
| 9 | AUTHORITY TO DISAPPLY PRE-EMPTION RIGHTS | Management | No Action | |||||||||||
| 10 | AUTHORITY TO DISAPPLY PRE-EMPTION RIGHTS FOR AN ADDITIONAL 5 PERCENT FOR SPECIFIED TRANSACTIONS | Management | No Action | |||||||||||
| 11 | AUTHORITY TO MAKE MARKET PURCHASES OF THE COMPANY'S OWN SHARES | Management | No Action | |||||||||||
| 12 | TO APPROVE THE KERRY GLOBAL EMPLOYEE SHARE PLAN | Management | No Action | |||||||||||
| CMMT | 29 MAR 2023: INTERMEDIARY CLIENTS ONLY - PLEASE NOTE THAT IF YOU ARE-CLASSIFIED AS AN INTERMEDIARY CLIENT UNDER THE SHAREHOLDER RIGHTS DIRECTIVE-II, YOU SHOULD BE PROVIDING THE UNDERLYING SHAREHOLDER INFORMATION AT THE-VOTE INSTRUCTION LEVEL. IF YOU ARE UNSURE ON HOW TO PROVIDE THIS LEVEL OF- DATA TO BROADRIDGE OUTSIDE OF PROXYEDGE, PLEASE SPEAK TO YOUR DEDICATED-CLIENT SERVICE REPRESENTATIVE FOR ASSISTANCE | Non-Voting | ||||||||||||
| CMMT | 14 APR 2023: PLEASE NOTE THAT THIS IS A REVISION DUE TO ADDITION OF COMMENT-AND CHANGE IN NUMBERING OF RESOLUTION 3.A . IF YOU HAVE ALREADY SENT IN YOUR-VOTES, PLEASE DO NOT VOTE AGAIN UNLESS YOU DECIDE TO AMEND YOUR ORIGINAL-INSTRUCTIONS. THANK YOU | Non-Voting | ||||||||||||
| DANONE SA | ||||||||||||||
| Security | F12033134 | Meeting Type | MIX | |||||||||||
| Ticker Symbol | DANGY | Meeting Date | 27-Apr-2023 | |||||||||||
| ISIN | FR0000120644 | Agenda | 716928532 - Management | |||||||||||
| Item | Proposal | Proposed by |
Vote | For/Against Management |
||||||||||
| CMMT | FOR SHAREHOLDERS NOT HOLDING SHARES DIRECTLY WITH A FRENCH CUSTODIAN, VOTING- INSTRUCTIONS WILL BE FORWARDED TO YOUR GLOBAL CUSTODIAN ON VOTE DEADLINE-DATE. THE GLOBAL CUSTODIAN AS THE REGISTERED INTERMEDIARY WILL SIGN THE PROXY-CARD AND FORWARD TO THE LOCAL CUSTODIAN FOR LODGMENT. | Non-Voting | ||||||||||||
| CMMT | FOR FRENCH MEETINGS 'ABSTAIN' IS A VALID VOTING OPTION. FOR ANY ADDITIONAL- RESOLUTIONS RAISED AT THE MEETING THE VOTING INSTRUCTION WILL DEFAULT TO-'AGAINST.' IF YOUR CUSTODIAN IS COMPLETING THE PROXY CARD, THE VOTING-INSTRUCTION WILL DEFAULT TO THE PREFERENCE OF YOUR CUSTODIAN. | Non-Voting | ||||||||||||
| CMMT | VOTING MUST BE LODGED WITH SHAREHOLDER DETAILS AS PROVIDED BY YOUR CUSTODIAN- BANK. IF NO SHAREHOLDER DETAILS ARE PROVIDED, YOUR INSTRUCTIONS MAY BE- REJECTED. | Non-Voting | ||||||||||||
| CMMT | FOR SHAREHOLDERS HOLDING SHARES DIRECTLY REGISTERED IN THEIR OWN NAME ON THE- COMPANY SHARE REGISTER, YOU SHOULD RECEIVE A PROXY CARD/VOTING FORM DIRECTLY- FROM THE ISSUER. PLEASE SUBMIT YOUR VOTE DIRECTLY BACK TO THE ISSUER VIA THE-PROXY CARD/VOTING FORM, DO NOT SUBMIT YOUR VOTE VIA BROADRIDGE-SYSTEMS/PLATFORMS OR YOUR INSTRUCTIONS MAY BE REJECTED. | Non-Voting | ||||||||||||
| CMMT | INTERMEDIARY CLIENTS ONLY - PLEASE NOTE THAT IF YOU ARE CLASSIFIED AS AN- INTERMEDIARY CLIENT UNDER THE SHAREHOLDER RIGHTS DIRECTIVE II, YOU SHOULD BE-PROVIDING THE UNDERLYING SHAREHOLDER INFORMATION AT THE VOTE INSTRUCTION-LEVEL. IF YOU ARE UNSURE ON HOW TO PROVIDE THIS LEVEL OF DATA TO BROADRIDGE-OUTSIDE OF PROXYEDGE, PLEASE SPEAK TO YOUR DEDICATED CLIENT SERVICE-REPRESENTATIVE FOR ASSISTANCE | Non-Voting | ||||||||||||
| CMMT | PLEASE NOTE THAT IMPORTANT ADDITIONAL MEETING INFORMATION IS AVAILABLE BY-CLICKING ON THE MATERIAL URL LINK:-https://www.journal- officiel.gouv.fr/telechargements/BALO/pdf/2023/0405/202 304-052300677.pdf | Non-Voting | ||||||||||||
| CMMT | PLEASE NOTE THAT THIS IS AN AMENDMENT TO MEETING ID 880519 DUE TO RECEIPT OF-UPDATED AGENDA. ALL VOTES RECEIVED ON THE PREVIOUS MEETING WILL BE-DISREGARDED AND YOU WILL NEED TO REINSTRUCT ON THIS MEETING NOTICE. THANK YOU | Non-Voting | ||||||||||||
| 1 | APPROVAL OF THE CORPORATE FINANCIAL STATEMENTS FOR THE FINANCIAL YEAR ENDED 31 DECEMBER 2022 | Management | No Action | |||||||||||
| 2 | APPROVAL OF THE CONSOLIDATED FINANCIAL STATEMENTS FOR THE FINANCIAL YEAR ENDED 31 DECEMBER 2022 | Management | No Action | |||||||||||
| 3 | ALLOCATION OF INCOME FOR THE FINANCIAL YEAR ENDED 31 DECEMBER 2022 AND SETTING OF THE DIVIDEND AT 2.00 EUROS PER SHARE | Management | No Action | |||||||||||
| 4 | RENEWAL OF THE TERM OF OFFICE OF VALERIE CHAPOULAUD-FLOQUET AS DIRECTOR | Management | No Action | |||||||||||
| 5 | RENEWAL OF THE TERM OF OFFICE OF GILLES SCHNEPP AS DIRECTOR | Management | No Action | |||||||||||
| 6 | RATIFICATION OF THE CO-OPTION OF GILBERT GHOSTINE AS DIRECTOR, AS A REPLACEMENT FOR GUIDO BARILLA WHO RESIGNED | Management | No Action | |||||||||||
| 7 | RATIFICATION OF THE CO-OPTION OF LISE KINGO AS DIRECTOR, AS A REPLACEMENT FOR CECILE CABANIS WHO RESIGNED | Management | No Action | |||||||||||
| 8 | APPROVAL OF THE INFORMATION RELATING TO THE REMUNERATION OF CORPORATE OFFICERS MENTIONED IN SECTION I OF ARTICLE L.22-10-9 OF THE FRENCH COMMERCIAL CODE FOR THE FINANCIAL YEAR 2022 | Management | No Action | |||||||||||
| 9 | APPROVAL OF THE COMPENSATION ELEMENTS PAID DURING OR AWARDED FOR THE FINANCIAL YEAR ENDED 31 DECEMBER 2022 TO ANTOINE DE SAINT-AFFRIQUE, CHIEF EXECUTIVE OFFICER | Management | No Action | |||||||||||
| 10 | APPROVAL OF THE COMPENSATION ELEMENTS PAID DURING OR AWARDED FOR THE FINANCIAL YEAR ENDED 31 DECEMBER 2022 TO GILLES SCHNEPP, CHAIRMAN OF THE BOARD OF DIRECTORS | Management | No Action | |||||||||||
| 11 | APPROVAL OF THE REMUNERATION POLICY FOR EXECUTIVE CORPORATE OFFICERS FOR THE FINANCIAL YEAR 2023 | Management | No Action | |||||||||||
| 12 | APPROVAL OF THE REMUNERATION POLICY FOR THE CHAIRMAN OF THE BOARD OF DIRECTORS FOR THE FINANCIAL YEAR 2023 | Management | No Action | |||||||||||
| 13 | APPROVAL OF THE REMUNERATION POLICY FOR DIRECTORS FOR THE FINANCIAL YEAR 2023 | Management | No Action | |||||||||||
| 14 | AUTHORISATION TO BE GRANTED TO THE BOARD OF DIRECTORS IN ORDER TO PURCHASE, HOLD OR TRANSFER THE COMPANYS SHARES | Management | No Action | |||||||||||
| 15 | DELEGATION OF AUTHORITY TO THE BOARD OF DIRECTORS TO ISSUE COMMON SHARES AND TRANSFERABLE SECURITIES, WITH RETENTION OF THE SHAREHOLDERS PRE-EMPTIVE SUBSCRIPTION RIGHT | Management | No Action | |||||||||||
| 16 | DELEGATION OF AUTHORITY TO THE BOARD OF DIRECTORS TO ISSUE COMMON SHARES AND TRANSFERABLE SECURITIES, WITH CANCELLATION OF THE SHAREHOLDERS PRE-EMPTIVE SUBSCRIPTION RIGHT, BUT WITH AN OBLIGATION TO GRANT A PRIORITY RIGHT | Management | No Action | |||||||||||
| 17 | DELEGATION OF AUTHORITY TO THE BOARD OF DIRECTORS IN THE EVENT OF A CAPITAL INCREASE WITH CANCELLATION OF THE SHAREHOLDERS PRE-EMPTIVE SUBSCRIPTION RIGHT, TO INCREASE THE NUMBER OF SECURITIES TO BE ISSUED | Management | No Action | |||||||||||
| 18 | DELEGATION OF AUTHORITY TO THE BOARD OF DIRECTORS TO ISSUE COMMON SHARES AND TRANSFERABLE SECURITIES, WITHOUT THE SHAREHOLDERS PRE-EMPTIVE SUBSCRIPTION RIGHT, IN THE EVENT OF A PUBLIC EXCHANGE OFFER INITIATED BY THE COMPANY | Management | No Action | |||||||||||
| 19 | DELEGATION OF POWERS TO THE BOARD OF DIRECTORS FOR THE PURPOSE OF ISSUING COMMON SHARES AND TRANSFERABLE SECURITIES, WITHOUT THE SHAREHOLDERS PRE- EMPTIVE SUBSCRIPTION RIGHT, IN ORDER TO REMUNERATE CONTRIBUTIONS IN KIND GRANTED TO THE COMPANY AND CONSISTING OF EQUITY SECURITIES OR TRANSFERABLE SECURITIES GRANTING ACCESS TO THE CAPITAL | Management | No Action | |||||||||||
| 20 | DELEGATION OF AUTHORITY TO THE BOARD OF DIRECTORS TO INCREASE THE COMPANYS CAPITAL BY INCORPORATION OF RESERVES, PROFITS, PREMIUMS OR OTHER AMOUNTS WHOSE CAPITALIZATION WOULD BE ALLOWED | Management | No Action | |||||||||||
| 21 | DELEGATION OF AUTHORITY TO THE BOARD OF DIRECTORS TO ISSUE COMMON SHARES AND TRANSFERABLE SECURITIES RESERVED FOR EMPLOYEES WHO ARE MEMBERS OF A COMPANY SAVINGS PLAN AND/OR THE TRANSFER OF RESERVED SECURITIES, WITHOUT THE SHAREHOLDERS PRE-EMPTIVE SUBSCRIPTION RIGHT | Management | No Action | |||||||||||
| 22 | DELEGATION OF AUTHORITY TO THE BOARD OF DIRECTORS TO ISSUE COMMON SHARES AND TRANSFERABLE SECURITIES GRANTING ACCESS TO THE CAPITAL, WITH CANCELLATION OF THE PRE-EMPTIVE SUBSCRIPTION RIGHT, RESERVED FOR CATEGORIES OF BENEFICIARIES CONSISTING OF EMPLOYEES WORKING IN FOREIGN COMPANIES OF THE DANONE GROUP, OR IN A SITUATION OF INTERNATIONAL MOBILITY, IN THE CONTEXT OF EMPLOYEE SHAREHOLDING OPERATIONS | Management | No Action | |||||||||||
| 23 | AUTHORIZATION GRANTED TO THE BOARD OF DIRECTORS TO PROCEED WITH ALLOCATIONS OF EXISTING OR FUTURE PERFORMANCE SHARES OF THE COMPANY, WITHOUT THE SHAREHOLDERS PRE-EMPTIVE SUBSCRIPTION RIGHT | Management | No Action | |||||||||||
| 24 | AUTHORIZATION GRANTED TO THE BOARD OF DIRECTORS TO REDUCE THE CAPITAL BY CANCELLING SHARES | Management | No Action | |||||||||||
| 25 | POWERS TO CARRY OUT FORMALITIES | Management | No Action | |||||||||||
| 26 | APPOINTMENT OF SANJIV MEHTA AS DIRECTOR | Management | No Action | |||||||||||
| CMMT | 11 APR 2023: PLEASE NOTE THAT IF YOU HOLD CREST DEPOSITORY INTERESTS (CDIS)-AND PARTICIPATE AT THIS MEETING, YOU (OR YOUR CREST SPONSORED-MEMBER/CUSTODIAN) WILL BE REQUIRED TO INSTRUCT A TRANSFER OF THE RELEVANT-CDIS TO THE ESCROW ACCOUNT SPECIFIED IN THE ASSOCIATED CORPORATE EVENT IN THE-CREST SYSTEM. THIS TRANSFER WILL NEED TO BE COMPLETED BY THE SPECIFIED CREST-SYSTEM DEADLINE. ONCE THIS TRANSFER HAS SETTLED, THE CDIS WILL BE BLOCKED IN-THE CREST SYSTEM. THE CDIS WILL TYPICALLY BE RELEASED FROM ESCROW AS SOON AS- PRACTICABLE ON RECORD DATE +1 DAY (OR ON MEETING DATE +1 DAY IF NO RECORD-DATE APPLIES) UNLESS OTHERWISE SPECIFIED, AND ONLY AFTER THE AGENT HAS-CONFIRMED AVAILABILITY OF THE POSITION. IN ORDER FOR A VOTE TO BE ACCEPTED,-THE VOTED POSITION MUST BE BLOCKED IN THE REQUIRED ESCROW ACCOUNT IN THE-CREST SYSTEM. BY VOTING ON THIS MEETING, YOUR CREST SPONSORED- MEMBER/CUSTODIAN MAY USE YOUR VOTE INSTRUCTION AS THE AUTHORIZATION TO TAKE- THE NECESSARY ACTION WHICH WILL INCLUDE TRANSFERRING YOUR INSTRUCTED POSITION-TO ESCROW. PLEASE CONTACT YOUR CREST SPONSORED MEMBER/CUSTODIAN DIRECTLY FOR- FURTHER INFORMATION ON THE CUSTODY PROCESS AND WHETHER OR NOT THEY REQUIRE- SEPARATE INSTRUCTIONS FROM YOU | Non-Voting | ||||||||||||
| CMMT | 11 APR 2023: PLEASE NOTE SHARE BLOCKING WILL APPLY FOR ANY VOTED POSITIONS-SETTLING THROUGH EUROCLEAR BANK. | Non-Voting | ||||||||||||
| CMMT | 11 APR 2023: PLEASE NOTE THAT THIS IS A REVISION DUE TO ADDITION OF COMMENTS.-IF YOU HAVE ALREADY SENT IN YOUR VOTES, PLEASE DO NOT VOTE AGAIN UNLESS YOU-DECIDE TO AMEND YOUR ORIGINAL INSTRUCTIONS. THANK YOU | Non-Voting | ||||||||||||
| TREEHOUSE FOODS, INC. | ||||||||||||||
| Security | 89469A104 | Meeting Type | Annual | |||||||||||
| Ticker Symbol | THS | Meeting Date | 27-Apr-2023 | |||||||||||
| ISIN | US89469A1043 | Agenda | 935775544 - Management | |||||||||||
| Item | Proposal | Proposed by |
Vote | For/Against Management |
||||||||||
| 1a. | Election of Director: Scott D. Ostfeld | Management | For | For | ||||||||||
| 1b. | Election of Director: Jean E. Spence | Management | For | For | ||||||||||
| 2. | Advisory vote to approve the Company's executive compensation. | Management | For | For | ||||||||||
| 3. | Advisory vote to approve the frequency of future advisory votes on the Company's executive compensation. | Management | 1 Year | For | ||||||||||
| 4. | Ratification of the selection of Deloitte & Touche LLP as the Company's independent registered public accounting firm for fiscal year 2023. | Management | For | For | ||||||||||
| 5. | Approval of amendments to the Company's Certificate of Incorporation to declassify the Board of Directors and phase-in annual director elections. | Management | For | For | ||||||||||
| 6. | Approval of the amendment and restatement of the TreeHouse Foods, Inc. Equity and Incentive Plan, including an increase in the number of shares subject to the plan. | Management | Against | Against | ||||||||||
| JOHNSON & JOHNSON | ||||||||||||||
| Security | 478160104 | Meeting Type | Annual | |||||||||||
| Ticker Symbol | JNJ | Meeting Date | 27-Apr-2023 | |||||||||||
| ISIN | US4781601046 | Agenda | 935776813 - Management | |||||||||||
| Item | Proposal | Proposed by |
Vote | For/Against Management |
||||||||||
| 1a. | Election of Director: Darius Adamczyk | Management | For | For | ||||||||||
| 1b. | Election of Director: Mary C. Beckerle | Management | For | For | ||||||||||
| 1c. | Election of Director: D. Scott Davis | Management | For | For | ||||||||||
| 1d. | Election of Director: Jennifer A. Doudna | Management | For | For | ||||||||||
| 1e. | Election of Director: Joaquin Duato | Management | For | For | ||||||||||
| 1f. | Election of Director: Marillyn A. Hewson | Management | For | For | ||||||||||
| 1g. | Election of Director: Paula A. Johnson | Management | For | For | ||||||||||
| 1h. | Election of Director: Hubert Joly | Management | For | For | ||||||||||
| 1I. | Election of Director: Mark B. McClellan | Management | For | For | ||||||||||
| 1j. | Election of Director: Anne M. Mulcahy | Management | For | For | ||||||||||
| 1k. | Election of Director: Mark A. Weinberger | Management | For | For | ||||||||||
| 1l. | Election of Director: Nadja Y. West | Management | For | For | ||||||||||
| 2. | Advisory Vote to Approve Named Executive Officer Compensation | Management | For | For | ||||||||||
| 3. | Advisory Vote on the Frequency of Voting to Approve Named Executive Officer Compensation | Management | 1 Year | For | ||||||||||
| 4. | Ratification of Appointment of PricewaterhouseCoopers LLP as the Independent Registered Public Accounting Firm | Management | For | For | ||||||||||
| 5. | Proposal Withdrawn (Federal Securities Laws Mandatory Arbitration Bylaw) | Shareholder | Abstain | |||||||||||
| 6. | Vaccine Pricing Report | Shareholder | Against | For | ||||||||||
| 7. | Executive Compensation Adjustment Policy | Shareholder | Against | For | ||||||||||
| 8. | Impact of Extended Patent Exclusivities on Product Access | Shareholder | Against | For | ||||||||||
| PFIZER INC. | ||||||||||||||
| Security | 717081103 | Meeting Type | Annual | |||||||||||
| Ticker Symbol | PFE | Meeting Date | 27-Apr-2023 | |||||||||||
| ISIN | US7170811035 | Agenda | 935778451 - Management | |||||||||||
| Item | Proposal | Proposed by |
Vote | For/Against Management |
||||||||||
| 1a. | Election of Director: Ronald E. Blaylock | Management | For | For | ||||||||||
| 1b. | Election of Director: Albert Bourla | Management | For | For | ||||||||||
| 1c. | Election of Director: Susan Desmond-Hellmann | Management | For | For | ||||||||||
| 1d. | Election of Director: Joseph J. Echevarria | Management | For | For | ||||||||||
| 1e. | Election of Director: Scott Gottlieb | Management | For | For | ||||||||||
| 1f. | Election of Director: Helen H. Hobbs | Management | For | For | ||||||||||
| 1g. | Election of Director: Susan Hockfield | Management | For | For | ||||||||||
| 1h. | Election of Director: Dan R. Littman | Management | For | For | ||||||||||
| 1i. | Election of Director: Shantanu Narayen | Management | For | For | ||||||||||
| 1j. | Election of Director: Suzanne Nora Johnson | Management | For | For | ||||||||||
| 1k. | Election of Director: James Quincey | Management | For | For | ||||||||||
| 1l. | Election of Director: James C. Smith | Management | For | For | ||||||||||
| 2. | Ratify the selection of KPMG LLP as independent registered public accounting firm for 2023 | Management | For | For | ||||||||||
| 3. | 2023 advisory approval of executive compensation | Management | For | For | ||||||||||
| 4. | Advisory vote on frequency of future advisory votes to approve executive compensation | Management | 1 Year | For | ||||||||||
| 5. | Shareholder proposal regarding ratification of termination pay | Shareholder | Against | For | ||||||||||
| 6. | Shareholder proposal regarding independent board chairman policy | Shareholder | Against | For | ||||||||||
| 7. | Shareholder proposal regarding transfer of intellectual property to potential COVID-19 manufacturers feasibility report | Shareholder | Against | For | ||||||||||
| 8. | Shareholder proposal regarding impact of extended patent exclusivities on product access report | Shareholder | Against | For | ||||||||||
| 9. | Shareholder proposal regarding political contributions congruency report | Shareholder | Abstain | Against | ||||||||||
| LANTHEUS HOLDINGS, INC. | ||||||||||||||
| Security | 516544103 | Meeting Type | Annual | |||||||||||
| Ticker Symbol | LNTH | Meeting Date | 27-Apr-2023 | |||||||||||
| ISIN | US5165441032 | Agenda | 935779403 - Management | |||||||||||
| Item | Proposal | Proposed by |
Vote | For/Against Management |
||||||||||
| 1.1 | Election of Class II Director: Ms. Minnie Baylor-Henry | Management | For | For | ||||||||||
| 1.2 | Election of Class II Director: Mr. Heinz Mäusli | Management | For | For | ||||||||||
| 1.3 | Election of Class II Director: Ms. Julie McHugh | Management | For | For | ||||||||||
| 2. | The approval, on an advisory basis, of the compensation paid to our named executive officers. | Management | For | For | ||||||||||
| 3. | The approval of the Lantheus Holdings, Inc. 2023 Employee Stock Purchase Plan. | Management | For | For | ||||||||||
| 4. | The ratification of the appointment of Deloitte & Touche LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2023. | Management | For | For | ||||||||||
| INTUITIVE SURGICAL, INC. | ||||||||||||||
| Security | 46120E602 | Meeting Type | Annual | |||||||||||
| Ticker Symbol | ISRG | Meeting Date | 27-Apr-2023 | |||||||||||
| ISIN | US46120E6023 | Agenda | 935779744 - Management | |||||||||||
| Item | Proposal | Proposed by |
Vote | For/Against Management |
||||||||||
| 1a. | Election of Director: Craig H. Barratt, Ph.D. | Management | For | For | ||||||||||
| 1b. | Election of Director: Joseph C. Beery | Management | For | For | ||||||||||
| 1c. | Election of Director: Gary S. Guthart, Ph.D. | Management | For | For | ||||||||||
| 1d. | Election of Director: Amal M. Johnson | Management | For | For | ||||||||||
| 1e. | Election of Director: Don R. Kania, Ph.D. | Management | For | For | ||||||||||
| 1f. | Election of Director: Amy L. Ladd, M.D. | Management | For | For | ||||||||||
| 1g. | Election of Director: Keith R. Leonard, Jr. | Management | For | For | ||||||||||
| 1h. | Election of Director: Alan J. Levy, Ph.D. | Management | For | For | ||||||||||
| 1i. | Election of Director: Jami Dover Nachtsheim | Management | For | For | ||||||||||
| 1j. | Election of Director: Monica P. Reed, M.D. | Management | For | For | ||||||||||
| 1k. | Election of Director: Mark J. Rubash | Management | For | For | ||||||||||
| 2. | To approve, by advisory vote, the compensation of the Company's Named Executive Officers | Management | For | For | ||||||||||
| 3. | To approve, by advisory vote, the frequency of the advisory vote on the compensation of the Company's Named Executive Officers. | Management | 1 Year | For | ||||||||||
| 4. | The ratification of appointment of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2023. | Management | For | For | ||||||||||
| 5. | The stockholder proposal regarding pay equity disclosure. | Shareholder | Abstain | Against | ||||||||||
| CHURCH & DWIGHT CO., INC. | ||||||||||||||
| Security | 171340102 | Meeting Type | Annual | |||||||||||
| Ticker Symbol | CHD | Meeting Date | 27-Apr-2023 | |||||||||||
| ISIN | US1713401024 | Agenda | 935780622 - Management | |||||||||||
| Item | Proposal | Proposed by |
Vote | For/Against Management |
||||||||||
| 1a. | Election of Director for a term of one year: Bradlen S. Cashaw | Management | For | For | ||||||||||
| 1b. | Election of Director for a term of one year: Matthew T. Farrell | Management | For | For | ||||||||||
| 1c. | Election of Director for a term of one year: Bradley C. Irwin | Management | For | For | ||||||||||
| 1d. | Election of Director for a term of one year: Penry W. Price | Management | For | For | ||||||||||
| 1e. | Election of Director for a term of one year: Susan G. Saideman | Management | For | For | ||||||||||
| 1f. | Election of Director for a term of one year: Ravichandra K. Saligram | Management | For | For | ||||||||||
| 1g. | Election of Director for a term of one year: Robert K. Shearer | Management | For | For | ||||||||||
| 1h. | Election of Director for a term of one year: Janet S. Vergis | Management | For | For | ||||||||||
| 1i. | Election of Director for a term of one year: Arthur B. Winkleblack | Management | For | For | ||||||||||
| 1j. | Election of Director for a term of one year: Laurie J. Yoler | Management | For | For | ||||||||||
| 2. | An advisory vote to approve compensation of our named executive officers; | Management | For | For | ||||||||||
| 3. | An advisory vote to approve the preferred frequency of the advisory vote on compensation of our named executive officers. | Management | 1 Year | For | ||||||||||
| 4. | Ratification of the appointment of Deloitte & Touche LLP as our independent registered public accounting firm for 2023. | Management | For | For | ||||||||||
| 5. | Approval of the Church & Dwight Co., Inc. Employee Stock Purchase Plan. | Management | For | For | ||||||||||
| 6. | Stockholder Proposal - Independent Board Chairman. | Shareholder | Against | For | ||||||||||
| ASTRAZENECA PLC | ||||||||||||||
| Security | 046353108 | Meeting Type | Annual | |||||||||||
| Ticker Symbol | AZN | Meeting Date | 27-Apr-2023 | |||||||||||
| ISIN | US0463531089 | Agenda | 935796841 - Management | |||||||||||
| Item | Proposal | Proposed by |
Vote | For/Against Management |
||||||||||
| 1. | To receive the Company's Accounts, the Reports of the Directors and Auditor and the Strategic Report for the year ended 31 December 2022 | Management | For | For | ||||||||||
| 2. | To confirm dividends | Management | For | For | ||||||||||
| 3. | To reappoint PricewaterhouseCoopers LLP as Auditor | Management | For | For | ||||||||||
| 4. | To authorise the Directors to agree the remuneration of the Auditor | Management | For | For | ||||||||||
| 5a. | Re-election of Director: Michel Demaré | Management | For | For | ||||||||||
| 5b. | Re-election of Director: Pascal Soriot | Management | For | For | ||||||||||
| 5c. | Re-election of Director: Aradhana Sarin | Management | For | For | ||||||||||
| 5d. | Re-election of Director: Philip Broadley | Management | For | For | ||||||||||
| 5e. | Re-election of Director: Euan Ashley | Management | For | For | ||||||||||
| 5f. | Re-election of Director: Deborah DiSanzo | Management | For | For | ||||||||||
| 5g. | Re-election of Director: Diana Layfield | Management | For | For | ||||||||||
| 5h. | Re-election of Director: Sheri McCoy | Management | For | For | ||||||||||
| 5i. | Re-election of Director: Tony Mok | Management | For | For | ||||||||||
| 5j. | Re-election of Director: Nazneen Rahman | Management | For | For | ||||||||||
| 5k. | Re-election of Director: Andreas Rummelt | Management | For | For | ||||||||||
| 5l. | Re-election of Director: Marcus Wallenberg | Management | For | For | ||||||||||
| 6. | To approve the Annual Report on Remuneration for the year ended 31 December 2022 | Management | For | For | ||||||||||
| 7. | To authorise limited political donations | Management | For | For | ||||||||||
| 8. | To authorise the Directors to allot shares | Management | For | For | ||||||||||
| 9. | To authorise the Directors to disapply pre-emption rights (Special Resolution) | Management | Abstain | Against | ||||||||||
| 10. | To authorise the Directors to further disapply pre-emption rights for acquisitions and specified capital investments (Special Resolution) | Management | For | For | ||||||||||
| 11. | To authorise the Company to purchase its own shares (Special Resolution) | Management | For | For | ||||||||||
| 12. | To reduce the notice period for general meetings (Special Resolution) | Management | For | For | ||||||||||
| 13. | To adopt new Articles of Association (Special Resolution) | Management | For | For | ||||||||||
| CARDIOVASCULAR SYSTEMS, INC. | ||||||||||||||
| Security | 141619106 | Meeting Type | Special | |||||||||||
| Ticker Symbol | CSII | Meeting Date | 27-Apr-2023 | |||||||||||
| ISIN | US1416191062 | Agenda | 935800880 - Management | |||||||||||
| Item | Proposal | Proposed by |
Vote | For/Against Management |
||||||||||
| 1. | To adopt the Agreement and Plan of Merger, dated February 8, 2023 (such agreement, as it may be amended, modified or supplemented from time to time, the "Merger Agreement"), by and among Cardiovascular Systems, Inc. ("CSI"), Abbott Laboratories ("Abbott"), and Cobra Acquisition Co. ("Merger Sub"). Upon the terms and subject to the conditions of the Merger Agreement, Abbott will acquire CSI via a merger of Merger Sub with and into CSI, with CSI continuing as the surviving corporation and a wholly owned subsidiary of Abbott (the "Merger"). | Management | For | For | ||||||||||
| 2. | To approve, on an advisory (non-binding) basis, the compensation that may be paid or become payable to CSI's named executive officers that is based on or otherwise relates to the Merger Agreement, the Merger, and the other transactions contemplated by the Merger Agreement. | Management | For | For | ||||||||||
| 3. | To adjourn the Special Meeting to a later date or dates, if necessary or appropriate, including to solicit additional proxies to approve the proposal to adopt the Merger Agreement if there are insufficient votes to adopt the Merger Agreement at the time of the Special Meeting. | Management | For | For | ||||||||||
| NUVASIVE, INC. | ||||||||||||||
| Security | 670704105 | Meeting Type | Special | |||||||||||
| Ticker Symbol | NUVA | Meeting Date | 27-Apr-2023 | |||||||||||
| ISIN | US6707041058 | Agenda | 935811352 - Management | |||||||||||
| Item | Proposal | Proposed by |
Vote | For/Against Management |
||||||||||
| 1. | To adopt the Agreement and Plan of Merger, dated February 8, 2023 (which agreement is referred to as the "Merger Agreement"), by and among Globus Medical, Inc., Zebra Merger Sub, Inc., and NuVasive, Inc. ("NuVasive"), as it may be amended from time to time (which proposal is referred to as the "NuVasive Merger Proposal"). | Management | For | For | ||||||||||
| 2. | To approve, on a non-binding advisory basis, the compensation that may be paid or become payable to NuVasive named executive officers that is based on or otherwise relates to the transactions contemplated by the Merger Agreement. | Management | For | For | ||||||||||
| 3. | To approve the adjournment of the NuVasive special meeting, if necessary or appropriate, to solicit additional proxies if there are insufficient votes at the time of the NuVasive special meeting to approve the NuVasive Merger Proposal. | Management | For | For | ||||||||||
| GLOBUS MEDICAL, INC. | ||||||||||||||
| Security | 379577208 | Meeting Type | Special | |||||||||||
| Ticker Symbol | GMED | Meeting Date | 27-Apr-2023 | |||||||||||
| ISIN | US3795772082 | Agenda | 935813964 - Management | |||||||||||
| Item | Proposal | Proposed by |
Vote | For/Against Management |
||||||||||
| 1. | To approve the issuance of shares of Class A common stock, par value $0.001 per share, of Globus Medical, Inc. ("Globus") in connection with the merger contemplated by the Agreement and Plan of Merger, dated as of February 8, 2023, by and among Globus, NuVasive, Inc. and Zebra Merger Sub, Inc. (the "Globus Share Issuance Proposal"). | Management | For | For | ||||||||||
| 2. | To approve adjournments of the special meeting from time to time, if necessary or appropriate, including to solicit additional proxies in favor of the Globus Share Issuance Proposal if there are insufficient votes at the time of such adjournment to approve such proposal. | Management | For | For | ||||||||||
| ASTRAZENECA PLC | ||||||||||||||
| Security | 046353108 | Meeting Type | Annual | |||||||||||
| Ticker Symbol | AZN | Meeting Date | 27-Apr-2023 | |||||||||||
| ISIN | US0463531089 | Agenda | 935820793 - Management | |||||||||||
| Item | Proposal | Proposed by |
Vote | For/Against Management |
||||||||||
| 1. | To receive the Company's Accounts, the Reports of the Directors and Auditor and the Strategic Report for the year ended 31 December 2022 | Management | For | For | ||||||||||
| 2. | To confirm dividends | Management | For | For | ||||||||||
| 3. | To reappoint PricewaterhouseCoopers LLP as Auditor | Management | For | For | ||||||||||
| 4. | To authorise the Directors to agree the remuneration of the Auditor | Management | For | For | ||||||||||
| 5a. | Re-election of Director: Michel Demaré | Management | For | For | ||||||||||
| 5b. | Re-election of Director: Pascal Soriot | Management | For | For | ||||||||||
| 5c. | Re-election of Director: Aradhana Sarin | Management | For | For | ||||||||||
| 5d. | Re-election of Director: Philip Broadley | Management | For | For | ||||||||||
| 5e. | Re-election of Director: Euan Ashley | Management | For | For | ||||||||||
| 5f. | Re-election of Director: Deborah DiSanzo | Management | For | For | ||||||||||
| 5g. | Re-election of Director: Diana Layfield | Management | For | For | ||||||||||
| 5h. | Re-election of Director: Sheri McCoy | Management | For | For | ||||||||||
| 5i. | Re-election of Director: Tony Mok | Management | For | For | ||||||||||
| 5j. | Re-election of Director: Nazneen Rahman | Management | For | For | ||||||||||
| 5k. | Re-election of Director: Andreas Rummelt | Management | For | For | ||||||||||
| 5l. | Re-election of Director: Marcus Wallenberg | Management | For | For | ||||||||||
| 6. | To approve the Annual Report on Remuneration for the year ended 31 December 2022 | Management | For | For | ||||||||||
| 7. | To authorise limited political donations | Management | For | For | ||||||||||
| 8. | To authorise the Directors to allot shares | Management | For | For | ||||||||||
| 9. | To authorise the Directors to disapply pre-emption rights (Special Resolution) | Management | Abstain | Against | ||||||||||
| 10. | To authorise the Directors to further disapply pre-emption rights for acquisitions and specified capital investments (Special Resolution) | Management | For | For | ||||||||||
| 11. | To authorise the Company to purchase its own shares (Special Resolution) | Management | For | For | ||||||||||
| 12. | To reduce the notice period for general meetings (Special Resolution) | Management | For | For | ||||||||||
| 13. | To adopt new Articles of Association (Special Resolution) | Management | For | For | ||||||||||
| KELLOGG COMPANY | ||||||||||||||
| Security | 487836108 | Meeting Type | Annual | |||||||||||
| Ticker Symbol | K | Meeting Date | 28-Apr-2023 | |||||||||||
| ISIN | US4878361082 | Agenda | 935773540 - Management | |||||||||||
| Item | Proposal | Proposed by |
Vote | For/Against Management |
||||||||||
| 1a. | Election of Director (term expires 2026): Stephanie Burns | Management | For | For | ||||||||||
| 1b. | Election of Director (term expires 2026): Steve Cahillane | Management | For | For | ||||||||||
| 1c. | Election of Director (term expires 2026): La June Montgomery Tabron | Management | For | For | ||||||||||
| 2. | Advisory resolution to approve executive compensation. | Management | For | For | ||||||||||
| 3. | Advisory vote on the frequency of holding an advisory vote on executive compensation. | Management | 1 Year | For | ||||||||||
| 4. | Ratification of the appointment of PricewaterhouseCoopers LLP as Kellogg's independent registered public accounting firm for fiscal year 2023. | Management | For | For | ||||||||||
| 5. | Shareowner proposal requesting a civil rights, nondiscrimination and return to merits audit, if properly presented at the meeting. | Shareholder | Abstain | Against | ||||||||||
| 6. | Shareowner proposal requesting additional reporting on pay equity disclosure, if properly presented at the meeting. | Shareholder | Abstain | Against | ||||||||||
| ABBOTT LABORATORIES | ||||||||||||||
| Security | 002824100 | Meeting Type | Annual | |||||||||||
| Ticker Symbol | ABT | Meeting Date | 28-Apr-2023 | |||||||||||
| ISIN | US0028241000 | Agenda | 935777865 - Management | |||||||||||
| Item | Proposal | Proposed by |
Vote | For/Against Management |
||||||||||
| 1a. | Election of Director: R. J. Alpern | Management | For | For | ||||||||||
| 1b. | Election of Director: C. Babineaux-Fontenot | Management | For | For | ||||||||||
| 1c. | Election of Director: S. E. Blount | Management | For | For | ||||||||||
| 1d. | Election of Director: R. B. Ford | Management | For | For | ||||||||||
| 1e. | Election of Director: P. Gonzalez | Management | For | For | ||||||||||
| 1f. | Election of Director: M. A. Kumbier | Management | For | For | ||||||||||
| 1g. | Election of Director: D. W. McDew | Management | For | For | ||||||||||
| 1h. | Election of Director: N. McKinstry | Management | For | For | ||||||||||
| 1i. | Election of Director: M. G. O'Grady | Management | For | For | ||||||||||
| 1j. | Election of Director: M. F. Roman | Management | For | For | ||||||||||
| 1k. | Election of Director: D. J. Starks | Management | For | For | ||||||||||
| 1l. | Election of Director: J. G. Stratton | Management | For | For | ||||||||||
| 2. | Ratification of Ernst & Young LLP As Auditors | Management | For | For | ||||||||||
| 3. | Say on Pay - An Advisory Vote on the Approval of Executive Compensation | Management | For | For | ||||||||||
| 4. | Say When on Pay - An Advisory Vote on the Approval of the Frequency of Shareholder Votes on Executive Compensation | Management | 1 Year | For | ||||||||||
| 5. | Shareholder Proposal - Special Shareholder Meeting Threshold | Shareholder | Against | For | ||||||||||
| 6. | Shareholder Proposal - Independent Board Chairman | Shareholder | Against | For | ||||||||||
| 7. | Shareholder Proposal - Lobbying Disclosure | Shareholder | Abstain | Against | ||||||||||
| 8. | Shareholder Proposal - Incentive Compensation | Shareholder | Against | For | ||||||||||
| BAXTER INTERNATIONAL INC. | ||||||||||||||
| Security | 071813109 | Meeting Type | Annual | |||||||||||
| Ticker Symbol | BAX | Meeting Date | 02-May-2023 | |||||||||||
| ISIN | US0718131099 | Agenda | 935786218 - Management | |||||||||||
| Item | Proposal | Proposed by |
Vote | For/Against Management |
||||||||||
| 1a. | Election of Director: José (Joe) Almeida | Management | For | For | ||||||||||
| 1b. | Election of Director: Michael F. Mahoney | Management | For | For | ||||||||||
| 1c. | Election of Director: Patricia B. Morrison | Management | For | For | ||||||||||
| 1d. | Election of Director: Stephen N. Oesterle | Management | For | For | ||||||||||
| 1e. | Election of Director: Nancy M. Schlichting | Management | For | For | ||||||||||
| 1f. | Election of Director: Brent Shafer | Management | For | For | ||||||||||
| 1g. | Election of Director: Cathy R. Smith | Management | For | For | ||||||||||
| 1h. | Election of Director: Amy A. Wendell | Management | For | For | ||||||||||
| 1i. | Election of Director: David S. Wilkes | Management | For | For | ||||||||||
| 1j. | Election of Director: Peter M. Wilver | Management | For | For | ||||||||||
| 2. | Advisory Vote to Approve Named Executive Officer Compensation. | Management | For | For | ||||||||||
| 3. | Advisory Vote on the Frequency of Executive Compensation Advisory Votes. | Management | 1 Year | For | ||||||||||
| 4. | Ratification of Appointment of Independent Registered Public Accounting Firm. | Management | For | For | ||||||||||
| 5. | Stockholder Proposal - Shareholder Ratification of Excessive Termination Pay. | Shareholder | Against | For | ||||||||||
| 6. | Stockholder Proposal - Executives to Retain Significant Stock. | Shareholder | Against | For | ||||||||||
| BRISTOL-MYERS SQUIBB COMPANY | ||||||||||||||
| Security | 110122108 | Meeting Type | Annual | |||||||||||
| Ticker Symbol | BMY | Meeting Date | 02-May-2023 | |||||||||||
| ISIN | US1101221083 | Agenda | 935788286 - Management | |||||||||||
| Item | Proposal | Proposed by |
Vote | For/Against Management |
||||||||||
| 1A. | Election of Director: Peter J. Arduini | Management | For | For | ||||||||||
| 1B. | Election of Director: Deepak L. Bhatt, M.D., M.P.H. | Management | For | For | ||||||||||
| 1C. | Election of Director: Giovanni Caforio, M.D. | Management | For | For | ||||||||||
| 1D. | Election of Director: Julia A. Haller, M.D. | Management | For | For | ||||||||||
| 1E. | Election of Director: Manuel Hidalgo Medina, M.D., Ph.D. | Management | For | For | ||||||||||
| 1F. | Election of Director: Paula A. Price | Management | For | For | ||||||||||
| 1G. | Election of Director: Derica W. Rice | Management | For | For | ||||||||||
| 1H. | Election of Director: Theodore R. Samuels | Management | For | For | ||||||||||
| 1I. | Election of Director: Gerald L. Storch | Management | For | For | ||||||||||
| 1J. | Election of Director: Karen H. Vousden, Ph.D. | Management | For | For | ||||||||||
| 1K. | Election of Director: Phyllis R. Yale | Management | For | For | ||||||||||
| 2. | Advisory Vote to Approve the Compensation of our Named Executive Officers. | Management | For | For | ||||||||||
| 3. | Advisory Vote on the Frequency of the Advisory Vote on the Compensation of our Named Executive Officers. | Management | 1 Year | For | ||||||||||
| 4. | Ratification of the Appointment of an Independent Registered Public Accounting Firm. | Management | For | For | ||||||||||
| 5. | Shareholder Proposal on the Adoption of a Board Policy that the Chairperson of the Board be an Independent Director. | Shareholder | Against | For | ||||||||||
| 6. | Shareholder Proposal on Workplace Non-Discrimination Audit. | Shareholder | Abstain | Against | ||||||||||
| 7. | Shareholder Proposal on Special Shareholder Meeting Improvement. | Shareholder | Against | For | ||||||||||
| PEPSICO, INC. | ||||||||||||||
| Security | 713448108 | Meeting Type | Annual | |||||||||||
| Ticker Symbol | PEP | Meeting Date | 03-May-2023 | |||||||||||
| ISIN | US7134481081 | Agenda | 935784795 - Management | |||||||||||
| Item | Proposal | Proposed by |
Vote | For/Against Management |
||||||||||
| 1a. | Election of Director: Segun Agbaje | Management | For | For | ||||||||||
| 1b. | Election of Director: Jennifer Bailey | Management | For | For | ||||||||||
| 1c. | Election of Director: Cesar Conde | Management | For | For | ||||||||||
| 1d. | Election of Director: Ian Cook | Management | For | For | ||||||||||
| 1e. | Election of Director: Edith W. Cooper | Management | For | For | ||||||||||
| 1f. | Election of Director: Susan M. Diamond | Management | For | For | ||||||||||
| 1g. | Election of Director: Dina Dublon | Management | For | For | ||||||||||
| 1h. | Election of Director: Michelle Gass | Management | For | For | ||||||||||
| 1i. | Election of Director: Ramon L. Laguarta | Management | For | For | ||||||||||
| 1j. | Election of Director: Dave J. Lewis | Management | For | For | ||||||||||
| 1k. | Election of Director: David C. Page | Management | For | For | ||||||||||
| 1l. | Election of Director: Robert C. Pohlad | Management | For | For | ||||||||||
| 1m. | Election of Director: Daniel Vasella | Management | For | For | ||||||||||
| 1n. | Election of Director: Darren Walker | Management | For | For | ||||||||||
| 1o. | Election of Director: Alberto Weisser | Management | For | For | ||||||||||
| 2. | Ratification of the appointment of KPMG LLP as the Company's independent registered public accounting firm for fiscal year 2023. | Management | For | For | ||||||||||
| 3. | Advisory approval of the Company's executive compensation | Management | For | For | ||||||||||
| 4. | Advisory vote on frequency of future shareholder advisory approval of the Company's executive compensation. | Management | 1 Year | For | ||||||||||
| 5. | Shareholder Proposal - Independent Board Chair. | Shareholder | Against | For | ||||||||||
| 6. | Shareholder Proposal - Global Transparency Report. | Shareholder | Abstain | Against | ||||||||||
| 7. | Shareholder Proposal - Report on Impacts of Reproductive Healthcare Legislation | Shareholder | Abstain | Against | ||||||||||
| 8. | Shareholder Proposal - Congruency Report on Net-Zero Emissions Policies. | Shareholder | Abstain | Against | ||||||||||
| INTERNATIONAL FLAVORS & FRAGRANCES INC. | ||||||||||||||
| Security | 459506101 | Meeting Type | Annual | |||||||||||
| Ticker Symbol | IFF | Meeting Date | 03-May-2023 | |||||||||||
| ISIN | US4595061015 | Agenda | 935785470 - Management | |||||||||||
| Item | Proposal | Proposed by |
Vote | For/Against Management |
||||||||||
| 1a. | Election of Director for a one-year term expiring at the 2024 Annual Meeting of Shareholders: Kathryn J. Boor | Management | For | For | ||||||||||
| 1b. | Election of Director for a one-year term expiring at the 2024 Annual Meeting of Shareholders: Barry A. Bruno | Management | For | For | ||||||||||
| 1c. | Election of Director for a one-year term expiring at the 2024 Annual Meeting of Shareholders: Frank K. Clyburn, Jr. | Management | For | For | ||||||||||
| 1d. | Election of Director for a one-year term expiring at the 2024 Annual Meeting of Shareholders: Mark J. Costa | Management | For | For | ||||||||||
| 1e. | Election of Director for a one-year term expiring at the 2024 Annual Meeting of Shareholders: Carol Anthony (John) Davidson | Management | For | For | ||||||||||
| 1f. | Election of Director for a one-year term expiring at the 2024 Annual Meeting of Shareholders: Roger W. Ferguson, Jr. | Management | For | For | ||||||||||
| 1g. | Election of Director for a one-year term expiring at the 2024 Annual Meeting of Shareholders: John F. Ferraro | Management | For | For | ||||||||||
| 1h. | Election of Director for a one-year term expiring at the 2024 Annual Meeting of Shareholders: Christina Gold | Management | For | For | ||||||||||
| 1i. | Election of Director for a one-year term expiring at the 2024 Annual Meeting of Shareholders: Gary Hu | Management | For | For | ||||||||||
| 1j. | Election of Director for a one-year term expiring at the 2024 Annual Meeting of Shareholders: Kevin O'Byrne | Management | For | For | ||||||||||
| 1k. | Election of Director for a one-year term expiring at the 2024 Annual Meeting of Shareholders: Dawn C. Willoughby | Management | For | For | ||||||||||
| 2. | Ratify the selection of PricewaterhouseCoopers LLP as our independent registered public accounting firm for the 2023 fiscal year. | Management | For | For | ||||||||||
| 3. | Approve, on an advisory basis, the compensation of our named executive officers in 2022. | Management | For | For | ||||||||||
| 4. | Vote, on an advisory basis, on the frequency of votes on executive compensation. | Management | 1 Year | For | ||||||||||
| VERICEL CORPORATION | ||||||||||||||
| Security | 92346J108 | Meeting Type | Annual | |||||||||||
| Ticker Symbol | VCEL | Meeting Date | 03-May-2023 | |||||||||||
| ISIN | US92346J1088 | Agenda | 935786674 - Management | |||||||||||
| Item | Proposal | Proposed by |
Vote | For/Against Management |
||||||||||
| 1. | DIRECTOR | Management | ||||||||||||
| 1 | Robert L. Zerbe | For | For | |||||||||||
| 2 | Alan L. Rubino | For | For | |||||||||||
| 3 | Heidi Hagen | For | For | |||||||||||
| 4 | Steven C. Gilman | For | For | |||||||||||
| 5 | Kevin F. McLaughlin | For | For | |||||||||||
| 6 | Paul K. Wotton | For | For | |||||||||||
| 7 | Dominick C. Colangelo | For | For | |||||||||||
| 8 | Lisa Wright | For | For | |||||||||||
| 2. | To approve, on an advisory basis, the compensation of Vericel Corporation's named executive officers. | Management | For | For | ||||||||||
| 3. | To ratify the appointment of PricewaterhouseCoopers LLP as Vericel Corporation's independent registered public accounting firm for the fiscal year ending December 31, 2023. | Management | For | For | ||||||||||
| UNILEVER PLC | ||||||||||||||
| Security | 904767704 | Meeting Type | Annual | |||||||||||
| Ticker Symbol | UL | Meeting Date | 03-May-2023 | |||||||||||
| ISIN | US9047677045 | Agenda | 935793124 - Management | |||||||||||
| Item | Proposal | Proposed by |
Vote | For/Against Management |
||||||||||
| 1. | To receive the Report and Accounts for the year ended 31 December 2022. | Management | For | For | ||||||||||
| 2. | To approve the Directors' Remuneration Report. | Management | Against | Against | ||||||||||
| 3. | To re-elect Nils Andersen as a Director. | Management | For | For | ||||||||||
| 4. | To re-elect Judith Hartmann as a Director. | Management | For | For | ||||||||||
| 5. | To re-elect Adrian Hennah as a Director. | Management | For | For | ||||||||||
| 6. | To re-elect Alan Jope as a Director. | Management | For | For | ||||||||||
| 7. | To re-elect Andrea Jung as a Director. | Management | For | For | ||||||||||
| 8. | To re-elect Susan Kilsby as a Director. | Management | For | For | ||||||||||
| 9. | To re-elect Ruby Lu as a Director. | Management | For | For | ||||||||||
| 10. | To re-elect Strive Masiyiwa as a Director. | Management | For | For | ||||||||||
| 11. | To re-elect Youngme Moon as a Director. | Management | For | For | ||||||||||
| 12. | To re-elect Graeme Pitkethly as a Director. | Management | For | For | ||||||||||
| 13. | To re-elect Feike Sijbesma as a Director. | Management | For | For | ||||||||||
| 14. | To elect Nelson Peltz as a Director. | Management | For | For | ||||||||||
| 15. | To elect Hein Schumacher as a Director. | Management | For | For | ||||||||||
| 16. | To reappoint KPMG LLP as Auditor of the Company. | Management | For | For | ||||||||||
| 17. | To authorise the Directors to fix the remuneration of the Auditor. | Management | For | For | ||||||||||
| 18. | To authorise Political Donations and expenditure. | Management | For | For | ||||||||||
| 19. | To renew the authority to Directors to issue shares. | Management | For | For | ||||||||||
| 20. | To renew the authority to Directors to disapply pre- emption rights. | Management | Abstain | Against | ||||||||||
| 21. | To renew the authority to Directors to disapply pre- emption rights for the purposes of acquisitions or capital investments. | Management | For | For | ||||||||||
| 22. | To renew the authority to the Company to purchase its own shares. | Management | For | For | ||||||||||
| 23. | To shorten the notice period for General Meetings to 14 clear days' notice. | Management | For | For | ||||||||||
| IDORSIA LTD | ||||||||||||||
| Security | H3879B109 | Meeting Type | Annual General Meeting | |||||||||||
| Ticker Symbol | Meeting Date | 04-May-2023 | ||||||||||||
| ISIN | CH0363463438 | Agenda | 716957064 - Management | |||||||||||
| Item | Proposal | Proposed by |
Vote | For/Against Management |
||||||||||
| CMMT | VOTING MUST BE LODGED WITH BENEFICIAL OWNER DETAILS AS PROVIDED BY YOUR- CUSTODIAN BANK. IF NO BENEFICIAL OWNER DETAILS ARE PROVIDED, YOUR INSTRUCTION-MAY BE REJECTED. | Non-Voting | ||||||||||||
| 1.1 | ACCEPT FINANCIAL STATEMENTS AND STATUTORY REPORTS | Management | No Action | |||||||||||
| 1.2 | APPROVE REMUNERATION REPORT (NON-BINDING) | Management | No Action | |||||||||||
| 2 | APPROVE TREATMENT OF NET LOSS | Management | No Action | |||||||||||
| 3 | APPROVE DISCHARGE OF BOARD AND SENIOR MANAGEMENT | Management | No Action | |||||||||||
| 4.1.1 | REELECT MATHIEU SIMON AS DIRECTOR | Management | No Action | |||||||||||
| 4.1.2 | REELECT JOERN ALDAG AS DIRECTOR | Management | No Action | |||||||||||
| 4.1.3 | REELECT JEAN-PAUL CLOZEL AS DIRECTOR | Management | No Action | |||||||||||
| 4.1.4 | REELECT FELIX EHRAT AS DIRECTOR | Management | No Action | |||||||||||
| 4.1.5 | REELECT SRISHTI GUPTA AS DIRECTOR | Management | No Action | |||||||||||
| 4.1.6 | REELECT PETER KELLOGG AS DIRECTOR | Management | No Action | |||||||||||
| 4.1.7 | REELECT SANDY MAHATME AS DIRECTOR | Management | No Action | |||||||||||
| 4.1.8 | ELECT SOPHIE KORNOWSKI AS DIRECTOR | Management | No Action | |||||||||||
| 4.2 | REELECT MATHIEU SIMON AS BOARD CHAIR | Management | No Action | |||||||||||
| 4.3.1 | REAPPOINT FELIX EHRAT AS CHAIRMAN OF THE NOMINATION, COMPENSATION AND GOVERNANCE COMMITTEE | Management | No Action | |||||||||||
| 4.3.2 | REAPPOINT SRISHTI GUPTA AS MEMBER OF THE NOMINATION, COMPENSATION AND GOVERNANCE COMMITTEE | Management | No Action | |||||||||||
| 4.3.3 | REAPPOINT MATHIEU SIMON AS MEMBER OF THE NOMINATION, COMPENSATION AND GOVERNANCE COMMITTEE | Management | No Action | |||||||||||
| 4.3.4 | APPOINT SOPHIE KORNOWSKI AS MEMBER OF THE NOMINATION, COMPENSATION AND GOVERNANCE COMMITTEE | Management | No Action | |||||||||||
| 5.1 | APPROVE REMUNERATION OF DIRECTORS IN THE AMOUNT OF CHF 1.5 MILLION | Management | No Action | |||||||||||
| 5.2 | APPROVE REMUNERATION OF EXECUTIVE COMMITTEE IN THE AMOUNT OF CHF 17.2 MILLION | Management | No Action | |||||||||||
| 6 | DESIGNATE BACHMANNPARTNER AG AS INDEPENDENT PROXY | Management | No Action | |||||||||||
| 7 | RATIFY ERNST & YOUNG AG AS AUDITORS | Management | No Action | |||||||||||
| 8.1 | AMEND CORPORATE PURPOSE | Management | No Action | |||||||||||
| 8.2 | APPROVE CREATION OF CHF 1.3 MILLION POOL OF CONDITIONAL CAPITAL FOR EMPLOYEE EQUITY PARTICIPATION | Management | No Action | |||||||||||
| 8.3 | APPROVE CREATION OF CAPITAL BAND WITHIN THE UPPER LIMIT OF CHF 14.1 MILLION AND THE LOWER LIMIT OF CHF 4.7 MILLION WITH OR WITHOUT EXCLUSION OF PREEMPTIVE RIGHTS | Management | No Action | |||||||||||
| 8.4 | AMEND ARTICLES RE: SHARES AND SHARE REGISTER | Management | No Action | |||||||||||
| 8.5 | AMEND ARTICLES OF ASSOCIATION (INCL. APPROVAL OF VIRTUAL-ONLY OR HYBRID SHAREHOLDER MEETINGS) | Management | No Action | |||||||||||
| 8.6 | AMEND ARTICLES RE: BOARD OF DIRECTORS; COMPENSATION; EXTERNAL MANDATES FOR MEMBERS OF THE BOARD OF DIRECTORS AND EXECUTIVE COMMITTEE | Management | No Action | |||||||||||
| CMMT | PART 2 OF THIS MEETING IS FOR VOTING ON AGENDA AND MEETING ATTENDANCE-REQUESTS ONLY. PLEASE ENSURE THAT YOU HAVE FIRST VOTED IN FAVOUR OF THE-REGISTRATION OF SHARES IN PART 1 OF THE MEETING. IT IS A MARKET REQUIREMENT-FOR MEETINGS OF THIS TYPE THAT THE SHARES ARE REGISTERED AND MOVED TO A-REGISTERED LOCATION AT THE CSD, AND SPECIFIC POLICIES AT THE INDIVIDUAL-SUB- CUSTODIANS MAY VARY. UPON RECEIPT OF THE VOTE INSTRUCTION, IT IS POSSIBLE-THAT A MARKER MAY BE PLACED ON YOUR SHARES TO ALLOW FOR RECONCILIATION AND-RE- REGISTRATION FOLLOWING A TRADE. THEREFORE WHILST THIS DOES NOT PREVENT THE-TRADING OF SHARES, ANY THAT ARE REGISTERED MUST BE FIRST DEREGISTERED IF-REQUIRED FOR SETTLEMENT. DEREGISTRATION CAN AFFECT THE VOTING RIGHTS OF THOSE-SHARES. IF YOU HAVE CONCERNS REGARDING YOUR ACCOUNTS, PLEASE CONTACT YOUR-CLIENT REPRESENTATIVE | Non-Voting | ||||||||||||
| THE KRAFT HEINZ COMPANY | ||||||||||||||
| Security | 500754106 | Meeting Type | Annual | |||||||||||
| Ticker Symbol | KHC | Meeting Date | 04-May-2023 | |||||||||||
| ISIN | US5007541064 | Agenda | 935780557 - Management | |||||||||||
| Item | Proposal | Proposed by |
Vote | For/Against Management |
||||||||||
| 1a. | Election of Director: Gregory E. Abel | Management | For | For | ||||||||||
| 1b. | Election of Director: Humberto P. Alfonso | Management | For | For | ||||||||||
| 1c. | Election of Director: John T. Cahill | Management | For | For | ||||||||||
| 1d. | Election of Director: Lori Dickerson Fouché | Management | For | For | ||||||||||
| 1e. | Election of Director: Diane Gherson | Management | For | For | ||||||||||
| 1f. | Election of Director: Timothy Kenesey | Management | For | For | ||||||||||
| 1g. | Election of Director: Alicia Knapp | Management | For | For | ||||||||||
| 1h. | Election of Director: Elio Leoni Sceti | Management | For | For | ||||||||||
| 1i. | Election of Director: Susan Mulder | Management | For | For | ||||||||||
| 1j. | Election of Director: James Park | Management | For | For | ||||||||||
| 1k. | Election of Director: Miguel Patricio | Management | For | For | ||||||||||
| 1l. | Election of Director: John C. Pope | Management | For | For | ||||||||||
| 2. | Advisory vote to approve executive compensation. | Management | For | For | ||||||||||
| 3. | Ratification of the selection of PricewaterhouseCoopers LLP as our independent auditors for 2023. | Management | For | For | ||||||||||
| 4. | Stockholder Proposal - Simple majority vote, if properly presented. | Shareholder | Against | For | ||||||||||
| 5. | Stockholder Proposal - Report on water risk, if properly presented. | Shareholder | Abstain | Against | ||||||||||
| 6. | Stockholder Proposal - Civil rights audit, if properly presented. | Shareholder | Abstain | Against | ||||||||||
| BOSTON SCIENTIFIC CORPORATION | ||||||||||||||
| Security | 101137107 | Meeting Type | Annual | |||||||||||
| Ticker Symbol | BSX | Meeting Date | 04-May-2023 | |||||||||||
| ISIN | US1011371077 | Agenda | 935784860 - Management | |||||||||||
| Item | Proposal | Proposed by |
Vote | For/Against Management |
||||||||||
| 1a. | Election of Director: Nelda J. Connors | Management | For | For | ||||||||||
| 1b. | Election of Director: Charles J. Dockendorff | Management | For | For | ||||||||||
| 1c. | Election of Director: Yoshiaki Fujimori | Management | For | For | ||||||||||
| 1d. | Election of Director: Edward J. Ludwig | Management | For | For | ||||||||||
| 1e. | Election of Director: Michael F. Mahoney | Management | For | For | ||||||||||
| 1f. | Election of Director: David J. Roux | Management | For | For | ||||||||||
| 1g. | Election of Director: John E. Sununu | Management | For | For | ||||||||||
| 1h. | Election of Director: David S. Wichmann | Management | For | For | ||||||||||
| 1i. | Election of Director: Ellen M. Zane | Management | For | For | ||||||||||
| 2. | To approve, on a non-binding, advisory basis, the compensation of our named executive officers. | Management | For | For | ||||||||||
| 3. | To approve, on a non-binding, advisory basis, the frequency of future advisory votes on the compensation of our named executive officers. | Management | 1 Year | For | ||||||||||
| 4. | To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for the 2023 fiscal year. | Management | For | For | ||||||||||
| PERRIGO COMPANY PLC | ||||||||||||||
| Security | G97822103 | Meeting Type | Annual | |||||||||||
| Ticker Symbol | PRGO | Meeting Date | 04-May-2023 | |||||||||||
| ISIN | IE00BGH1M568 | Agenda | 935788464 - Management | |||||||||||
| Item | Proposal | Proposed by |
Vote | For/Against Management |
||||||||||
| 1A. | Election of Director to hold office until the 2024 Annual General Meeting: Bradley A. Alford | Management | For | For | ||||||||||
| 1B. | Election of Director to hold office until the 2024 Annual General Meeting: Orlando D. Ashford | Management | For | For | ||||||||||
| 1C. | Election of Director to hold office until the 2024 Annual General Meeting: Katherine C. Doyle | Management | For | For | ||||||||||
| 1D. | Election of Director to hold office until the 2024 Annual General Meeting: Adriana Karaboutis | Management | For | For | ||||||||||
| 1E. | Election of Director to hold office until the 2024 Annual General Meeting: Murray S. Kessler | Management | For | For | ||||||||||
| 1F. | Election of Director to hold office until the 2024 Annual General Meeting: Jeffrey B. Kindler | Management | For | For | ||||||||||
| 1G. | Election of Director to hold office until the 2024 Annual General Meeting: Erica L. Mann | Management | For | For | ||||||||||
| 1H. | Election of Director to hold office until the 2024 Annual General Meeting: Albert A. Manzone | Management | For | For | ||||||||||
| 1I. | Election of Director to hold office until the 2024 Annual General Meeting: Donal O'Connor | Management | For | For | ||||||||||
| 1J. | Election of Director to hold office until the 2024 Annual General Meeting: Geoffrey M. Parker | Management | For | For | ||||||||||
| 2. | Ratify, in a non-binding advisory vote, the appointment of Ernst & Young LLP as the Company's independent auditor, and authorize, in a binding vote, the Board of Directors, acting through the Audit Committee, to fix the remuneration of the auditor | Management | For | For | ||||||||||
| 3. | Advisory vote on executive compensation | Management | For | For | ||||||||||
| 4. | Advisory vote on the frequency of future advisory votes on executive compensation | Management | 1 Year | For | ||||||||||
| 5. | Renew the Board's authority to issue shares under Irish law | Management | For | For | ||||||||||
| 6. | Renew the Board's authority to opt-out of statutory pre- emption rights under Irish law | Management | Against | Against | ||||||||||
| 7. | Approve the creation of distributable reserves by reducing some or all of the Company's share premium | Management | For | For | ||||||||||
| HALOZYME THERAPEUTICS, INC. | ||||||||||||||
| Security | 40637H109 | Meeting Type | Annual | |||||||||||
| Ticker Symbol | HALO | Meeting Date | 05-May-2023 | |||||||||||
| ISIN | US40637H1095 | Agenda | 935782121 - Management | |||||||||||
| Item | Proposal | Proposed by |
Vote | For/Against Management |
||||||||||
| 1A. | Election of Class I Director: Bernadette Connaughton | Management | For | For | ||||||||||
| 1B. | Election of Class I Director: Moni Miyashita | Management | For | For | ||||||||||
| 1C. | Election of Class I Director: Matthew L. Posard | Management | For | For | ||||||||||
| 2. | To approve, by a non-binding advisory vote, the compensation of the Company's named executive officers. | Management | For | For | ||||||||||
| 3. | To recommend, by non-binding vote, the frequency of executive compensation votes. | Management | 1 Year | For | ||||||||||
| 4. | To ratify the selection of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2023. | Management | For | For | ||||||||||
| ABBVIE INC. | ||||||||||||||
| Security | 00287Y109 | Meeting Type | Annual | |||||||||||
| Ticker Symbol | ABBV | Meeting Date | 05-May-2023 | |||||||||||
| ISIN | US00287Y1091 | Agenda | 935786484 - Management | |||||||||||
| Item | Proposal | Proposed by |
Vote | For/Against Management |
||||||||||
| 1a. | Election of Class II Director: Robert J. Alpern | Management | For | For | ||||||||||
| 1b. | Election of Class II Director: Melody B. Meyer | Management | For | For | ||||||||||
| 1c. | Election of Class II Director: Frederick H. Waddell | Management | For | For | ||||||||||
| 2. | Ratification of Ernst & Young LLP as AbbVie's independent registered public accounting firm for 2023. | Management | For | For | ||||||||||
| 3. | Say on Pay - An advisory vote on the approval of executive compensation. | Management | For | For | ||||||||||
| 4. | Approval of a management proposal regarding amendment of the certificate of incorporation to eliminate supermajority voting. | Management | For | For | ||||||||||
| 5. | Stockholder Proposal - to Implement Simple Majority Vote. | Shareholder | Against | For | ||||||||||
| 6. | Stockholder Proposal - to Issue an Annual Report on Political Spending. | Shareholder | Abstain | Against | ||||||||||
| 7. | Stockholder Proposal - to Issue an Annual Report on Lobbying. | Shareholder | Abstain | Against | ||||||||||
| 8. | Stockholder Proposal - to Issue a Report on Patent Process. | Shareholder | Against | For | ||||||||||
| TACTILE SYSTEMS TECHNOLOGY, INC. | ||||||||||||||
| Security | 87357P100 | Meeting Type | Annual | |||||||||||
| Ticker Symbol | TCMD | Meeting Date | 08-May-2023 | |||||||||||
| ISIN | US87357P1003 | Agenda | 935791625 - Management | |||||||||||
| Item | Proposal | Proposed by |
Vote | For/Against Management |
||||||||||
| 1. | DIRECTOR | Management | ||||||||||||
| 1 | Valerie Asbury | For | For | |||||||||||
| 2 | Bill Burke | For | For | |||||||||||
| 3 | Sheri Dodd | For | For | |||||||||||
| 4 | Raymond Huggenberger | For | For | |||||||||||
| 5 | Daniel Reuvers | For | For | |||||||||||
| 6 | Brent Shafer | For | For | |||||||||||
| 7 | Carmen Volkart | For | For | |||||||||||
| 2. | Ratify the appointment of Grant Thornton LLP as our independent registered public accounting firm for the year ending December 31, 2023. | Management | For | For | ||||||||||
| 3. | Approve, on an advisory basis, the 2022 compensation of our named executive officers. | Management | For | For | ||||||||||
| CHARLES RIVER LABORATORIES INTL., INC. | ||||||||||||||
| Security | 159864107 | Meeting Type | Annual | |||||||||||
| Ticker Symbol | CRL | Meeting Date | 09-May-2023 | |||||||||||
| ISIN | US1598641074 | Agenda | 935808999 - Management | |||||||||||
| Item | Proposal | Proposed by |
Vote | For/Against Management |
||||||||||
| 1a. | Election of Director: James C. Foster | Management | For | For | ||||||||||
| 1b. | Election of Director: Nancy C. Andrews | Management | For | For | ||||||||||
| 1c. | Election of Director: Robert Bertolini | Management | For | For | ||||||||||
| 1d. | Election of Director: Deborah T. Kochevar | Management | For | For | ||||||||||
| 1e. | Election of Director: George Llado, Sr. | Management | For | For | ||||||||||
| 1f. | Election of Director: Martin W. Mackay | Management | For | For | ||||||||||
| 1g. | Election of Director: George E. Massaro | Management | For | For | ||||||||||
| 1h. | Election of Director: C. Richard Reese | Management | For | For | ||||||||||
| 1i. | Election of Director: Craig B. Thompson | Management | For | For | ||||||||||
| 1j. | Election of Director: Richard F. Wallman | Management | For | For | ||||||||||
| 1k. | Election of Director: Virginia M. Wilson | Management | For | For | ||||||||||
| 2. | Advisory Approval of 2022 Executive Officer Compensation | Management | For | For | ||||||||||
| 3. | Advisory Vote on the Frequency of Future Advisory Votes on Executive Compensation | Management | 1 Year | For | ||||||||||
| 4. | Ratification of PricewaterhouseCoopers LLC as independent registered public accounting firm for 2023 | Management | For | For | ||||||||||
| 5. | Proposal to publish a report on non-human primates imported by Charles River Laboratories International, Inc. | Management | Abstain | Against | ||||||||||
| STRYKER CORPORATION | ||||||||||||||
| Security | 863667101 | Meeting Type | Annual | |||||||||||
| Ticker Symbol | SYK | Meeting Date | 10-May-2023 | |||||||||||
| ISIN | US8636671013 | Agenda | 935785444 - Management | |||||||||||
| Item | Proposal | Proposed by |
Vote | For/Against Management |
||||||||||
| 1a. | Election of Director: Mary K. Brainerd | Management | For | For | ||||||||||
| 1b. | Election of Director: Giovanni Caforio, M.D. | Management | For | For | ||||||||||
| 1c. | Election of Director: Srikant M. Datar, Ph.D. | Management | For | For | ||||||||||
| 1d. | Election of Director: Allan C. Golston | Management | For | For | ||||||||||
| 1e. | Election of Director: Kevin A. Lobo (Chair of the Board, Chief Executive Officer and President) | Management | For | For | ||||||||||
| 1f. | Election of Director: Sherilyn S. McCoy (Lead Independent Director) | Management | For | For | ||||||||||
| 1g. | Election of Director: Andrew K. Silvernail | Management | For | For | ||||||||||
| 1h. | Election of Director: Lisa M. Skeete Tatum | Management | For | For | ||||||||||
| 1i. | Election of Director: Ronda E. Stryker | Management | For | For | ||||||||||
| 1j. | Election of Director: Rajeev Suri | Management | For | For | ||||||||||
| 2. | Ratification of Appointment of Ernst & Young LLP as Our Independent Registered Public Accounting Firm for 2023. | Management | For | For | ||||||||||
| 3. | Advisory Vote to Approve Named Executive Officer Compensation. | Management | For | For | ||||||||||
| 4. | Advisory Vote on the Frequency of Future Advisory Votes on Named Executive Officer Compensation. | Management | 1 Year | For | ||||||||||
| 5. | Shareholder Proposal on Political Disclosure. | Shareholder | Abstain | Against | ||||||||||
| ELEVANCE HEALTH, INC. | ||||||||||||||
| Security | 036752103 | Meeting Type | Annual | |||||||||||
| Ticker Symbol | ELV | Meeting Date | 10-May-2023 | |||||||||||
| ISIN | US0367521038 | Agenda | 935797502 - Management | |||||||||||
| Item | Proposal | Proposed by |
Vote | For/Against Management |
||||||||||
| 1a. | Election of Director: Gail K. Boudreaux | Management | For | For | ||||||||||
| 1b. | Election of Director: R. Kerry Clark | Management | For | For | ||||||||||
| 1c. | Election of Director: Robert L. Dixon, Jr. | Management | For | For | ||||||||||
| 1d. | Election of Director: Deanna D. Strable | Management | For | For | ||||||||||
| 2. | Advisory vote to approve the compensation of our named executive officers. | Management | For | For | ||||||||||
| 3. | Advisory vote on the frequency of the advisory vote to approve the compensation of our named executive officers. | Management | 1 Year | For | ||||||||||
| 4. | To ratify the appointment of Ernst & Young LLP as the independent registered public accounting firm for 2023. | Management | For | For | ||||||||||
| 5. | Shareholder proposal to allow shareholders owning 10% or more of our common stock to call a special meeting of shareholders. | Shareholder | Against | For | ||||||||||
| 6. | Shareholder proposal requesting annual reporting from third parties seeking financial support. | Shareholder | Abstain | Against | ||||||||||
| MAPLE LEAF FOODS INC | ||||||||||||||
| Security | 564905107 | Meeting Type | Annual General Meeting | |||||||||||
| Ticker Symbol | Meeting Date | 11-May-2023 | ||||||||||||
| ISIN | CA5649051078 | Agenda | 716848051 - Management | |||||||||||
| Item | Proposal | Proposed by |
Vote | For/Against Management |
||||||||||
| CMMT | PLEASE NOTE THAT SHAREHOLDERS ARE ALLOWED TO VOTE 'IN FAVOR' OR 'AGAINST'-ONLY FOR RESOLUTIONS 1.A TO 1.I AND 3 AND 'IN FAVOR' OR 'ABSTAIN' ONLY FOR-RESOLUTION NUMBER 2. THANK YOU | Non-Voting | ||||||||||||
| 1.A | ELECTION OF DIRECTOR: WILLIAM E. AZIZ | Management | For | For | ||||||||||
| 1.B | ELECTION OF DIRECTOR: RONALD G. CLOSE | Management | For | For | ||||||||||
| 1.C | ELECTION OF DIRECTOR: THOMAS P. HAYES | Management | For | For | ||||||||||
| 1.D | ELECTION OF DIRECTOR: KATHERINE N. LEMON | Management | For | For | ||||||||||
| 1.E | ELECTION OF DIRECTOR: ANDREW G. MACDONALD | Management | For | For | ||||||||||
| 1.F | ELECTION OF DIRECTOR: LINDA MANTIA | Management | For | For | ||||||||||
| 1.G | ELECTION OF DIRECTOR: JONATHAN W.F. MCCAIN | Management | For | For | ||||||||||
| 1.H | ELECTION OF DIRECTOR: MICHAEL H. MCCAIN | Management | For | For | ||||||||||
| 1.I | ELECTION OF DIRECTOR: BETH NEWLANDS CAMPBELL | Management | For | For | ||||||||||
| 2 | APPOINTMENT OF KPMG LLP, AS AUDITORS OF MAPLE LEAF FOODS INC. FOR THE ENSUING YEAR AND AUTHORIZING THE DIRECTORS TO FIX THEIR REMUNERATION | Management | For | For | ||||||||||
| 3 | TO APPROVE, ON AN ADVISORY AND NON-BINDING BASIS, MAPLE LEAF FOODS INC.'S APPROACH TO EXECUTIVECOMPENSATION | Management | For | For | ||||||||||
| AVANTOR, INC. | ||||||||||||||
| Security | 05352A100 | Meeting Type | Annual | |||||||||||
| Ticker Symbol | AVTR | Meeting Date | 11-May-2023 | |||||||||||
| ISIN | US05352A1007 | Agenda | 935794075 - Management | |||||||||||
| Item | Proposal | Proposed by |
Vote | For/Against Management |
||||||||||
| 1a. | Election of Director: Juan Andres | Management | For | For | ||||||||||
| 1b. | Election of Director: John Carethers | Management | For | For | ||||||||||
| 1c. | Election of Director: Lan Kang | Management | For | For | ||||||||||
| 1d. | Election of Director: Joseph Massaro | Management | For | For | ||||||||||
| 1e. | Election of Director: Mala Murthy | Management | For | For | ||||||||||
| 1f. | Election of Director: Jonathan Peacock | Management | For | For | ||||||||||
| 1g. | Election of Director: Michael Severino | Management | For | For | ||||||||||
| 1h. | Election of Director: Christi Shaw | Management | For | For | ||||||||||
| 1i. | Election of Director: Michael Stubblefield | Management | For | For | ||||||||||
| 1j. | Election of Director: Gregory Summe | Management | For | For | ||||||||||
| 2. | Ratification of the Appointment of Deloitte & Touche LLP as the Company's independent registered accounting firm for 2023. | Management | For | For | ||||||||||
| 3. | Approve, on an Advisory Basis, Named Executive Officer Compensation. | Management | For | For | ||||||||||
| LABORATORY CORP. OF AMERICA HOLDINGS | ||||||||||||||
| Security | 50540R409 | Meeting Type | Annual | |||||||||||
| Ticker Symbol | LH | Meeting Date | 11-May-2023 | |||||||||||
| ISIN | US50540R4092 | Agenda | 935798972 - Management | |||||||||||
| Item | Proposal | Proposed by |
Vote | For/Against Management |
||||||||||
| 1a. | Election of Director: Kerrii B. Anderson | Management | For | For | ||||||||||
| 1b. | Election of Director: Jean-Luc Bélingard | Management | For | For | ||||||||||
| 1c. | Election of Director: Jeffrey A. Davis | Management | For | For | ||||||||||
| 1d. | Election of Director: D. Gary Gilliland, M.D., Ph.D. | Management | For | For | ||||||||||
| 1e. | Election of Director: Kirsten M. Kliphouse | Management | For | For | ||||||||||
| 1f. | Election of Director: Garheng Kong, M.D., Ph.D. | Management | For | For | ||||||||||
| 1g. | Election of Director: Peter M. Neupert | Management | For | For | ||||||||||
| 1h. | Election of Director: Richelle P. Parham | Management | For | For | ||||||||||
| 1i. | Election of Director: Adam H. Schechter | Management | For | For | ||||||||||
| 1j. | Election of Director: Kathryn E. Wengel | Management | For | For | ||||||||||
| 1k. | Election of Director: R. Sanders Williams, M.D. | Management | For | For | ||||||||||
| 2. | To approve, by non-binding vote, executive compensation. | Management | For | For | ||||||||||
| 3. | To recommend by non-binding vote, the frequency of future non- binding votes on executive compensation. | Management | 1 Year | For | ||||||||||
| 4. | Ratification of the appointment of Deloitte and Touche LLP as Laboratory Corporation of America Holdings' independent registered public accounting firm for the year ending December 31, 2023. | Management | For | For | ||||||||||
| 5. | Shareholder proposal relating to a policy regarding separation of the roles of Board Chairman and Chief Executive Officer. | Shareholder | Against | For | ||||||||||
| 6. | Shareholder proposal regarding a Board report on transport of nonhuman primates within the U.S. | Shareholder | Abstain | Against | ||||||||||
| 7. | Shareholder proposal regarding a Board report on known risks of fulfilling information requests and mitigation strategies. | Shareholder | Abstain | Against | ||||||||||
| ZIMMER BIOMET HOLDINGS, INC. | ||||||||||||||
| Security | 98956P102 | Meeting Type | Annual | |||||||||||
| Ticker Symbol | ZBH | Meeting Date | 12-May-2023 | |||||||||||
| ISIN | US98956P1021 | Agenda | 935784909 - Management | |||||||||||
| Item | Proposal | Proposed by |
Vote | For/Against Management |
||||||||||
| 1a. | Election of Director: Christopher B. Begley | Management | For | For | ||||||||||
| 1b. | Election of Director: Betsy J. Bernard | Management | For | For | ||||||||||
| 1c. | Election of Director: Michael J. Farrell | Management | For | For | ||||||||||
| 1d. | Election of Director: Robert A. Hagemann | Management | For | For | ||||||||||
| 1e. | Election of Director: Bryan C. Hanson | Management | For | For | ||||||||||
| 1f. | Election of Director: Arthur J. Higgins | Management | For | For | ||||||||||
| 1g. | Election of Director: Maria Teresa Hilado | Management | For | For | ||||||||||
| 1h. | Election of Director: Syed Jafry | Management | For | For | ||||||||||
| 1i. | Election of Director: Sreelakshmi Kolli | Management | For | For | ||||||||||
| 1j. | Election of Director: Michael W. Michelson | Management | For | For | ||||||||||
| 2. | Ratify the appointment of PricewaterhouseCoopers LLP as our independent registered public accounting firm for 2023 | Management | For | For | ||||||||||
| 3. | Approve, on a non-binding advisory basis, named executive officer compensation ("Say on Pay") | Management | For | For | ||||||||||
| 4. | Approve, on a non-binding advisory basis, the frequency of future Say on Pay votes | Management | 1 Year | For | ||||||||||
| COLGATE-PALMOLIVE COMPANY | ||||||||||||||
| Security | 194162103 | Meeting Type | Annual | |||||||||||
| Ticker Symbol | CL | Meeting Date | 12-May-2023 | |||||||||||
| ISIN | US1941621039 | Agenda | 935795382 - Management | |||||||||||
| Item | Proposal | Proposed by |
Vote | For/Against Management |
||||||||||
| 1a. | Election of Director: John P. Bilbrey | Management | For | For | ||||||||||
| 1b. | Election of Director: John T. Cahill | Management | For | For | ||||||||||
| 1c. | Election of Director: Steve Cahillane | Management | For | For | ||||||||||
| 1d. | Election of Director: Lisa M. Edwards | Management | For | For | ||||||||||
| 1e. | Election of Director: C. Martin Harris | Management | For | For | ||||||||||
| 1f. | Election of Director: Martina Hund-Mejean | Management | For | For | ||||||||||
| 1g. | Election of Director: Kimberly A. Nelson | Management | For | For | ||||||||||
| 1h. | Election of Director: Lorrie M. Norrington | Management | For | For | ||||||||||
| 1i. | Election of Director: Michael B. Polk | Management | For | For | ||||||||||
| 1j. | Election of Director: Stephen I. Sadove | Management | For | For | ||||||||||
| 1k. | Election of Director: Noel R. Wallace | Management | For | For | ||||||||||
| 2. | Ratify selection of PricewaterhouseCoopers LLP as Colgate's independent registered public accounting firm. | Management | For | For | ||||||||||
| 3. | Advisory vote on executive compensation. | Management | For | For | ||||||||||
| 4. | Advisory vote on the frequency of future advisory votes on executive compensation. | Management | 1 Year | For | ||||||||||
| 5. | Stockholder proposal on independent Board Chairman. | Shareholder | Against | For | ||||||||||
| 6. | Stockholder proposal on executives to retain significant stock. | Shareholder | Against | For | ||||||||||
| ZIMVIE INC. | ||||||||||||||
| Security | 98888T107 | Meeting Type | Annual | |||||||||||
| Ticker Symbol | ZIMV | Meeting Date | 12-May-2023 | |||||||||||
| ISIN | US98888T1079 | Agenda | 935795522 - Management | |||||||||||
| Item | Proposal | Proposed by |
Vote | For/Against Management |
||||||||||
| 1a. | Election of Director: Vinit Asar | Management | For | For | ||||||||||
| 1b. | Election of Director: Richard Kuntz, M.D., M.Sc. | Management | For | For | ||||||||||
| 2. | Ratify the appointment of PricewaterhouseCoopers LLP as our independent registered public accounting firm for 2023. | Management | For | For | ||||||||||
| 3. | Approve, on a non-binding advisory basis, named executive officer compensation ("Say on Pay"). | Management | For | For | ||||||||||
| 4. | Approve, on a non-binding advisory basis, the frequency of future Say on Pay votes. | Management | 1 Year | For | ||||||||||
| 5. | Approve the amended 2022 Stock Incentive Plan. | Management | Against | Against | ||||||||||
| CHEMED CORPORATION | ||||||||||||||
| Security | 16359R103 | Meeting Type | Annual | |||||||||||
| Ticker Symbol | CHE | Meeting Date | 15-May-2023 | |||||||||||
| ISIN | US16359R1032 | Agenda | 935809698 - Management | |||||||||||
| Item | Proposal | Proposed by |
Vote | For/Against Management |
||||||||||
| 1a. | Election of Director: Kevin J. McNamara | Management | For | For | ||||||||||
| 1b. | Election of Director: Ron DeLyons | Management | For | For | ||||||||||
| 1c. | Election of Director: Patrick P. Grace | Management | For | For | ||||||||||
| 1d. | Election of Director: Christopher J. Heaney | Management | For | For | ||||||||||
| 1e. | Election of Director: Thomas C. Hutton | Management | For | For | ||||||||||
| 1f. | Election of Director: Andrea R. Lindell | Management | For | For | ||||||||||
| 1g. | Election of Director: Eileen P. McCarthy | Management | For | For | ||||||||||
| 1h. | Election of Director: John M. Mount, Jr. | Management | For | For | ||||||||||
| 1i. | Election of Director: Thomas P. Rice | Management | For | For | ||||||||||
| 1j. | Election of Director: George J. Walsh III | Management | For | For | ||||||||||
| 2. | Ratification of Audit Committee's selection of PricewaterhouseCoopers LLP as independent accountants for 2023. | Management | For | For | ||||||||||
| 3. | Advisory vote to approve executive compensation. | Management | For | For | ||||||||||
| 4. | Advisory vote to determine the frequency of future advisory votes on executive compensation. | Management | 1 Year | For | ||||||||||
| 5. | Stockholder proposal requesting Stockholder Ratification of Termination Pay. | Shareholder | Against | For | ||||||||||
| QUIDELORTHO CORPORATION | ||||||||||||||
| Security | 219798105 | Meeting Type | Annual | |||||||||||
| Ticker Symbol | QDEL | Meeting Date | 16-May-2023 | |||||||||||
| ISIN | US2197981051 | Agenda | 935803393 - Management | |||||||||||
| Item | Proposal | Proposed by |
Vote | For/Against Management |
||||||||||
| 1. | DIRECTOR | Management | ||||||||||||
| 1 | Douglas C. Bryant | For | For | |||||||||||
| 2 | Kenneth F. Buechler PhD | For | For | |||||||||||
| 3 | Evelyn S. Dilsaver | For | For | |||||||||||
| 4 | Edward L. Michael | For | For | |||||||||||
| 5 | Mary L Polan MD PhD MPH | For | For | |||||||||||
| 6 | Ann D. Rhoads | For | For | |||||||||||
| 7 | Robert R. Schmidt | For | For | |||||||||||
| 8 | Christopher M. Smith | For | For | |||||||||||
| 9 | Matthew W. Strobeck PhD | For | For | |||||||||||
| 10 | Kenneth J. Widder, M.D. | For | For | |||||||||||
| 11 | Joseph D. Wilkins Jr. | For | For | |||||||||||
| 12 | Stephen H. Wise | For | For | |||||||||||
| 2. | To approve, on an advisory basis, the compensation of QuidelOrtho's named executive officers. | Management | For | For | ||||||||||
| 3. | To hold a non-binding advisory vote on the frequency of future advisory votes on the compensation of QuidelOrtho's named executive officers. | Management | 1 Year | For | ||||||||||
| 4. | To ratify the selection of Ernst & Young LLP as QuidelOrtho's independent registered public accounting firm for the fiscal year ending December 31, 2023. | Management | For | For | ||||||||||
| STERICYCLE, INC. | ||||||||||||||
| Security | 858912108 | Meeting Type | Annual | |||||||||||
| Ticker Symbol | SRCL | Meeting Date | 16-May-2023 | |||||||||||
| ISIN | US8589121081 | Agenda | 935808468 - Management | |||||||||||
| Item | Proposal | Proposed by |
Vote | For/Against Management |
||||||||||
| 1a. | Election of Director: Robert S. Murley | Management | For | For | ||||||||||
| 1b. | Election of Director: Cindy J. Miller | Management | For | For | ||||||||||
| 1c. | Election of Director: Brian P. Anderson | Management | For | For | ||||||||||
| 1d. | Election of Director: Lynn D. Bleil | Management | For | For | ||||||||||
| 1e. | Election of Director: Thomas F. Chen | Management | For | For | ||||||||||
| 1f. | Election of Director: Victoria L. Dolan | Management | For | For | ||||||||||
| 1g. | Election of Director: Naren K. Gursahaney | Management | For | For | ||||||||||
| 1h. | Election of Director: J. Joel Hackney, Jr. | Management | For | For | ||||||||||
| 1i. | Election of Director: Stephen C. Hooley | Management | For | For | ||||||||||
| 1j. | Election of Director: James L. Welch | Management | For | For | ||||||||||
| 2. | Advisory vote to approve executive compensation ("say- on-pay vote"). | Management | For | For | ||||||||||
| 3. | Advisory vote on the frequency of the say-on-pay vote. | Management | 1 Year | For | ||||||||||
| 4. | Ratification of the appointment of Ernst & Young LLP as our independent registered public accounting firm for 2023. | Management | For | For | ||||||||||
| 5. | Stockholder proposal entitled Improve Political Spending Disclosure. | Shareholder | Abstain | Against | ||||||||||
| 6. | Stockholder proposal regarding a policy on accelerated vesting of equity awards in the event of a change in control. | Shareholder | Against | For | ||||||||||
| BAUSCH HEALTH COMPANIES, INC. | ||||||||||||||
| Security | 071734107 | Meeting Type | Annual | |||||||||||
| Ticker Symbol | BHC | Meeting Date | 16-May-2023 | |||||||||||
| ISIN | CA0717341071 | Agenda | 935808557 - Management | |||||||||||
| Item | Proposal | Proposed by |
Vote | For/Against Management |
||||||||||
| 1a. | Election of Director: Thomas J. Appio | Management | For | For | ||||||||||
| 1b. | Election of Director: Brett M. Icahn | Management | For | For | ||||||||||
| 1c. | Election of Director: Sarah B. Kavanagh | Management | For | For | ||||||||||
| 1d. | Election of Director: Steven D. Miller | Management | For | For | ||||||||||
| 1e. | Election of Director: Dr. Richard C. Mulligan | Management | For | For | ||||||||||
| 1f. | Election of Director: John A. Paulson | Management | For | For | ||||||||||
| 1g. | Election of Director: Robert N. Power | Management | For | For | ||||||||||
| 1h. | Election of Director: Russel C. Robertson | Management | For | For | ||||||||||
| 1i. | Election of Director: Thomas W. Ross, Sr. | Management | For | For | ||||||||||
| 1j. | Election of Director: Amy B. Wechsler, M.D. | Management | For | For | ||||||||||
| 2. | The approval, in an advisory vote, of the compensation of our Named Executive Officers. | Management | For | For | ||||||||||
| 3. | The approval, in an advisory vote, of the frequency of advisory votes on the compensation of our Named Executive Officers. | Management | 1 Year | For | ||||||||||
| 4. | The approval of an amendment and restatement of the Company's Amended and Restated 2014 Omnibus Incentive Plan. | Management | Withheld | Against | ||||||||||
| 5. | The appointment of PricewaterhouseCoopers LLP to serve as the Company's auditor until the close of the 2024 Annual Meeting of Shareholders and to authorize the Board to fix the auditor's remuneration. | Management | For | For | ||||||||||
| INFUSYSTEM HOLDINGS, INC. | ||||||||||||||
| Security | 45685K102 | Meeting Type | Annual | |||||||||||
| Ticker Symbol | INFU | Meeting Date | 16-May-2023 | |||||||||||
| ISIN | US45685K1025 | Agenda | 935821872 - Management | |||||||||||
| Item | Proposal | Proposed by |
Vote | For/Against Management |
||||||||||
| 1.1 | Election of Director: Ralph Boyd | Management | For | For | ||||||||||
| 1.2 | Election of Director: Richard Dilorio | Management | For | For | ||||||||||
| 1.3 | Election of Director: Paul Gendron | Management | For | For | ||||||||||
| 1.4 | Election of Director: Carrie Lachance | Management | For | For | ||||||||||
| 1.5 | Election of Director: Gregg Lehman | Management | For | For | ||||||||||
| 1.6 | Election of Director: R. Rimmy Malhotra | Management | For | For | ||||||||||
| 1.7 | Election of Director: Scott Shuda | Management | For | For | ||||||||||
| 2. | Approval, on an advisory basis, of the Company's Executive Compensation. | Management | For | For | ||||||||||
| 3. | Approval of an amendment to the 2021 Equity Incentive Plan to increase the number of shares under the Plan. | Management | Against | Against | ||||||||||
| 4. | Approval of the 2023 Employee Stock Purchase Plan. | Management | For | For | ||||||||||
| 5. | Ratification of the appointment of BDO USA, LLP as independent registered public accounting firm for the fiscal year ending December 31, 2023. | Management | For | For | ||||||||||
| ICU MEDICAL, INC. | ||||||||||||||
| Security | 44930G107 | Meeting Type | Annual | |||||||||||
| Ticker Symbol | ICUI | Meeting Date | 17-May-2023 | |||||||||||
| ISIN | US44930G1076 | Agenda | 935798453 - Management | |||||||||||
| Item | Proposal | Proposed by |
Vote | For/Against Management |
||||||||||
| 1. | DIRECTOR | Management | ||||||||||||
| 1 | Vivek Jain | For | For | |||||||||||
| 2 | George A. Lopez, M.D. | For | For | |||||||||||
| 3 | David C. Greenberg | For | For | |||||||||||
| 4 | Elisha W. Finney | For | For | |||||||||||
| 5 | David F. Hoffmeister | For | For | |||||||||||
| 6 | Donald M. Abbey | For | For | |||||||||||
| 7 | Laurie Hernandez | For | For | |||||||||||
| 8 | Kolleen T. Kennedy | For | For | |||||||||||
| 9 | William Seeger | For | For | |||||||||||
| 2. | To approve an amendment to the Amended and Restated ICU Medical, Inc. 2011 Stock Incentive Plan. | Management | Against | Against | ||||||||||
| 3. | To ratify the selection of Deloitte & Touche LLP as the independent registered public accounting firm for the Company for the year ending December 31, 2023. | Management | For | For | ||||||||||
| 4. | To approve named executive officer compensation on an advisory basis. | Management | For | For | ||||||||||
| 5. | Approve, on an advisory basis, the frequency of future advisory votes on named executive officer compensation. | Management | 1 Year | For | ||||||||||
| QUEST DIAGNOSTICS INCORPORATED | ||||||||||||||
| Security | 74834L100 | Meeting Type | Annual | |||||||||||
| Ticker Symbol | DGX | Meeting Date | 17-May-2023 | |||||||||||
| ISIN | US74834L1008 | Agenda | 935807137 - Management | |||||||||||
| Item | Proposal | Proposed by |
Vote | For/Against Management |
||||||||||
| 1a. | Election of Director: James E. Davis | Management | For | For | ||||||||||
| 1b. | Election of Director: Luis A. Diaz, Jr., M.D. | Management | For | For | ||||||||||
| 1c. | Election of Director: Tracey C. Doi | Management | For | For | ||||||||||
| 1d. | Election of Director: Vicky B. Gregg | Management | For | For | ||||||||||
| 1e. | Election of Director: Wright L. Lassiter, III | Management | For | For | ||||||||||
| 1f. | Election of Director: Timothy L. Main | Management | For | For | ||||||||||
| 1g. | Election of Director: Denise M. Morrison | Management | For | For | ||||||||||
| 1h. | Election of Director: Gary M. Pfeiffer | Management | For | For | ||||||||||
| 1i. | Election of Director: Timothy M. Ring | Management | For | For | ||||||||||
| 1j. | Election of Director: Gail R. Wilensky, Ph.D. | Management | For | For | ||||||||||
| 2. | An advisory resolution to approve the executive officer compensation disclosed in the Company's 2023 proxy statement | Management | For | For | ||||||||||
| 3. | An advisory vote to recommend the frequency of the stockholder advisory vote to approve executive officer compensation | Management | 1 Year | For | ||||||||||
| 4. | Ratification of the appointment of our independent registered public accounting firm for 2023 | Management | For | For | ||||||||||
| 5. | Approval of the Amended and Restated Employee Long- Term Incentive Plan | Management | Against | Against | ||||||||||
| 6. | Stockholder proposal regarding a report on the Company's greenhouse gas emissions | Shareholder | Abstain | Against | ||||||||||
| MONDELEZ INTERNATIONAL, INC. | ||||||||||||||
| Security | 609207105 | Meeting Type | Annual | |||||||||||
| Ticker Symbol | MDLZ | Meeting Date | 17-May-2023 | |||||||||||
| ISIN | US6092071058 | Agenda | 935809357 - Management | |||||||||||
| Item | Proposal | Proposed by |
Vote | For/Against Management |
||||||||||
| 1a. | Election of Director: Lewis W.K. Booth | Management | For | For | ||||||||||
| 1b. | Election of Director: Charles E. Bunch | Management | For | For | ||||||||||
| 1c. | Election of Director: Ertharin Cousin | Management | For | For | ||||||||||
| 1d. | Election of Director: Jorge S. Mesquita | Management | For | For | ||||||||||
| 1e. | Election of Director: Anindita Mukherjee | Management | For | For | ||||||||||
| 1f. | Election of Director: Jane Hamilton Nielsen | Management | For | For | ||||||||||
| 1g. | Election of Director: Patrick T. Siewert | Management | For | For | ||||||||||
| 1h. | Election of Director: Michael A. Todman | Management | For | For | ||||||||||
| 1i. | Election of Director: Dirk Van de Put | Management | For | For | ||||||||||
| 2. | Advisory Vote to Approve Executive Compensation. | Management | For | For | ||||||||||
| 3. | Advisory Vote on the Frequency of Future Votes to Approve Executive Compensation. | Management | 1 Year | For | ||||||||||
| 4. | Ratification of the Selection of PricewaterhouseCoopers LLP as Independent Registered Public Accountants for Fiscal Year Ending December 31, 2023. | Management | For | For | ||||||||||
| 5. | Require Independent Chair of the Board. | Shareholder | Against | For | ||||||||||
| 6. | Publish Annual Benchmarks for Achieving Company's 2025 Cage-Free Egg Goal. | Shareholder | Abstain | Against | ||||||||||
| 7. | Adopt Public Targets to Eradicate Child Labor in Cocoa Supply Chain | Shareholder | Abstain | Against | ||||||||||
| VERTEX PHARMACEUTICALS INCORPORATED | ||||||||||||||
| Security | 92532F100 | Meeting Type | Annual | |||||||||||
| Ticker Symbol | VRTX | Meeting Date | 17-May-2023 | |||||||||||
| ISIN | US92532F1003 | Agenda | 935809852 - Management | |||||||||||
| Item | Proposal | Proposed by |
Vote | For/Against Management |
||||||||||
| 1.1 | Election of Director: Sangeeta Bhatia | Management | For | For | ||||||||||
| 1.2 | Election of Director: Lloyd Carney | Management | For | For | ||||||||||
| 1.3 | Election of Director: Alan Garber | Management | For | For | ||||||||||
| 1.4 | Election of Director: Terrence Kearney | Management | For | For | ||||||||||
| 1.5 | Election of Director: Reshma Kewalramani | Management | For | For | ||||||||||
| 1.6 | Election of Director: Jeffrey Leiden | Management | For | For | ||||||||||
| 1.7 | Election of Director: Diana McKenzie | Management | For | For | ||||||||||
| 1.8 | Election of Director: Bruce Sachs | Management | For | For | ||||||||||
| 1.9 | Election of Director: Suketu Upadhyay | Management | For | For | ||||||||||
| 2. | Ratification of Ernst & Young LLP as independent Registered Public Accounting firm for the year ending December 31, 2023. | Management | For | For | ||||||||||
| 3. | Advisory vote to approve named executive office compensation. | Management | For | For | ||||||||||
| 4. | Advisory vote on the frequency of future advisory votes on executive compensation. | Management | 1 Year | For | ||||||||||
| OPTION CARE HEALTH, INC. | ||||||||||||||
| Security | 68404L201 | Meeting Type | Annual | |||||||||||
| Ticker Symbol | OPCH | Meeting Date | 17-May-2023 | |||||||||||
| ISIN | US68404L2016 | Agenda | 935812758 - Management | |||||||||||
| Item | Proposal | Proposed by |
Vote | For/Against Management |
||||||||||
| 1. | DIRECTOR | Management | ||||||||||||
| 1 | John J. Arlotta | Withheld | Against | |||||||||||
| 2 | Elizabeth Q. Betten | Withheld | Against | |||||||||||
| 3 | Elizabeth D. Bierbower | Withheld | Against | |||||||||||
| 4 | Natasha Deckmann | Withheld | Against | |||||||||||
| 5 | David W. Golding | Withheld | Against | |||||||||||
| 6 | Harry M. J. Kraemer Jr. | Withheld | Against | |||||||||||
| 7 | R. Carter Pate | Withheld | Against | |||||||||||
| 8 | John C. Rademacher | Withheld | Against | |||||||||||
| 9 | Nitin Sahney | Withheld | Against | |||||||||||
| 10 | Timothy P. Sullivan | Withheld | Against | |||||||||||
| 2. | To ratify the appointment of KPMG LLP as our independent registered public accounting firm for the year ending December 31, 2023. | Management | For | For | ||||||||||
| 3. | To approve, on a non-binding advisory basis, our executive compensation. | Management | For | For | ||||||||||
| 4. | To conduct an advisory vote on the frequency of a stockholder vote on our executive compensation. | Management | 1 Year | For | ||||||||||
| ZOETIS INC. | ||||||||||||||
| Security | 98978V103 | Meeting Type | Annual | |||||||||||
| Ticker Symbol | ZTS | Meeting Date | 18-May-2023 | |||||||||||
| ISIN | US98978V1035 | Agenda | 935801224 - Management | |||||||||||
| Item | Proposal | Proposed by |
Vote | For/Against Management |
||||||||||
| 1a. | Election of Director: Paul M. Bisaro | Management | For | For | ||||||||||
| 1b. | Election of Director: Vanessa Broadhurst | Management | For | For | ||||||||||
| 1c. | Election of Director: Frank A. D'Amelio | Management | For | For | ||||||||||
| 1d. | Election of Director: Michael B. McCallister | Management | For | For | ||||||||||
| 1e. | Election of Director: Gregory Norden | Management | For | For | ||||||||||
| 1f. | Election of Director: Louise M. Parent | Management | For | For | ||||||||||
| 1g. | Election of Director: Kristin C. Peck | Management | For | For | ||||||||||
| 1h. | Election of Director: Robert W. Scully | Management | For | For | ||||||||||
| 2. | Advisory vote to approve our executive compensation. | Management | For | For | ||||||||||
| 3. | Ratification of appointment of KPMG LLP as our independent registered public accounting firm for 2023. | Management | For | For | ||||||||||
| 4. | Approval of an amendment to our Restated Certificate of Incorporation to create a right to call a special meeting. | Management | For | For | ||||||||||
| 5. | Shareholder proposal regarding ability to call a special meeting. | Shareholder | Against | For | ||||||||||
| ELANCO ANIMAL HEALTH INCORPORATED | ||||||||||||||
| Security | 28414H103 | Meeting Type | Annual | |||||||||||
| Ticker Symbol | ELAN | Meeting Date | 18-May-2023 | |||||||||||
| ISIN | US28414H1032 | Agenda | 935803420 - Management | |||||||||||
| Item | Proposal | Proposed by |
Vote | For/Against Management |
||||||||||
| 1a. | Election of Director: Michael J. Harrington | Management | For | For | ||||||||||
| 1b. | Election of Director: R. David Hoover | Management | For | For | ||||||||||
| 1c. | Election of Director: Deborah T. Kochevar | Management | For | For | ||||||||||
| 1d. | Election of Director: Kirk P. McDonald | Management | For | For | ||||||||||
| 2. | Ratification of the appointment of Ernst & Young LLP as the company's independent registered public accounting firm for 2023. | Management | For | For | ||||||||||
| 3. | Advisory vote on the approval of executive compensation. | Management | For | For | ||||||||||
| 4. | Approval of the Amended and Restated Elanco Animal Health Incorporated Employee Stock Purchase Plan. | Management | For | For | ||||||||||
| 5. | Approval of the Amended and Restated 2018 Elanco Animal Health Incorporated Stock Plan. | Management | For | For | ||||||||||
| MERIT MEDICAL SYSTEMS, INC. | ||||||||||||||
| Security | 589889104 | Meeting Type | Annual | |||||||||||
| Ticker Symbol | MMSI | Meeting Date | 18-May-2023 | |||||||||||
| ISIN | US5898891040 | Agenda | 935806200 - Management | |||||||||||
| Item | Proposal | Proposed by |
Vote | For/Against Management |
||||||||||
| 1a. | Election of Director for a three year term: Lonny J. Carpenter | Management | For | For | ||||||||||
| 1b. | Election of Director for a three year term: David K. Floyd | Management | For | For | ||||||||||
| 1c. | Election of Director for a three year term: Lynne N. Ward | Management | For | For | ||||||||||
| 2. | Approval of a non-binding, advisory resolution approving the compensation of the Company's named executive officers as described in the Merit Medical Systems, Inc. Proxy Statement. | Management | For | For | ||||||||||
| 3. | Approval of a non-binding advisory resolution to determine whether, during the next six years, the Company's shareholders will be asked to approve the compensation of the Company's named executive officers every one, two or three years. | Management | 1 Year | For | ||||||||||
| 4. | Ratification of the Audit Committee's appointment of Deloitte & Touche LLP to serve as the independent registered public accounting firm of the Company for the year ending December 31, 2023. | Management | For | For | ||||||||||
| CVS HEALTH CORPORATION | ||||||||||||||
| Security | 126650100 | Meeting Type | Annual | |||||||||||
| Ticker Symbol | CVS | Meeting Date | 18-May-2023 | |||||||||||
| ISIN | US1266501006 | Agenda | 935806375 - Management | |||||||||||
| Item | Proposal | Proposed by |
Vote | For/Against Management |
||||||||||
| 1a. | Election of Director: Fernando Aguirre | Management | For | For | ||||||||||
| 1b. | Election of Director: Jeffrey R. Balser, M.D., Ph.D. | Management | For | For | ||||||||||
| 1c. | Election of Director: C. David Brown II | Management | For | For | ||||||||||
| 1d. | Election of Director: Alecia A. DeCoudreaux | Management | For | For | ||||||||||
| 1e. | Election of Director: Nancy-Ann M. DeParle | Management | For | For | ||||||||||
| 1f. | Election of Director: Roger N. Farah | Management | For | For | ||||||||||
| 1g. | Election of Director: Anne M. Finucane | Management | For | For | ||||||||||
| 1h. | Election of Director: Edward J. Ludwig | Management | For | For | ||||||||||
| 1i. | Election of Director: Karen S. Lynch | Management | For | For | ||||||||||
| 1j. | Election of Director: Jean-Pierre Millon | Management | For | For | ||||||||||
| 1k. | Election of Director: Mary L. Schapiro | Management | For | For | ||||||||||
| 2. | Ratification of the Appointment of Our Independent Registered Public Accounting Firm for 2023 | Management | For | For | ||||||||||
| 3. | Say on Pay, a Proposal to Approve, on an Advisory Basis, the Company's Executive Compensation | Management | For | For | ||||||||||
| 4. | Proposal to Recommend, on an Advisory Basis, the Frequency of Advisory Votes on Executive Compensation Votes | Management | 1 Year | For | ||||||||||
| 5. | Stockholder Proposal Requesting Paid Sick Leave for All Employees | Shareholder | Abstain | Against | ||||||||||
| 6. | Stockholder Proposal for Reducing our Ownership Threshold to Request a Special Stockholder Meeting | Shareholder | Against | For | ||||||||||
| 7. | Stockholder Proposal Regarding "Fair Elections" and Requiring Stockholder Approval of Certain Types of By- law Amendments | Shareholder | Against | For | ||||||||||
| 8. | Stockholder Proposal Requesting a Report on a "Worker Rights Assessment" | Shareholder | Abstain | Against | ||||||||||
| 9. | Stockholder Proposal to Prevent Company Directors from Simultaneously Sitting on the Boards of Directors of Any Other Company | Shareholder | Against | For | ||||||||||
| MEDPACE HOLDINGS, INC. | ||||||||||||||
| Security | 58506Q109 | Meeting Type | Annual | |||||||||||
| Ticker Symbol | MEDP | Meeting Date | 19-May-2023 | |||||||||||
| ISIN | US58506Q1094 | Agenda | 935806680 - Management | |||||||||||
| Item | Proposal | Proposed by |
Vote | For/Against Management |
||||||||||
| 1. | DIRECTOR | Management | ||||||||||||
| 1 | Brian T. Carley | For | For | |||||||||||
| 2 | F. H. Gwadry-Sridhar | For | For | |||||||||||
| 3 | Robert O. Kraft | For | For | |||||||||||
| 2. | To ratify the appointment of Deloitte & Touche LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2023. | Management | For | For | ||||||||||
| 3. | To approve, on an advisory basis, the compensation of our named executive officers as disclosed in the proxy statement for the 2023 Annual Meeting. | Management | For | For | ||||||||||
| CARECLOUD, INC. | ||||||||||||||
| Security | 14167R100 | Meeting Type | Annual | |||||||||||
| Ticker Symbol | CCLD | Meeting Date | 22-May-2023 | |||||||||||
| ISIN | US14167R1005 | Agenda | 935818635 - Management | |||||||||||
| Item | Proposal | Proposed by |
Vote | For/Against Management |
||||||||||
| 1) | DIRECTOR | Management | ||||||||||||
| 1 | Anne Busquet | For | For | |||||||||||
| 2 | Lawrence Sharnak | For | For | |||||||||||
| 2) | Nonbinding Say-On-Pay Proposal: ADVISORY VOTE TO APPROVE THE EXECUTIVE COMPENSATION PROGRAMS OF THE COMPANY NOTED IN PROPOSAL 2. | Management | For | For | ||||||||||
| 3) | Nonbinding Say-On-Pay Frequency Proposal: ADVISORY VOTE ON THE FREQUENCY TO VOTE ON THE EXECUTIVE COMPENSATION OF THE NAMED EXECUTIVES NOTED IN PROPOSAL 3. | Management | 1 Year | For | ||||||||||
| TREACE MEDICAL CONCEPTS, INC. | ||||||||||||||
| Security | 89455T109 | Meeting Type | Annual | |||||||||||
| Ticker Symbol | TMCI | Meeting Date | 23-May-2023 | |||||||||||
| ISIN | US89455T1097 | Agenda | 935803773 - Management | |||||||||||
| Item | Proposal | Proposed by |
Vote | For/Against Management |
||||||||||
| 1. | DIRECTOR | Management | ||||||||||||
| 1 | Lance A. Berry | For | For | |||||||||||
| 2 | Elizabeth S. Hanna | For | For | |||||||||||
| 3 | Jane E. Kiernan | For | For | |||||||||||
| 2. | Proposal to ratify the appointment of Grant Thornton LLP as independent registered public accounting firm for the year ending December 31, 2023. | Management | For | For | ||||||||||
| MERCK & CO., INC. | ||||||||||||||
| Security | 58933Y105 | Meeting Type | Annual | |||||||||||
| Ticker Symbol | MRK | Meeting Date | 23-May-2023 | |||||||||||
| ISIN | US58933Y1055 | Agenda | 935809080 - Management | |||||||||||
| Item | Proposal | Proposed by |
Vote | For/Against Management |
||||||||||
| 1a. | Election of Director: Douglas M. Baker, Jr. | Management | For | For | ||||||||||
| 1b. | Election of Director: Mary Ellen Coe | Management | For | For | ||||||||||
| 1c. | Election of Director: Pamela J. Craig | Management | For | For | ||||||||||
| 1d. | Election of Director: Robert M. Davis | Management | For | For | ||||||||||
| 1e. | Election of Director: Thomas H. Glocer | Management | For | For | ||||||||||
| 1f. | Election of Director: Risa J. Lavizzo-Mourey, M.D. | Management | For | For | ||||||||||
| 1g. | Election of Director: Stephen L. Mayo, Ph.D. | Management | For | For | ||||||||||
| 1h. | Election of Director: Paul B. Rothman, M.D. | Management | For | For | ||||||||||
| 1i. | Election of Director: Patricia F. Russo | Management | For | For | ||||||||||
| 1j. | Election of Director: Christine E. Seidman, M.D. | Management | For | For | ||||||||||
| 1k. | Election of Director: Inge G. Thulin | Management | For | For | ||||||||||
| 1l. | Election of Director: Kathy J. Warden | Management | For | For | ||||||||||
| 1m. | Election of Director: Peter C. Wendell | Management | For | For | ||||||||||
| 2. | Non-binding advisory vote to approve the compensation of our named executive officers. | Management | For | For | ||||||||||
| 3. | Non-binding advisory vote to approve the frequency of future votes to approve the compensation of our named executive officers. | Management | 1 Year | For | ||||||||||
| 4. | Ratification of the appointment of the Company's independent registered public accounting firm for 2023. | Management | For | For | ||||||||||
| 5. | Shareholder proposal regarding business operations in China. | Shareholder | Abstain | Against | ||||||||||
| 6. | Shareholder proposal regarding access to COVID-19 products. | Shareholder | Against | For | ||||||||||
| 7. | Shareholder proposal regarding indirect political spending. | Shareholder | Abstain | Against | ||||||||||
| 8. | Shareholder proposal regarding patents and access. | Shareholder | Against | For | ||||||||||
| 9. | Shareholder proposal regarding a congruency report of partnerships with globalist organizations. | Shareholder | Abstain | Against | ||||||||||
| 10. | Shareholder proposal regarding an independent board chairman. | Shareholder | Against | For | ||||||||||
| HENRY SCHEIN, INC. | ||||||||||||||
| Security | 806407102 | Meeting Type | Annual | |||||||||||
| Ticker Symbol | HSIC | Meeting Date | 23-May-2023 | |||||||||||
| ISIN | US8064071025 | Agenda | 935809636 - Management | |||||||||||
| Item | Proposal | Proposed by |
Vote | For/Against Management |
||||||||||
| 1a. | Election of Director: Mohamad Ali | Management | For | For | ||||||||||
| 1b. | Election of Director: Stanley M. Bergman | Management | For | For | ||||||||||
| 1c. | Election of Director: James P. Breslawski | Management | For | For | ||||||||||
| 1d. | Election of Director: Deborah Derby | Management | For | For | ||||||||||
| 1e. | Election of Director: Joseph L. Herring | Management | For | For | ||||||||||
| 1f. | Election of Director: Kurt P. Kuehn | Management | For | For | ||||||||||
| 1g. | Election of Director: Philip A. Laskawy | Management | For | For | ||||||||||
| 1h. | Election of Director: Anne H. Margulies | Management | For | For | ||||||||||
| 1i. | Election of Director: Mark E. Mlotek | Management | For | For | ||||||||||
| 1j. | Election of Director: Steven Paladino | Management | For | For | ||||||||||
| 1k. | Election of Director: Carol Raphael | Management | For | For | ||||||||||
| 1l. | Election of Director: Scott Serota | Management | For | For | ||||||||||
| 1m. | Election of Director: Bradley T. Sheares, Ph.D. | Management | For | For | ||||||||||
| 1n. | Election of Director: Reed V. Tuckson, M.D., FACP | Management | For | For | ||||||||||
| 2. | Proposal to amend and restate the Company's 2015 Non- Employee Director Stock Incentive Plan. | Management | For | For | ||||||||||
| 3. | Proposal to approve, by non-binding vote, the 2022 compensation paid to the Company's Named Executive Officers. | Management | For | For | ||||||||||
| 4. | Proposal to recommend, by non-binding vote, the frequency of future advisory votes on executive compensation. | Management | 1 Year | For | ||||||||||
| 5. | Proposal to ratify the selection of BDO USA, LLP as the Company's independent registered public accounting firm for the fiscal year ending December 30, 2023. | Management | For | For | ||||||||||
| WATERS CORPORATION | ||||||||||||||
| Security | 941848103 | Meeting Type | Annual | |||||||||||
| Ticker Symbol | WAT | Meeting Date | 23-May-2023 | |||||||||||
| ISIN | US9418481035 | Agenda | 935817481 - Management | |||||||||||
| Item | Proposal | Proposed by |
Vote | For/Against Management |
||||||||||
| 1.1 | Election of Director: Dr. Flemming Ornskov, M.D., M.P.H. | Management | For | For | ||||||||||
| 1.2 | Election of Director: Linda Baddour | Management | For | For | ||||||||||
| 1.3 | Election of Director: Dr. Udit Batra, Ph.D. | Management | For | For | ||||||||||
| 1.4 | Election of Director: Dan Brennan | Management | For | For | ||||||||||
| 1.5 | Election of Director: Richard Fearon | Management | For | For | ||||||||||
| 1.6 | Election of Director: Dr. Pearl S. Huang, Ph.D. | Management | For | For | ||||||||||
| 1.7 | Election of Director: Wei Jiang | Management | For | For | ||||||||||
| 1.8 | Election of Director: Christopher A. Kuebler | Management | For | For | ||||||||||
| 1.9 | Election of Director: Mark Vergnano | Management | For | For | ||||||||||
| 2. | To ratify the selection of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2023. | Management | For | For | ||||||||||
| 3. | To approve, by non-binding vote, executive compensation. | Management | For | For | ||||||||||
| 4. | To approve, by non-binding vote, the frequency of executive compensation votes. | Management | 1 Year | For | ||||||||||
| THERMO FISHER SCIENTIFIC INC. | ||||||||||||||
| Security | 883556102 | Meeting Type | Annual | |||||||||||
| Ticker Symbol | TMO | Meeting Date | 24-May-2023 | |||||||||||
| ISIN | US8835561023 | Agenda | 935803709 - Management | |||||||||||
| Item | Proposal | Proposed by |
Vote | For/Against Management |
||||||||||
| 1a. | Election of Director: Marc N. Casper | Management | For | For | ||||||||||
| 1b. | Election of Director: Nelson J. Chai | Management | For | For | ||||||||||
| 1c. | Election of Director: Ruby R. Chandy | Management | For | For | ||||||||||
| 1d. | Election of Director: C. Martin Harris | Management | For | For | ||||||||||
| 1e. | Election of Director: Tyler Jacks | Management | For | For | ||||||||||
| 1f. | Election of Director: R. Alexandra Keith | Management | For | For | ||||||||||
| 1g. | Election of Director: James C. Mullen | Management | For | For | ||||||||||
| 1h. | Election of Director: Lars R. Sørensen | Management | For | For | ||||||||||
| 1i. | Election of Director: Debora L. Spar | Management | For | For | ||||||||||
| 1j. | Election of Director: Scott M. Sperling | Management | For | For | ||||||||||
| 1k. | Election of Director: Dion J. Weisler | Management | For | For | ||||||||||
| 2. | An advisory vote to approve named executive officer compensation. | Management | For | For | ||||||||||
| 3. | An advisory vote on the frequency of future named executive officer advisory votes. | Management | 1 Year | For | ||||||||||
| 4. | Ratification of the Audit Committee's selection of PricewaterhouseCoopers LLP as the Company's independent auditors for 2023. | Management | For | For | ||||||||||
| 5. | Approval of the Company's Amended and Restated 2013 Stock Incentive Plan. | Management | For | For | ||||||||||
| 6. | Approval of the Company's 2023 Global Employee Stock Purchase Plan. | Management | For | For | ||||||||||
| TANDEM DIABETES CARE, INC. | ||||||||||||||
| Security | 875372203 | Meeting Type | Annual | |||||||||||
| Ticker Symbol | TNDM | Meeting Date | 24-May-2023 | |||||||||||
| ISIN | US8753722037 | Agenda | 935806123 - Management | |||||||||||
| Item | Proposal | Proposed by |
Vote | For/Against Management |
||||||||||
| 1a. | Election of Director: Kim D. Blickenstaff | Management | For | For | ||||||||||
| 1b. | Election of Director: Myoungil Cha | Management | For | For | ||||||||||
| 1c. | Election of Director: Peyton R. Howell | Management | For | For | ||||||||||
| 1d. | Election of Director: Joao Paulo Falcao Malagueira | Management | For | For | ||||||||||
| 1e. | Election of Director: Kathleen McGroddy-Goetz | Management | For | For | ||||||||||
| 1f. | Election of Director: John F. Sheridan | Management | For | For | ||||||||||
| 1g. | Election of Director: Christopher J. Twomey | Management | For | For | ||||||||||
| 2. | To approve the Company's 2023 Long-Term Incentive Plan, which will replace the 2013 Stock Incentive Plan expiring on November 15, 2023. | Management | Against | Against | ||||||||||
| 3. | To approve, on a non-binding, advisory basis, the compensation of our named executive officers. | Management | For | For | ||||||||||
| 4. | To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2023. | Management | For | For | ||||||||||
| SPROUTS FARMERS MARKET, INC. | ||||||||||||||
| Security | 85208M102 | Meeting Type | Annual | |||||||||||
| Ticker Symbol | SFM | Meeting Date | 24-May-2023 | |||||||||||
| ISIN | US85208M1027 | Agenda | 935814649 - Management | |||||||||||
| Item | Proposal | Proposed by |
Vote | For/Against Management |
||||||||||
| 1. | DIRECTOR | Management | ||||||||||||
| 1 | Joel D. Anderson | For | For | |||||||||||
| 2 | Terri Funk Graham | For | For | |||||||||||
| 3 | Doug G. Rauch | For | For | |||||||||||
| 2. | To vote on a non-binding advisory resolution to approve the compensation paid to our named executive officers for fiscal 2022 ("say-on-pay"). | Management | For | For | ||||||||||
| 3. | To ratify the appointment of PricewaterhouseCoopers LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2023. | Management | For | For | ||||||||||
| INTEGER HOLDINGS CORPORATION | ||||||||||||||
| Security | 45826H109 | Meeting Type | Annual | |||||||||||
| Ticker Symbol | ITGR | Meeting Date | 24-May-2023 | |||||||||||
| ISIN | US45826H1095 | Agenda | 935818293 - Management | |||||||||||
| Item | Proposal | Proposed by |
Vote | For/Against Management |
||||||||||
| 1a. | Election of Director for a one-year term: Sheila Antrum | Management | For | For | ||||||||||
| 1b. | Election of Director for a one-year term: Pamela G. Bailey | Management | For | For | ||||||||||
| 1c. | Election of Director for a one-year term: Cheryl C. Capps | Management | For | For | ||||||||||
| 1d. | Election of Director for a one-year term: Joseph W. Dziedzic | Management | For | For | ||||||||||
| 1e. | Election of Director for a one-year term: James F. Hinrichs | Management | For | For | ||||||||||
| 1f. | Election of Director for a one-year term: Jean Hobby | Management | For | For | ||||||||||
| 1g. | Election of Director for a one-year term: Tyrone Jeffers | Management | For | For | ||||||||||
| 1h. | Election of Director for a one-year term: M. Craig Maxwell | Management | For | For | ||||||||||
| 1i. | Election of Director for a one-year term: Filippo Passerini | Management | For | For | ||||||||||
| 1j. | Election of Director for a one-year term: Donald J. Spence | Management | For | For | ||||||||||
| 1k. | Election of Director for a one-year term: William B. Summers, Jr. | Management | For | For | ||||||||||
| 2. | To ratify the appointment of Deloitte & Touche LLP as the independent registered public accounting firm for Integer Holdings Corporation for fiscal year 2023. | Management | For | For | ||||||||||
| 3. | To approve, on an advisory basis, the compensation of our named executive officers. | Management | For | For | ||||||||||
| 4. | To approve, on an advisory basis, the frequency of future advisory votes on compensation of our named executive officers. | Management | 1 Year | For | ||||||||||
| DENTSPLY SIRONA INC. | ||||||||||||||
| Security | 24906P109 | Meeting Type | Annual | |||||||||||
| Ticker Symbol | XRAY | Meeting Date | 24-May-2023 | |||||||||||
| ISIN | US24906P1093 | Agenda | 935821074 - Management | |||||||||||
| Item | Proposal | Proposed by |
Vote | For/Against Management |
||||||||||
| 1a. | Election of Director: Eric K. Brandt | Management | For | For | ||||||||||
| 1b. | Election of Director: Simon D. Campion | Management | For | For | ||||||||||
| 1c. | Election of Director: Willie A. Deese | Management | For | For | ||||||||||
| 1d. | Election of Director: Betsy D. Holden | Management | For | For | ||||||||||
| 1e. | Election of Director: Clyde R. Hosein | Management | For | For | ||||||||||
| 1f. | Election of Director: Harry M. Kraemer, Jr. | Management | For | For | ||||||||||
| 1g. | Election of Director: Gregory T. Lucier | Management | For | For | ||||||||||
| 1h. | Election of Director: Jonathan J. Mazelsky | Management | For | For | ||||||||||
| 1i. | Election of Director: Leslie F. Varon | Management | For | For | ||||||||||
| 1j. | Election of Director: Janet S. Vergis | Management | For | For | ||||||||||
| 1k. | Election of Director: Dorothea Wenzel | Management | For | For | ||||||||||
| 2. | Ratification of the appointment of PricewaterhouseCoopers LLP as the Company's independent registered public accountants for 2023. | Management | For | For | ||||||||||
| 3. | Approval, by non-binding vote, of the Company's executive compensation for 2022. | Management | For | For | ||||||||||
| 4. | Approval, on a non-binding advisory basis, of the frequency of holding the say-on-pay vote. | Management | 1 Year | For | ||||||||||
| IRHYTHM TECHNOLOGIES, INC. | ||||||||||||||
| Security | 450056106 | Meeting Type | Annual | |||||||||||
| Ticker Symbol | IRTC | Meeting Date | 24-May-2023 | |||||||||||
| ISIN | US4500561067 | Agenda | 935821238 - Management | |||||||||||
| Item | Proposal | Proposed by |
Vote | For/Against Management |
||||||||||
| 1. | DIRECTOR | Management | ||||||||||||
| 1 | C. Noel Bairey Merz MD | For | For | |||||||||||
| 2 | Quentin S. Blackford | For | For | |||||||||||
| 3 | Bruce G. Bodaken | For | For | |||||||||||
| 4 | Karen Ling | For | For | |||||||||||
| 5 | Mark J. Rubash | For | For | |||||||||||
| 6 | Ralph Snyderman, M.D. | For | For | |||||||||||
| 7 | Abhijit Y. Talwalkar | For | For | |||||||||||
| 2. | To ratify the appointment of PricewaterhouseCoopers LLP as our independent registered public accounting firm for our fiscal year ending December 31, 2023. | Management | For | For | ||||||||||
| 3. | Advisory vote to approve Named Executive Officer compensation. | Management | For | For | ||||||||||
| NEURONETICS, INC. | ||||||||||||||
| Security | 64131A105 | Meeting Type | Annual | |||||||||||
| Ticker Symbol | STIM | Meeting Date | 25-May-2023 | |||||||||||
| ISIN | US64131A1051 | Agenda | 935817289 - Management | |||||||||||
| Item | Proposal | Proposed by |
Vote | For/Against Management |
||||||||||
| 1. | DIRECTOR | Management | ||||||||||||
| 1 | John K. Bakewell | For | For | |||||||||||
| 2 | Joseph H. Capper | For | For | |||||||||||
| 3 | Robert A. Cascella | For | For | |||||||||||
| 4 | Sheryl L. Conley | For | For | |||||||||||
| 5 | Wilfred E. Jaeger | For | For | |||||||||||
| 6 | Glenn P. Muir | For | For | |||||||||||
| 7 | Megan Rosengarten | For | For | |||||||||||
| 8 | Keith J. Sullivan | For | For | |||||||||||
| 2. | Ratification of the selection of KPMG LLP as our independent registered public accounting firm. | Management | For | For | ||||||||||
| FLOWERS FOODS, INC. | ||||||||||||||
| Security | 343498101 | Meeting Type | Annual | |||||||||||
| Ticker Symbol | FLO | Meeting Date | 25-May-2023 | |||||||||||
| ISIN | US3434981011 | Agenda | 935817354 - Management | |||||||||||
| Item | Proposal | Proposed by |
Vote | For/Against Management |
||||||||||
| 1a. | Election of Director to serve for a term of one year: George E. Deese | Management | For | For | ||||||||||
| 1b. | Election of Director to serve for a term of one year: Edward J. Casey, Jr. | Management | For | For | ||||||||||
| 1c. | Election of Director to serve for a term of one year: Thomas C. Chubb, III | Management | For | For | ||||||||||
| 1d. | Election of Director to serve for a term of one year: Rhonda Gass | Management | For | For | ||||||||||
| 1e. | Election of Director to serve for a term of one year: Margaret G. Lewis | Management | For | For | ||||||||||
| 1f. | Election of Director to serve for a term of one year: W. Jameson McFadden | Management | For | For | ||||||||||
| 1g. | Election of Director to serve for a term of one year: A. Ryals McMullian | Management | For | For | ||||||||||
| 1h. | Election of Director to serve for a term of one year: James T. Spear | Management | For | For | ||||||||||
| 1i. | Election of Director to serve for a term of one year: Melvin T. Stith, Ph.D. | Management | For | For | ||||||||||
| 1j. | Election of Director to serve for a term of one year: Terry S. Thomas | Management | For | For | ||||||||||
| 1k. | Election of Director to serve for a term of one year: C. Martin Wood III | Management | For | For | ||||||||||
| 2. | Advisory vote to approve the compensation of the company's named executive officers. | Management | For | For | ||||||||||
| 3. | Advisory vote on the frequency of future advisory votes to approve the compensation of the company's named executive officers. | Management | 1 Year | For | ||||||||||
| 4. | Approve the amendment and restatement of the Flowers Foods, Inc. 2014 Omnibus Equity and Incentive Compensation Plan. | Management | For | For | ||||||||||
| 5. | Ratify the appointment of PricewaterhouseCoopers LLP as the independent registered public accounting firm for Flowers Foods, Inc. for the fiscal year ending December 30, 2023. | Management | For | For | ||||||||||
| PHENOMEX INC. | ||||||||||||||
| Security | 084310101 | Meeting Type | Annual | |||||||||||
| Ticker Symbol | CELL | Meeting Date | 25-May-2023 | |||||||||||
| ISIN | US0843101017 | Agenda | 935817556 - Management | |||||||||||
| Item | Proposal | Proposed by |
Vote | For/Against Management |
||||||||||
| 1. | DIRECTOR | Management | ||||||||||||
| 1 | John Chiminski | For | For | |||||||||||
| 2 | Peter Silvester | For | For | |||||||||||
| 2. | Ratification of the appointment of KPMG LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2023. | Management | For | For | ||||||||||
| 3. | Approval, on an advisory basis, of the compensation of our named executive officers. | Management | For | For | ||||||||||
| TELADOC HEALTH, INC. | ||||||||||||||
| Security | 87918A105 | Meeting Type | Annual | |||||||||||
| Ticker Symbol | TDOC | Meeting Date | 25-May-2023 | |||||||||||
| ISIN | US87918A1051 | Agenda | 935819423 - Management | |||||||||||
| Item | Proposal | Proposed by |
Vote | For/Against Management |
||||||||||
| 1a. | Election of Director: Karen L. Daniel | Management | For | For | ||||||||||
| 1b. | Election of Director: Sandra L. Fenwick | Management | For | For | ||||||||||
| 1c. | Election of Director: Jason Gorevic | Management | For | For | ||||||||||
| 1d. | Election of Director: Catherine A. Jacobson | Management | For | For | ||||||||||
| 1e. | Election of Director: Thomas G. McKinley | Management | For | For | ||||||||||
| 1f. | Election of Director: Kenneth H. Paulus | Management | For | For | ||||||||||
| 1g. | Election of Director: David L. Shedlarz | Management | For | For | ||||||||||
| 1h. | Election of Director: Mark Douglas Smith, M.D., MBA | Management | For | For | ||||||||||
| 1i. | Election of Director: David B. Snow, Jr. | Management | For | For | ||||||||||
| 2. | Approve, on an advisory basis, the compensation of Teladoc Health's named executive officers. | Management | For | For | ||||||||||
| 3. | Approve the Teladoc Health, Inc. 2023 Incentive Award Plan. | Management | Against | Against | ||||||||||
| 4. | Approve an amendment to the Teladoc Health, Inc. 2015 Employee Stock Purchase Plan. | Management | For | For | ||||||||||
| 5. | Ratify the appointment of Ernst & Young LLP as Teladoc Health's independent registered public accounting firm for the fiscal year ending December 31, 2023. | Management | For | For | ||||||||||
| 6. | Stockholder proposal entitled "Fair Elections". | Shareholder | Against | For | ||||||||||
| NEVRO CORP. | ||||||||||||||
| Security | 64157F103 | Meeting Type | Annual | |||||||||||
| Ticker Symbol | NVRO | Meeting Date | 25-May-2023 | |||||||||||
| ISIN | US64157F1030 | Agenda | 935820387 - Management | |||||||||||
| Item | Proposal | Proposed by |
Vote | For/Against Management |
||||||||||
| 1. | DIRECTOR | Management | ||||||||||||
| 1 | D. Keith Grossman | For | For | |||||||||||
| 2 | Michael DeMane | For | For | |||||||||||
| 3 | Frank Fischer | For | For | |||||||||||
| 4 | Sri Kosaraju | For | For | |||||||||||
| 5 | Shawn T McCormick | For | For | |||||||||||
| 6 | Kevin O'Boyle | For | For | |||||||||||
| 7 | Karen Prange | For | For | |||||||||||
| 8 | Susan Siegel | For | For | |||||||||||
| 9 | Elizabeth Weatherman | For | For | |||||||||||
| 2. | To ratify the selection, by the Audit Committee of the Company's Board of Directors, of PricewaterhouseCoopers LLP as the independent registered public accounting firm of the Company for its fiscal year ending December 31, 2023 | Management | For | For | ||||||||||
| 3. | To approve, on a non-binding, advisory basis, the compensation of the named executive officers as disclosed in the Company's proxy statement in accordance with the compensation disclosure rules of the Securities and Exchange Commission | Management | For | For | ||||||||||
| TENET HEALTHCARE CORPORATION | ||||||||||||||
| Security | 88033G407 | Meeting Type | Annual | |||||||||||
| Ticker Symbol | THC | Meeting Date | 25-May-2023 | |||||||||||
| ISIN | US88033G4073 | Agenda | 935821593 - Management | |||||||||||
| Item | Proposal | Proposed by |
Vote | For/Against Management |
||||||||||
| 1a. | Election of Director: J. Robert Kerrey | Management | For | For | ||||||||||
| 1b. | Election of Director: James L. Bierman | Management | For | For | ||||||||||
| 1c. | Election of Director: Richard W. Fisher | Management | For | For | ||||||||||
| 1d. | Election of Director: Meghan M. FitzGerald | Management | For | For | ||||||||||
| 1e. | Election of Director: Cecil D. Haney | Management | For | For | ||||||||||
| 1f. | Election of Director: Christopher S. Lynch | Management | For | For | ||||||||||
| 1g. | Election of Director: Richard J. Mark | Management | For | For | ||||||||||
| 1h. | Election of Director: Tammy Romo | Management | For | For | ||||||||||
| 1i. | Election of Director: Saumya Sutaria | Management | For | For | ||||||||||
| 1j. | Election of Director: Nadja Y. West | Management | For | For | ||||||||||
| 2. | To approve, on an advisory basis, the Company's executive compensation. | Management | For | For | ||||||||||
| 3. | To approve, on an advisory basis, the frequency of future advisory votes on executive compensation. | Management | 1 Year | For | ||||||||||
| 4. | To ratify the selection of Deloitte & Touche LLP as the Company's independent registered public accountants for the year ending December 31, 2023. | Management | For | For | ||||||||||
| 5. | Shareholder Proposal requesting a report on patients' right to access abortion in emergencies. | Shareholder | Abstain | Against | ||||||||||
| ILLUMINA, INC. | ||||||||||||||
| Security | 452327109 | Meeting Type | Contested-Annual | |||||||||||
| Ticker Symbol | ILMN | Meeting Date | 25-May-2023 | |||||||||||
| ISIN | US4523271090 | Agenda | 935854516 - Opposition | |||||||||||
| Item | Proposal | Proposed by |
Vote | For/Against Management |
||||||||||
| 1a. | ICAHN NOMINEE: Vincent J. Intrieri | Management | For | For | ||||||||||
| 1b. | ICAHN NOMINEE: Jesse A. Lynn | Management | Withheld | Against | ||||||||||
| 1c. | ICAHN NOMINEE: Andrew J. Teno | Management | For | For | ||||||||||
| 1d. | ACCEPTABLE COMPANY NOMINEE: Frances Arnold | Management | For | |||||||||||
| 1e. | ACCEPTABLE COMPANY NOMINEE: Caroline D. Dorsa | Management | For | |||||||||||
| 1f. | ACCEPTABLE COMPANY NOMINEE: Scott Gottlieb | Management | For | |||||||||||
| 1g. | ACCEPTABLE COMPANY NOMINEE: Gary S. Guthart | Management | For | |||||||||||
| 1h. | ACCEPTABLE COMPANY NOMINEE: Philip W. Schiller | Management | For | |||||||||||
| 1i. | ACCEPTABLE COMPANY NOMINEE: Susan E. Siegel | Management | For | |||||||||||
| 1j. | OPPOSED COMPANY NOMINEE: Francis A. deSouza | Management | For | Against | ||||||||||
| 1k. | OPPOSED COMPANY NOMINEE: Robert S. Epstein | Management | Withheld | For | ||||||||||
| 1l. | OPPOSED COMPANY NOMINEE: John W. Thompson | Management | Withheld | For | ||||||||||
| 2. | TO RATIFY THE APPOINTMENT OF ERNST & YOUNG LLP AS ILLUMINA'S INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE FISCAL YEAR ENDING DECEMBER 31, 2023. | Management | For | For | ||||||||||
| 3. | TO APPROVE, ON AN ADVISORY BASIS, THE COMPENSATION OF THE "NAMED EXECUTIVE OFFICERS" AS DISCLOSED IN THE COMPANY'S PROXY STATEMENT. | Management | For | Against | ||||||||||
| 4. | TO APPROVE, ON AN ADVISORY BASIS, THE FREQUENCY OF HOLDING AN ADVISORY VOTE TO APPROVE THE COMPENSATION PROVIDED TO THE COMPANY'S "NAMED EXECUTIVE OFFICERS". | Management | 1 Year | For | ||||||||||
| 5. | To approve certain amendments to the Illumina, Inc. 2015 Stock and Incentive Plan. | Management | For | |||||||||||
| SMILEDIRECTCLUB, INC. | ||||||||||||||
| Security | 83192H106 | Meeting Type | Annual | |||||||||||
| Ticker Symbol | SDC | Meeting Date | 01-Jun-2023 | |||||||||||
| ISIN | US83192H1068 | Agenda | 935827646 - Management | |||||||||||
| Item | Proposal | Proposed by |
Vote | For/Against Management |
||||||||||
| 1. | DIRECTOR | Management | ||||||||||||
| 1 | David Katzman | For | For | |||||||||||
| 2 | Susan Greenspon Rammelt | For | For | |||||||||||
| 3 | Edward W. Ward, III | For | For | |||||||||||
| 2. | Ratification of Ernst & Young LLP as the company's independent registered accounting firm for the fiscal year ending December 31, 2023. | Management | For | For | ||||||||||
| 3. | Advisory vote to approve the company's named executive officer compensation. | Management | For | For | ||||||||||
| 4. | Approval of amendment to the company's Amended and Restated Certificate of Incorporation. | Management | For | For | ||||||||||
| GLAUKOS CORPORATION | ||||||||||||||
| Security | 377322102 | Meeting Type | Annual | |||||||||||
| Ticker Symbol | GKOS | Meeting Date | 01-Jun-2023 | |||||||||||
| ISIN | US3773221029 | Agenda | 935833930 - Management | |||||||||||
| Item | Proposal | Proposed by |
Vote | For/Against Management |
||||||||||
| 1. | DIRECTOR | Management | ||||||||||||
| 1 | Denice M. Torres | For | For | |||||||||||
| 2 | Aimee S. Weisner | For | For | |||||||||||
| 2. | Approval, on an advisory basis, of the compensation of the Company's named executive officers. | Management | For | For | ||||||||||
| 3. | Ratification of the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the year ending December 31, 2023. | Management | For | For | ||||||||||
| ACADIA PHARMACEUTICALS INC. | ||||||||||||||
| Security | 004225108 | Meeting Type | Annual | |||||||||||
| Ticker Symbol | ACAD | Meeting Date | 01-Jun-2023 | |||||||||||
| ISIN | US0042251084 | Agenda | 935860913 - Management | |||||||||||
| Item | Proposal | Proposed by |
Vote | For/Against Management |
||||||||||
| 1. | DIRECTOR | Management | ||||||||||||
| 1 | James M. Daly | For | For | |||||||||||
| 2 | Edmund P. Harrigan | For | For | |||||||||||
| 3 | Adora Ndu | For | For | |||||||||||
| 2. | To approve, on an advisory basis, the compensation of the Company's named executive officers, as disclosed in this proxy statement. | Management | For | For | ||||||||||
| 3. | To indicate, on an advisory basis, the preferred frequency of stockholder advisory votes on the compensation of the Company's named executive officers. | Management | 1 Year | For | ||||||||||
| 4. | To ratify the selection of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2023. | Management | For | For | ||||||||||
| TINGYI (CAYMAN ISLANDS) HOLDING CORP | ||||||||||||||
| Security | G8878S103 | Meeting Type | Annual General Meeting | |||||||||||
| Ticker Symbol | Meeting Date | 05-Jun-2023 | ||||||||||||
| ISIN | KYG8878S1030 | Agenda | 717097186 - Management | |||||||||||
| Item | Proposal | Proposed by |
Vote | For/Against Management |
||||||||||
| CMMT | PLEASE NOTE THAT THE COMPANY NOTICE AND PROXY FORM ARE AVAILABLE BY CLICKING-ON THE URL LINKS:- https://www1.hkexnews.hk/listedco/listconews/sehk/2023/ 0421/2023042100233.pdf-AND- https://www1.hkexnews.hk/listedco/listconews/sehk/2023/ 0421/2023042100281.pdf | Non-Voting | ||||||||||||
| CMMT | PLEASE NOTE THAT SHAREHOLDERS ARE ALLOWED TO VOTE 'IN FAVOR' OR 'AGAINST' FOR- ALL RESOLUTIONS, ABSTAIN IS NOT A VOTING OPTION ON THIS MEETING | Non-Voting | ||||||||||||
| 1 | TO RECEIVE AND CONSIDER THE AUDITED ACCOUNTS AND THE REPORTS OF THE DIRECTORS AND AUDITORS FOR THE YEAR ENDED 31 DECEMBER 2022 | Management | For | For | ||||||||||
| 2 | TO APPROVE THE PAYMENT OF A FINAL DIVIDEND FOR THE YEAR ENDED 31 DECEMBER 2022 | Management | For | For | ||||||||||
| 3 | TO APPROVE THE PAYMENT OF A SPECIAL FINAL DIVIDEND FOR THE YEAR ENDED 31 DECEMBER 2022 | Management | For | For | ||||||||||
| 4 | TO RE-ELECT MR. JUNICHIRO IDA AS AN EXECUTIVE DIRECTOR AND TO AUTHORIZE THE DIRECTORS TO FIX HIS REMUNERATION | Management | Against | Against | ||||||||||
| 5 | TO RE-ELECT MR. WEI HONG-CHEN AS AN EXECUTIVE DIRECTOR AND TO AUTHORIZE THE DIRECTORS TO FIX HIS REMUNERATION | Management | Against | Against | ||||||||||
| 6 | TO RE-ELECT MR. HIROMU FUKADA AS AN INDEPENDENT NON-EXECUTIVE DIRECTOR AND TO AUTHORIZE THE DIRECTORS TO FIX HIS REMUNERATION | Management | For | For | ||||||||||
| 7 | TO RE-APPOINT AUDITORS OF THE COMPANY AND AUTHORISE THE DIRECTORS TO FIX THEIR REMUNERATION | Management | For | For | ||||||||||
| 8 | TO CONSIDER AND APPROVE THE GENERAL MANDATE TO ISSUE SHARES | Management | Against | Against | ||||||||||
| 9 | TO CONSIDER AND APPROVE THE GENERAL MANDATE TO BUY BACK SHARES OF THE COMPANY | Management | For | For | ||||||||||
| 10 | TO CONSIDER AND APPROVE THAT THE TOTAL NUMBER OF SHARES WHICH ARE BOUGHT BACK BY THE COMPANY SHALL BE ADDED TO THE TOTAL NUMBER OF SHARES WHICH MAY BE ALLOTED PURSUANT TO THE GENERAL MANDATE FOR ISSUE OF SHARES | Management | Against | Against | ||||||||||
| 11 | TO APPROVE THE ADOPTION OF THE AMENDED AND RESTATED MEMORANDUM AND ARTICLES OF ASSOCIATION OF THE COMPANY IN SUBSTITUTION FOR AND TO THE EXCLUSION OF THE EXISTING MEMORANDUM AND ARTICLES OF ASSOCIATION OF THE COMPANY WITH IMMEDIATE EFFECT | Management | For | For | ||||||||||
| CMMT | 24 APR 2023: PLEASE NOTE THAT THIS IS A OF REVISION DUE TO DELETION OF-COMMENT. IF YOU HAVE ALREADY SENT IN YOUR VOTES, PLEASE DO NOT VOTE AGAIN-UNLESS YOU DECIDE TO AMEND YOUR ORIGINAL INSTRUCTIONS. THANK YOU | Non-Voting | ||||||||||||
| UNITEDHEALTH GROUP INCORPORATED | ||||||||||||||
| Security | 91324P102 | Meeting Type | Annual | |||||||||||
| Ticker Symbol | UNH | Meeting Date | 05-Jun-2023 | |||||||||||
| ISIN | US91324P1021 | Agenda | 935835237 - Management | |||||||||||
| Item | Proposal | Proposed by |
Vote | For/Against Management |
||||||||||
| 1a. | Election of Director: Timothy Flynn | Management | For | For | ||||||||||
| 1b. | Election of Director: Paul Garcia | Management | For | For | ||||||||||
| 1c. | Election of Director: Kristen Gil | Management | For | For | ||||||||||
| 1d. | Election of Director: Stephen Hemsley | Management | For | For | ||||||||||
| 1e. | Election of Director: Michele Hooper | Management | For | For | ||||||||||
| 1f. | Election of Director: F. William McNabb III | Management | For | For | ||||||||||
| 1g. | Election of Director: Valerie Montgomery Rice, M.D. | Management | For | For | ||||||||||
| 1h. | Election of Director: John Noseworthy, M.D. | Management | For | For | ||||||||||
| 1i. | Election of Director: Andrew Witty | Management | For | For | ||||||||||
| 2. | Advisory approval of the Company's executive compensation. | Management | For | For | ||||||||||
| 3. | Advisory approval of the frequency of holding future say- on-pay votes. | Management | 1 Year | For | ||||||||||
| 4. | Ratification of the appointment of Deloitte & Touche LLP as the independent registered public accounting firm for the Company for the year ending December 31, 2023. | Management | For | For | ||||||||||
| 5. | If properly presented at the 2023 Annual Meeting of Shareholders, the shareholder proposal seeking a third- party racial equity audit. | Shareholder | Abstain | Against | ||||||||||
| 6. | If properly presented at the 2023 Annual Meeting of Shareholders, the shareholder proposal requiring a political contributions congruency report. | Shareholder | Abstain | Against | ||||||||||
| 7. | If properly presented at the 2023 Annual Meeting of Shareholders, the shareholder proposal seeking shareholder ratification of termination pay. | Shareholder | Against | For | ||||||||||
| INVITAE CORPORATION | ||||||||||||||
| Security | 46185L103 | Meeting Type | Annual | |||||||||||
| Ticker Symbol | NVTA | Meeting Date | 05-Jun-2023 | |||||||||||
| ISIN | US46185L1035 | Agenda | 935837635 - Management | |||||||||||
| Item | Proposal | Proposed by |
Vote | For/Against Management |
||||||||||
| 1a. | Election of Class I Director: Geoffrey S. Crouse | Management | Abstain | Against | ||||||||||
| 1b. | Election of Class I Director: Christine M. Gorjanc | Management | Abstain | Against | ||||||||||
| 1c. | Election of Class I Director: Kenneth D. Knight | Management | For | For | ||||||||||
| 2. | Approval of, for purposes of complying with New York Stock Exchange listing rules, the issuance of shares of our common stock pursuant to the conversion of Notes and/or exercise of Warrants and the related change of control. | Management | For | For | ||||||||||
| 3. | Approval of, on a non-binding advisory basis, the compensation paid by us to our named executive officers. | Management | For | For | ||||||||||
| 4. | Ratification of the appointment of Ernst & Young LLP as our independent registered public accounting firm for the year ending December 31, 2023. | Management | For | For | ||||||||||
| CHINA MENGNIU DAIRY CO LTD | ||||||||||||||
| Security | G21096105 | Meeting Type | Annual General Meeting | |||||||||||
| Ticker Symbol | Meeting Date | 06-Jun-2023 | ||||||||||||
| ISIN | KYG210961051 | Agenda | 717123397 - Management | |||||||||||
| Item | Proposal | Proposed by |
Vote | For/Against Management |
||||||||||
| CMMT | PLEASE NOTE THAT THE COMPANY NOTICE AND PROXY FORM ARE AVAILABLE BY CLICKING-ON THE URL LINKS:- https://www1.hkexnews.hk/listedco/listconews/sehk/2023/ 0426/2023042600827.pdf-AND- https://www1.hkexnews.hk/listedco/listconews/sehk/2023/ 0426/2023042600926.pdf | Non-Voting | ||||||||||||
| CMMT | PLEASE NOTE THAT SHAREHOLDERS ARE ALLOWED TO VOTE 'IN FAVOR' OR 'AGAINST' FOR- ALL RESOLUTIONS, ABSTAIN IS NOT A VOTING OPTION ON THIS MEETING | Non-Voting | ||||||||||||
| 1 | TO REVIEW AND CONSIDER THE AUDITED FINANCIAL STATEMENTS AND THE REPORTS OF THE DIRECTORS AND THE INDEPENDENT AUDITORS FOR THE YEAR ENDED 31 DECEMBER 2022 | Management | For | For | ||||||||||
| 2 | TO APPROVE THE PROPOSED FINAL DIVIDEND OF RMB0.402 PER SHARE FOR THE YEAR ENDED 31 DECEMBER 2022 | Management | For | For | ||||||||||
| 3.A | TO RE-ELECT MR. LU MINFANG AS DIRECTOR AND AUTHORISE THE BOARD OF DIRECTORS OF THE COMPANY TO FIX HIS REMUNERATION | Management | For | For | ||||||||||
| 3.B | TO RE-ELECT MR. SIMON DOMINIC STEVENS AS DIRECTOR AND AUTHORISE THE BOARD OF DIRECTORS OF THE COMPANY TO FIX HIS REMUNERATION | Management | For | For | ||||||||||
| 3.C | TO RE-ELECT MR. GE JUN AS DIRECTOR AND AUTHORISE THE BOARD OF DIRECTORS OF THE COMPANY TO FIX HIS REMUNERATION | Management | For | For | ||||||||||
| 4 | TO RE-APPOINT KPMG AS THE AUDITORS OF THE COMPANY AND AUTHORISE THE BOARD OF DIRECTORS OF THE COMPANY TO FIX THEIR REMUNERATION FOR THE YEAR ENDING 31 DECEMBER 2023 | Management | For | For | ||||||||||
| 5 | ORDINARY RESOLUTION NO. 5 SET OUT IN THE NOTICE OF AGM (TO GIVE A GENERAL MANDATE TO THE DIRECTORS TO REPURCHASE SHARES IN THE COMPANY NOT EXCEEDING 10% OF THE ISSUED SHARE CAPITAL OF THE COMPANY) | Management | For | For | ||||||||||
| 6 | ORDINARY RESOLUTION NO. 6 SET OUT IN THE NOTICE OF AGM (TO GIVE A GENERAL MANDATE TO THE DIRECTORS TO ALLOT, ISSUE AND DEAL WITH ADDITIONAL SHARES NOT EXCEEDING 10% OF THE ISSUED SHARE CAPITAL OF THE COMPANY) | Management | Against | Against | ||||||||||
| 7 | SPECIAL RESOLUTION NO. 7 SET OUT IN THE NOTICE OF AGM (TO APPROVE THE AMENDMENTS RELATING TO CORE STANDARDS (AS DEFINED IN THE NOTICE OF AGM) TO THE EXISTING MEMORANDUM AND ARTICLES OF ASSOCIATION (AS DEFINED IN THE NOTICE OF AGM)) | Management | For | For | ||||||||||
| 8 | SPECIAL RESOLUTION NO. 8 SET OUT IN THE NOTICE OF AGM (TO APPROVE THE OTHER AMENDMENTS (AS DEFINED IN THE NOTICE OF AGM) TO THE EXISTING MEMORANDUM AND ARTICLES OF ASSOCIATION) | Management | For | For | ||||||||||
| 9 | SPECIAL RESOLUTION NO. 9 SET OUT IN THE NOTICE OF AGM (TO APPROVE THE ADOPTION OF THE NEW MEMORANDUM AND ARTICLES OF ASSOCIATION (AS DEFINED IN THE NOTICE OF AGM) IN SUBSTITUTION FOR AND TO THE EXCLUSION OF THE EXISTING MEMORANDUM AND ARTICLES OF ASSOCIATION) (WHICH, FOR THE AVOIDANCE OF DOUBT, IS SUBJECT TO THE SPECIAL RESOLUTIONS NOS. 7 AND 8 BEING PASSED) | Management | For | For | ||||||||||
| DAVITA INC. | ||||||||||||||
| Security | 23918K108 | Meeting Type | Annual | |||||||||||
| Ticker Symbol | DVA | Meeting Date | 06-Jun-2023 | |||||||||||
| ISIN | US23918K1088 | Agenda | 935837952 - Management | |||||||||||
| Item | Proposal | Proposed by |
Vote | For/Against Management |
||||||||||
| 1a. | Election of Director: Pamela M. Arway | Management | For | For | ||||||||||
| 1b. | Election of Director: Charles G. Berg | Management | For | For | ||||||||||
| 1c. | Election of Director: Barbara J. Desoer | Management | For | For | ||||||||||
| 1d. | Election of Director: Jason M. Hollar | Management | For | For | ||||||||||
| 1e. | Election of Director: Gregory J. Moore, MD, PhD | Management | For | For | ||||||||||
| 1f. | Election of Director: John M. Nehra | Management | For | For | ||||||||||
| 1g. | Election of Director: Javier J. Rodriguez | Management | For | For | ||||||||||
| 1h. | Election of Director: Adam H. Schechter | Management | For | For | ||||||||||
| 1i. | Election of Director: Phyllis R. Yale | Management | For | For | ||||||||||
| 2. | To ratify the appointment of KPMG LLP as our independent registered public accounting firm for fiscal year 2023. | Management | For | For | ||||||||||
| 3. | To approve, on an advisory basis, the compensation of our named executive officers. | Management | For | For | ||||||||||
| 4. | To approve, on an advisory basis, the frequency of future advisory votes on named executive officer compensation. | Management | 1 Year | For | ||||||||||
| 5. | To approve an amendment and restatement of the Company's Restated Certificate of Incorporation to provide for the exculpation of officers as permitted by Delaware law. | Management | For | For | ||||||||||
| GERRESHEIMER AG | ||||||||||||||
| Security | D2852S109 | Meeting Type | Annual General Meeting | |||||||||||
| Ticker Symbol | Meeting Date | 07-Jun-2023 | ||||||||||||
| ISIN | DE000A0LD6E6 | Agenda | 717143779 - Management | |||||||||||
| Item | Proposal | Proposed by |
Vote | For/Against Management |
||||||||||
| CMMT | VOTING MUST BE LODGED WITH SHAREHOLDER DETAILS AS PROVIDED BY YOUR CUSTODIAN.-IF NO SHAREHOLDER DETAILS ARE PROVIDED, YOUR INSTRUCTION MAY BE REJECTED. | Non-Voting | ||||||||||||
| 1 | RECEIVE FINANCIAL STATEMENTS AND STATUTORY REPORTS FOR SHORT FISCAL YEAR 2022 | Non-Voting | ||||||||||||
| 2 | APPROVE ALLOCATION OF INCOME AND DIVIDENDS OF EUR 1.25 PER SHARE | Management | No Action | |||||||||||
| 3 | APPROVE DISCHARGE OF MANAGEMENT BOARD FOR FISCAL YEAR 2022 | Management | No Action | |||||||||||
| 4 | APPROVE DISCHARGE OF SUPERVISORY BOARD FOR FISCAL YEAR 2022 | Management | No Action | |||||||||||
| 5 | RATIFY DELOITTE GMBH AS AUDITORS FOR FISCAL YEAR 2023 AND FOR THE REVIEW OF INTERIM FINANCIAL STATEMENTS FOR THE FIRST HALF OF FISCAL YEAR 2023 | Management | No Action | |||||||||||
| 6 | APPROVE REMUNERATION REPORT | Management | No Action | |||||||||||
| 7 | APPROVE VIRTUAL-ONLY SHAREHOLDER MEETINGS UNTIL 2025 | Management | No Action | |||||||||||
| 8 | APPROVE CREATION OF EUR 6.9 MILLION POOL OF AUTHORIZED CAPITAL I WITH OR WITHOUT EXCLUSION OF PREEMPTIVE RIGHTS | Management | No Action | |||||||||||
| 9 | APPROVE CREATION OF EUR 3.5 MILLION POOL OF AUTHORIZED CAPITAL II WITH OR WITHOUT EXCLUSION OF PREEMPTIVE RIGHTS | Management | No Action | |||||||||||
| 10 | APPROVE ISSUANCE OF WARRANTS/BONDS WITH WARRANTS ATTACHED/CONVERTIBLE BONDS WITHOUT PREEMPTIVE RIGHTS UP TO AGGREGATE NOMINAL AMOUNT OF EUR 500 MILLION; APPROVE CREATION OF EUR 3.5 MILLION POOL OF CAPITAL TO GUARANTEE CONVERSION RIGHTS | Management | No Action | |||||||||||
| CMMT | FROM 10TH FEBRUARY, BROADRIDGE WILL CODE ALL AGENDAS FOR GERMAN MEETINGS IN-ENGLISH ONLY. IF YOU WISH TO SEE THE AGENDA IN GERMAN, THIS WILL BE MADE-AVAILABLE AS A LINK UNDER THE MATERIAL URL DROPDOWN AT THE TOP OF THE BALLOT.-THE GERMAN AGENDAS FOR ANY EXISTING OR PAST MEETINGS WILL REMAIN IN PLACE.-FOR FURTHER INFORMATION, PLEASE CONTACT YOUR CLIENT SERVICE REPRESENTATIVE. | Non-Voting | ||||||||||||
| CMMT | ACCORDING TO GERMAN LAW, IN CASE OF SPECIFIC CONFLICTS OF INTEREST IN- CONNECTION WITH SPECIFIC ITEMS OF THE AGENDA FOR THE GENERAL MEETING YOU ARE- NOT ENTITLED TO EXERCISE YOUR VOTING RIGHTS. FURTHER, YOUR VOTING RIGHT MIGHT-BE EXCLUDED WHEN YOUR SHARE IN VOTING RIGHTS HAS REACHED CERTAIN THRESHOLDS-AND YOU HAVE NOT COMPLIED WITH ANY OF YOUR MANDATORY VOTING RIGHTS-NOTIFICATIONS PURSUANT TO THE GERMAN SECURITIES TRADING ACT (WPHG). FOR-QUESTIONS IN THIS REGARD PLEASE CONTACT YOUR CLIENT SERVICE REPRESENTATIVE-FOR CLARIFICATION. IF YOU DO NOT HAVE ANY INDICATION REGARDING SUCH CONFLICT-OF INTEREST, OR ANOTHER EXCLUSION FROM VOTING, PLEASE SUBMIT YOUR VOTE AS- USUAL. | Non-Voting | ||||||||||||
| CMMT | INFORMATION ON COUNTER PROPOSALS CAN BE FOUND DIRECTLY ON THE ISSUER'S-WEBSITE (PLEASE REFER TO THE MATERIAL URL SECTION OF THE APPLICATION). IF YOU-WISH TO ACT ON THESE ITEMS, YOU WILL NEED TO REQUEST A MEETING ATTEND AND-VOTE YOUR SHARES DIRECTLY AT THE COMPANY'S MEETING. COUNTER PROPOSALS CANNOT-BE REFLECTED ON THE BALLOT ON PROXYEDGE. | Non-Voting | ||||||||||||
| CMMT | INTERMEDIARY CLIENTS ONLY - PLEASE NOTE THAT IF YOU ARE CLASSIFIED AS AN- INTERMEDIARY CLIENT UNDER THE SHAREHOLDER RIGHTS DIRECTIVE II, YOU SHOULD BE-PROVIDING THE UNDERLYING SHAREHOLDER INFORMATION AT THE VOTE INSTRUCTION-LEVEL. IF YOU ARE UNSURE ON HOW TO PROVIDE THIS LEVEL OF DATA TO BROADRIDGE-OUTSIDE OF PROXYEDGE, PLEASE SPEAK TO YOUR DEDICATED CLIENT SERVICE-REPRESENTATIVE FOR ASSISTANCE | Non-Voting | ||||||||||||
| SOVOS BRANDS INC. | ||||||||||||||
| Security | 84612U107 | Meeting Type | Annual | |||||||||||
| Ticker Symbol | SOVO | Meeting Date | 07-Jun-2023 | |||||||||||
| ISIN | US84612U1079 | Agenda | 935842953 - Management | |||||||||||
| Item | Proposal | Proposed by |
Vote | For/Against Management |
||||||||||
| 1a. | Election of the Class II Director to serve until the 2026 Annual Meeting of Stockholders: David W. Roberts | Management | For | For | ||||||||||
| 1b. | Election of the Class II Director to serve until the 2026 Annual Meeting of Stockholders: Vijayanthimala (Mala) Singh | Management | For | For | ||||||||||
| 2. | Ratification of the appointment of Deloitte & Touche LLP as our independent registered public accounting firm for the fiscal year ending December 30, 2023. | Management | For | For | ||||||||||
| GLOBUS MEDICAL, INC. | ||||||||||||||
| Security | 379577208 | Meeting Type | Annual | |||||||||||
| Ticker Symbol | GMED | Meeting Date | 07-Jun-2023 | |||||||||||
| ISIN | US3795772082 | Agenda | 935847713 - Management | |||||||||||
| Item | Proposal | Proposed by |
Vote | For/Against Management |
||||||||||
| 1a. | Election of Director: Daniel T. Scavilla | Management | For | For | ||||||||||
| 1b. | Election of Director: Robert Douglas | Management | For | For | ||||||||||
| 2. | The approval of the amendment to the 2021 Equity Incentive Plan. | Management | Against | Against | ||||||||||
| 3. | To ratify the appointment of Deloitte & Touche LLP as the Company's independent registered public accounting firm for the year ending December 31, 2023. | Management | For | For | ||||||||||
| 4. | To approve, in an advisory vote, the compensation of the Company's named executive officers (the Say-on-Pay Vote). | Management | For | For | ||||||||||
| HESKA CORPORATION | ||||||||||||||
| Security | 42805E306 | Meeting Type | Special | |||||||||||
| Ticker Symbol | HSKA | Meeting Date | 07-Jun-2023 | |||||||||||
| ISIN | US42805E3062 | Agenda | 935869050 - Management | |||||||||||
| Item | Proposal | Proposed by |
Vote | For/Against Management |
||||||||||
| 1. | To adopt and approve the Agreement and Plan of Merger with Antech Diagnostics, Inc., a California corporation, Helsinki Merger Sub LLC, a Delaware limited liability company, and, solely for purposes of Section 9.15 of the Merger Agreement, Mars, Incorporated, a Delaware corporation (the "Merger Proposal"). | Management | For | For | ||||||||||
| 2. | To approve, on a non-binding, advisory basis, the compensation that may be paid or become payable to our named executive officers that is based on or otherwise relates to the merger. | Management | For | For | ||||||||||
| 3. | To approve one or more adjournments of the Special Meeting, if necessary, to solicit additional proxies if a quorum is not present or there are not sufficient votes cast at the Special Meeting to approve the Merger Proposal. | Management | For | For | ||||||||||
| EXACT SCIENCES CORPORATION | ||||||||||||||
| Security | 30063P105 | Meeting Type | Annual | |||||||||||
| Ticker Symbol | EXAS | Meeting Date | 08-Jun-2023 | |||||||||||
| ISIN | US30063P1057 | Agenda | 935836176 - Management | |||||||||||
| Item | Proposal | Proposed by |
Vote | For/Against Management |
||||||||||
| 1a. | Election of Class II Director to serve for three-year term: D. Scott Coward | Management | For | For | ||||||||||
| 1b. | Election of Class II Director to serve for three-year term: James Doyle | Management | For | For | ||||||||||
| 1c. | Election of Class II Director to serve for three-year term: Freda Lewis-Hall | Management | For | For | ||||||||||
| 1d. | Election of Class II Director to serve for three-year term: Kathleen Sebelius | Management | For | For | ||||||||||
| 2. | To ratify the selection of PricewaterhouseCoopers LLP as our independent registered public accounting firm for 2023. | Management | For | For | ||||||||||
| 3. | To approve, on an advisory basis, the compensation of our named executive officers. | Management | For | For | ||||||||||
| 4. | To approve, on an advisory basis, the frequency of future advisory votes on executive compensation. | Management | 1 Year | For | ||||||||||
| 5. | To approve an Amendment to our Sixth Amended and Restated Certificate of Incorporation to declassify our Board of Directors. | Management | For | For | ||||||||||
| 6. | To approve Amendment No. 2 to the Exact Sciences Corporation 2019 Omnibus Long-Term Incentive Plan. | Management | Against | Against | ||||||||||
| EVOLENT HEALTH, INC. | ||||||||||||||
| Security | 30050B101 | Meeting Type | Annual | |||||||||||
| Ticker Symbol | EVH | Meeting Date | 08-Jun-2023 | |||||||||||
| ISIN | US30050B1017 | Agenda | 935843513 - Management | |||||||||||
| Item | Proposal | Proposed by |
Vote | For/Against Management |
||||||||||
| 1a. | Election of Director: Craig Barbarosh | Management | For | For | ||||||||||
| 1b. | Election of Director: Seth Blackley | Management | For | For | ||||||||||
| 1c. | Election of Director: M. Bridget Duffy, MD | Management | For | For | ||||||||||
| 1d. | Election of Director: Peter Grua | Management | For | For | ||||||||||
| 1e. | Election of Director: Diane Holder | Management | For | For | ||||||||||
| 1f. | Election of Director: Richard Jelinek | Management | For | For | ||||||||||
| 1g. | Election of Director: Kim Keck | Management | For | For | ||||||||||
| 1h. | Election of Director: Cheryl Scott | Management | For | For | ||||||||||
| 1i. | Election of Director: Tunde Sotunde, MD | Management | For | For | ||||||||||
| 2. | Proposal to ratify the appointment of Deloitte & Touche LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2023. | Management | For | For | ||||||||||
| 3. | Proposal to approve the compensation of our named executive officers for 2022 on an advisory basis. | Management | For | For | ||||||||||
| 4. | Proposal to approve an amendment to the Amended and Restated Evolent Health, Inc. 2015 Omnibus Incentive Compensation Plan. | Management | Against | Against | ||||||||||
| REGENERON PHARMACEUTICALS, INC. | ||||||||||||||
| Security | 75886F107 | Meeting Type | Annual | |||||||||||
| Ticker Symbol | REGN | Meeting Date | 09-Jun-2023 | |||||||||||
| ISIN | US75886F1075 | Agenda | 935835338 - Management | |||||||||||
| Item | Proposal | Proposed by |
Vote | For/Against Management |
||||||||||
| 1a. | Election of Director: Joseph L. Goldstein, M.D. | Management | For | For | ||||||||||
| 1b. | Election of Director: Christine A. Poon | Management | For | For | ||||||||||
| 1c. | Election of Director: Craig B. Thompson, M.D. | Management | For | For | ||||||||||
| 1d. | Election of Director: Huda Y. Zoghbi, M.D. | Management | For | For | ||||||||||
| 2. | Ratification of the appointment of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2023. | Management | For | For | ||||||||||
| 3. | Proposal to approve, on an advisory basis, executive compensation. | Management | For | For | ||||||||||
| 4. | Proposal to approve, on an advisory basis, the frequency of future advisory votes on executive compensation. | Management | 1 Year | For | ||||||||||
| 5. | Non-binding shareholder proposal, if properly presented, requesting report on a process by which access to medicine is considered in matters related to protecting intellectual property. | Shareholder | Against | For | ||||||||||
| NATERA, INC. | ||||||||||||||
| Security | 632307104 | Meeting Type | Annual | |||||||||||
| Ticker Symbol | NTRA | Meeting Date | 09-Jun-2023 | |||||||||||
| ISIN | US6323071042 | Agenda | 935840529 - Management | |||||||||||
| Item | Proposal | Proposed by |
Vote | For/Against Management |
||||||||||
| 1. | DIRECTOR | Management | ||||||||||||
| 1 | Rowan Chapman | For | For | |||||||||||
| 2 | Herm Rosenman | For | For | |||||||||||
| 3 | Jonathan Sheena | For | For | |||||||||||
| 2. | To ratify the appointment of Ernst & Young LLP as Natera, Inc.'s independent registered public accounting firm for the fiscal year ending December 31, 2023. | Management | For | For | ||||||||||
| 3. | To approve, on an advisory (non-binding) basis, the compensation of Natera, Inc.'s named executive officers as disclosed in the proxy statement. | Management | For | For | ||||||||||
| NUVASIVE, INC. | ||||||||||||||
| Security | 670704105 | Meeting Type | Annual | |||||||||||
| Ticker Symbol | NUVA | Meeting Date | 09-Jun-2023 | |||||||||||
| ISIN | US6707041058 | Agenda | 935867121 - Management | |||||||||||
| Item | Proposal | Proposed by |
Vote | For/Against Management |
||||||||||
| 1.1 | Election of Class I Director: J. Christopher Barry | Management | For | For | ||||||||||
| 1.2 | Election of Class I Director: Leslie V. Norwalk, Esq. | Management | For | For | ||||||||||
| 1.3 | Election of Class I Director: Amy Belt Raimundo | Management | For | For | ||||||||||
| 2. | Ratification of the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2023. | Management | For | For | ||||||||||
| 3. | Approval of a non-binding advisory resolution regarding the compensation of the Company's named executive officers for the fiscal year ended December 31, 2022. | Management | For | For | ||||||||||
| 4. | Approval of a non-binding advisory vote on the frequency of the stockholders advisory vote on the compensation of the Company's named executive officers. | Management | 1 Year | For | ||||||||||
| 2SEVENTY BIO, INC. | ||||||||||||||
| Security | 901384107 | Meeting Type | Annual | |||||||||||
| Ticker Symbol | TSVT | Meeting Date | 13-Jun-2023 | |||||||||||
| ISIN | US9013841070 | Agenda | 935843119 - Management | |||||||||||
| Item | Proposal | Proposed by |
Vote | For/Against Management |
||||||||||
| 1. | DIRECTOR | Management | ||||||||||||
| 1 | Daniel S. Lynch | For | For | |||||||||||
| 2 | Sarah Glickman | For | For | |||||||||||
| 3 | Wei Lin, M.D. | For | For | |||||||||||
| 2. | To ratify the selection of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2023. | Management | For | For | ||||||||||
| 3. | To approve an amendment to our Amended and Restated Certificate of Incorporation to limit the liability of certain officers of 2seventy bio, Inc. as permitted by recent amendments to Delaware law. | Management | For | For | ||||||||||
| GUARDANT HEALTH, INC. | ||||||||||||||
| Security | 40131M109 | Meeting Type | Annual | |||||||||||
| Ticker Symbol | GH | Meeting Date | 14-Jun-2023 | |||||||||||
| ISIN | US40131M1099 | Agenda | 935837849 - Management | |||||||||||
| Item | Proposal | Proposed by |
Vote | For/Against Management |
||||||||||
| 1a. | Election of Class II Director: Ian Clark | Management | For | For | ||||||||||
| 1b. | Election of Class II Director: Meghan Joyce | Management | For | For | ||||||||||
| 1c. | Election of Class II Director: Samir Kaul | Management | For | For | ||||||||||
| 2. | Ratification of the appointment of Deloitte & Touche LLP as Guardant Health, Inc.'s independent registered public accounting firm for the year ending December 31, 2023. | Management | For | For | ||||||||||
| 3. | Non-binding advisory vote to approve Guardant Health, Inc.'s named executive officer compensation. | Management | For | For | ||||||||||
| INTELLIA THERAPEUTICS, INC. | ||||||||||||||
| Security | 45826J105 | Meeting Type | Annual | |||||||||||
| Ticker Symbol | NTLA | Meeting Date | 14-Jun-2023 | |||||||||||
| ISIN | US45826J1051 | Agenda | 935838562 - Management | |||||||||||
| Item | Proposal | Proposed by |
Vote | For/Against Management |
||||||||||
| 1. | DIRECTOR | Management | ||||||||||||
| 1 | Muna Bhanji, R.Ph. | For | For | |||||||||||
| 2 | John F. Crowley | For | For | |||||||||||
| 3 | Jesse Goodman, MD, MPH | For | For | |||||||||||
| 2. | Ratification of the appointment of Deloitte & Touche LLP as Intellia's independent registered public accounting firm for the fiscal year ending December 31, 2023. | Management | For | For | ||||||||||
| 3. | Approve, on a non-binding advisory basis, the compensation of the named executive officers. | Management | For | For | ||||||||||
| 4. | Approval of an amendment to our Second Amended and Restated Certificate of Incorporation to increase the number of authorized shares of common stock from 120,000,000 to 240,000,000. | Management | For | For | ||||||||||
| INCYTE CORPORATION | ||||||||||||||
| Security | 45337C102 | Meeting Type | Annual | |||||||||||
| Ticker Symbol | INCY | Meeting Date | 14-Jun-2023 | |||||||||||
| ISIN | US45337C1027 | Agenda | 935840719 - Management | |||||||||||
| Item | Proposal | Proposed by |
Vote | For/Against Management |
||||||||||
| 1.1 | Election of Director: Julian C. Baker | Management | For | For | ||||||||||
| 1.2 | Election of Director: Jean-Jacques Bienaimé | Management | For | For | ||||||||||
| 1.3 | Election of Director: Otis W. Brawley | Management | For | For | ||||||||||
| 1.4 | Election of Director: Paul J. Clancy | Management | For | For | ||||||||||
| 1.5 | Election of Director: Jacqualyn A. Fouse | Management | For | For | ||||||||||
| 1.6 | Election of Director: Edmund P. Harrigan | Management | For | For | ||||||||||
| 1.7 | Election of Director: Katherine A. High | Management | For | For | ||||||||||
| 1.8 | Election of Director: Hervé Hoppenot | Management | For | For | ||||||||||
| 1.9 | Election of Director: Susanne Schaffert | Management | For | For | ||||||||||
| 2. | Approve, on a non-binding, advisory basis, the compensation of the Company's named executive officers. | Management | For | For | ||||||||||
| 3. | Approve, on a non-binding, advisory basis, the frequency of future advisory votes on the compensation of the Company's named executive officers. | Management | 1 Year | For | ||||||||||
| 4. | Approve an amendment to the Company's Amended and Restated 2010 Stock Incentive Plan. | Management | Against | Against | ||||||||||
| 5. | Approve an amendment to the Company's 1997 Employee Stock Purchase Plan. | Management | For | For | ||||||||||
| 6. | Ratify the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for 2023. | Management | For | For | ||||||||||
| 10X GENOMICS, INC. | ||||||||||||||
| Security | 88025U109 | Meeting Type | Annual | |||||||||||
| Ticker Symbol | TXG | Meeting Date | 14-Jun-2023 | |||||||||||
| ISIN | US88025U1097 | Agenda | 935853095 - Management | |||||||||||
| Item | Proposal | Proposed by |
Vote | For/Against Management |
||||||||||
| 1.1 | Election of Class I Director to serve a three-year term expiring at the 2026 annual meeting: Benjamin J. Hindson, Ph.D. | Management | For | For | ||||||||||
| 1.2 | Election of Class I Director to serve a three-year term expiring at the 2026 annual meeting: Serge Saxonov, Ph.D. | Management | For | For | ||||||||||
| 1.3 | Election of Class I Director to serve a three-year term expiring at the 2026 annual meeting: John R. Stuelpnagel, D.V.M. | Management | For | For | ||||||||||
| 2. | Ratification of the appointment of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2023. | Management | For | For | ||||||||||
| 3. | A vote to approve, on a non-binding, advisory basis, the compensation of our named executive officers. | Management | For | For | ||||||||||
| GOODRX HOLDINGS, INC. | ||||||||||||||
| Security | 38246G108 | Meeting Type | Annual | |||||||||||
| Ticker Symbol | GDRX | Meeting Date | 14-Jun-2023 | |||||||||||
| ISIN | US38246G1085 | Agenda | 935856851 - Management | |||||||||||
| Item | Proposal | Proposed by |
Vote | For/Against Management |
||||||||||
| 1. | DIRECTOR | Management | ||||||||||||
| 1 | Julie Bradley | For | For | |||||||||||
| 2 | Dipanjan Deb | For | For | |||||||||||
| 3 | Stephen LeSieur | For | For | |||||||||||
| 4 | Gregory Mondre | For | For | |||||||||||
| 2. | Ratification of the appointment of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2023. | Management | For | For | ||||||||||
| 3. | Approval, on an advisory (non-binding) basis, of the compensation of the Company's named executive officers. | Management | For | For | ||||||||||
| TEVA PHARMACEUTICAL INDUSTRIES LIMITED | ||||||||||||||
| Security | 881624209 | Meeting Type | Annual | |||||||||||
| Ticker Symbol | TEVA | Meeting Date | 15-Jun-2023 | |||||||||||
| ISIN | US8816242098 | Agenda | 935846507 - Management | |||||||||||
| Item | Proposal | Proposed by |
Vote | For/Against Management |
||||||||||
| 1A. | Election of Director: Dr. Sol J. Barer | Management | For | For | ||||||||||
| 1B. | Election of Director: M. Braverman-Blumenstyk | Management | Abstain | Against | ||||||||||
| 1C. | Election of Director: Janet S. Vergis | Management | For | For | ||||||||||
| 2. | To approve, on a non-binding advisory basis, the compensation for Teva's named executive officers. | Management | For | For | ||||||||||
| 3. | To appoint Kesselman & Kesselman, a member of PricewaterhouseCoopers International Ltd., as Teva's independent registered public accounting firm until Teva's 2024 annual meeting of shareholders. | Management | For | For | ||||||||||
| TEVA PHARMACEUTICAL INDUSTRIES LIMITED | ||||||||||||||
| Security | 881624209 | Meeting Type | Annual | |||||||||||
| Ticker Symbol | TEVA | Meeting Date | 15-Jun-2023 | |||||||||||
| ISIN | US8816242098 | Agenda | 935867599 - Management | |||||||||||
| Item | Proposal | Proposed by |
Vote | For/Against Management |
||||||||||
| 1A. | Election of Director: Dr. Sol J. Barer | Management | For | For | ||||||||||
| 1B. | Election of Director: M. Braverman-Blumenstyk | Management | Abstain | Against | ||||||||||
| 1C. | Election of Director: Janet S. Vergis | Management | For | For | ||||||||||
| 2. | To approve, on a non-binding advisory basis, the compensation for Teva's named executive officers. | Management | For | For | ||||||||||
| 3. | To appoint Kesselman & Kesselman, a member of PricewaterhouseCoopers International Ltd., as Teva's independent registered public accounting firm until Teva's 2024 annual meeting of shareholders. | Management | For | For | ||||||||||
| BELLUS HEALTH INC. | ||||||||||||||
| Security | 07987C204 | Meeting Type | Special | |||||||||||
| Ticker Symbol | BLU | Meeting Date | 16-Jun-2023 | |||||||||||
| ISIN | CA07987C2040 | Agenda | 935879823 - Management | |||||||||||
| Item | Proposal | Proposed by |
Vote | For/Against Management |
||||||||||
| 1 | To consider and, if deemed advisable, to pass, with or without variation, a special resolution to approve a proposed plan of arrangement involving BELLUS Health Inc., 14934792 Canada Inc. and GSK plc, pursuant to section 192 of the Canada Business Corporations Act. The full text of the special resolution is set forth in Appendix B to the accompanying management information circular of BELLUS Health Inc. | Management | For | For | ||||||||||
| ORTHOFIX MEDICAL INC. | ||||||||||||||
| Security | 68752M108 | Meeting Type | Annual | |||||||||||
| Ticker Symbol | OFIX | Meeting Date | 19-Jun-2023 | |||||||||||
| ISIN | US68752M1080 | Agenda | 935860925 - Management | |||||||||||
| Item | Proposal | Proposed by |
Vote | For/Against Management |
||||||||||
| 1.1 | Election of Director: Wayne Burris | Management | For | For | ||||||||||
| 1.2 | Election of Director: Catherine M. Burzik | Management | For | For | ||||||||||
| 1.3 | Election of Director: Stuart M. Essig, Ph.D. | Management | For | For | ||||||||||
| 1.4 | Election of Director: Jason M. Hannon | Management | For | For | ||||||||||
| 1.5 | Election of Director: John B. Henneman, III | Management | For | For | ||||||||||
| 1.6 | Election of Director: James F. Hinrichs | Management | For | For | ||||||||||
| 1.7 | Election of Director: Shweta Singh Maniar | Management | For | For | ||||||||||
| 1.8 | Election of Director: Michael E. Paolucci | Management | For | For | ||||||||||
| 1.9 | Election of Director: Keith C. Valentine | Management | For | For | ||||||||||
| 2. | Advisory and Non-Binding Vote to Approve Executive Compensation | Management | For | For | ||||||||||
| 3. | Ratification of the Appointment of Ernst & Young LLP as Independent Registered Public Accounting Firm for the Fiscal Year Ending December 31, 2023 | Management | For | For | ||||||||||
| 4. | Approval of an Amendment and Restatement of the Certificate of Incorporation to Increase the Authorized Number of Shares of Common Stock from 50 Million to 100 Million | Management | For | For | ||||||||||
| 5. | Approval of an Amendment and Restatement of the Certificate of Incorporation to Provide for Exculpation of Officers as Permitted by Recent Amendments to Delaware Law | Management | For | For | ||||||||||
| 6. | Approval of an Amendment and Restatement of the Certificate of Incorporation to Add Forum Selection Provisions | Management | For | For | ||||||||||
| 7. | Approval of Amendment No. 4 to the Amended and Restated 2012 Long-Term Incentive Plan to Increase the Number of Shares of Common Stock Authorized for Issuance Thereunder by 2,900,000 and to Amend Certain Other Provisions Related to the Repayment, Reimbursement and Forfeiture of Awards Thereunder. | Management | Against | Against | ||||||||||
| 8. | Approval of Amendment No. 3 to the Second Amended and Restated Stock Purchase Plan to Increase the Number of Shares of Common Stock Authorized for Issuance Thereunder by 750,000. | Management | For | For | ||||||||||
| 9. | Advisory Vote on the Frequency of Future Advisory Votes to Approve Executive Compensation | Management | 1 Year | For | ||||||||||
| YAKULT HONSHA CO.,LTD. | ||||||||||||||
| Security | J95468120 | Meeting Type | Annual General Meeting | |||||||||||
| Ticker Symbol | Meeting Date | 21-Jun-2023 | ||||||||||||
| ISIN | JP3931600005 | Agenda | 717312451 - Management | |||||||||||
| Item | Proposal | Proposed by |
Vote | For/Against Management |
||||||||||
| Please reference meeting materials. | Non-Voting | |||||||||||||
| 1.1 | Appoint a Director Narita, Hiroshi | Management | For | For | ||||||||||
| 1.2 | Appoint a Director Wakabayashi, Hiroshi | Management | For | For | ||||||||||
| 1.3 | Appoint a Director Doi, Akifumi | Management | For | For | ||||||||||
| 1.4 | Appoint a Director Imada, Masao | Management | For | For | ||||||||||
| 1.5 | Appoint a Director Hirano, Koichi | Management | For | For | ||||||||||
| 1.6 | Appoint a Director Yasuda, Ryuji | Management | For | For | ||||||||||
| 1.7 | Appoint a Director Tobe, Naoko | Management | For | For | ||||||||||
| 1.8 | Appoint a Director Shimbo, Katsuyoshi | Management | For | For | ||||||||||
| 1.9 | Appoint a Director Nagasawa, Yumiko | Management | For | For | ||||||||||
| 1.10 | Appoint a Director Akutsu, Satoshi | Management | For | For | ||||||||||
| 1.11 | Appoint a Director Naito, Manabu | Management | For | For | ||||||||||
| 1.12 | Appoint a Director Nagira, Masatoshi | Management | For | For | ||||||||||
| 1.13 | Appoint a Director Hoshiko, Hideaki | Management | For | For | ||||||||||
| 1.14 | Appoint a Director Shimada, Junichi | Management | For | For | ||||||||||
| 1.15 | Appoint a Director Matthew Digby | Management | For | For | ||||||||||
| 2 | Approve Details of the Restricted-Stock Compensation to be received by Directors (Excluding Outside Directors and Part-time Directors) | Management | For | For | ||||||||||
| 3 | Approve Details of the Compensation to be received by Corporate Auditors | Management | For | For | ||||||||||
| PETIQ, INC. | ||||||||||||||
| Security | 71639T106 | Meeting Type | Annual | |||||||||||
| Ticker Symbol | PETQ | Meeting Date | 21-Jun-2023 | |||||||||||
| ISIN | US71639T1060 | Agenda | 935854287 - Management | |||||||||||
| Item | Proposal | Proposed by |
Vote | For/Against Management |
||||||||||
| 1a. | Election of Director: McCord Christensen | Management | For | For | ||||||||||
| 1b. | Election of Director: Kimberly Lefko | Management | For | For | ||||||||||
| 2. | To ratify the selection of KPMG LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2023. | Management | For | For | ||||||||||
| 3. | To approve, on an advisory, non-binding basis, the compensation of our named executive officers. | Management | For | For | ||||||||||
| SILK ROAD MEDICAL, INC. | ||||||||||||||
| Security | 82710M100 | Meeting Type | Annual | |||||||||||
| Ticker Symbol | SILK | Meeting Date | 21-Jun-2023 | |||||||||||
| ISIN | US82710M1009 | Agenda | 935860280 - Management | |||||||||||
| Item | Proposal | Proposed by |
Vote | For/Against Management |
||||||||||
| 1a. | Election of Class I Director to serve until our 2024 annual meeting: Rick D. Anderson | Management | For | For | ||||||||||
| 1b. | Election of Class I Director to serve until our 2024 annual meeting: Jack W. Lasersohn | Management | For | For | ||||||||||
| 1c. | Election of Class I Director to serve until our 2024 annual meeting: Erica J. Rogers | Management | For | For | ||||||||||
| 1d. | Election of Class III Director to serve until our 2024 annual meeting: Elizabeth H. Weatherman | Management | For | For | ||||||||||
| 1e. | Election of Class III Director to serve until our 2024 annual meeting: Donald J. Zurbay | Management | For | For | ||||||||||
| 2. | To approve Named Executive Officer Compensation on an advisory basis. | Management | For | For | ||||||||||
| 3. | To adopt and approve an amendment to our Certificate of Incorporation to eliminate or limit the personal liability of officers. | Management | For | For | ||||||||||
| 4. | To ratify the appointment of PricewaterhouseCoopers LLP as our independent registered public accounting firm for our fiscal year ending December 31, 2023. | Management | For | For | ||||||||||
| PETCO HEALTH AND WELLNESS COMPANY, INC. | ||||||||||||||
| Security | 71601V105 | Meeting Type | Annual | |||||||||||
| Ticker Symbol | WOOF | Meeting Date | 22-Jun-2023 | |||||||||||
| ISIN | US71601V1052 | Agenda | 935854453 - Management | |||||||||||
| Item | Proposal | Proposed by |
Vote | For/Against Management |
||||||||||
| 1. | DIRECTOR | Management | ||||||||||||
| 1 | Gary Briggs | For | For | |||||||||||
| 2 | Nishad Chande | For | For | |||||||||||
| 3 | Mary Sullivan | For | For | |||||||||||
| 2. | To approve, on a non-binding, advisory basis, the compensation of the Company's named executive officers. | Management | For | For | ||||||||||
| 3. | To approve the First Amendment to the Company's 2021 Equity Incentive Plan to increase the number of shares of Class A Common Stock authorized for issuance under the plan. | Management | Against | Against | ||||||||||
| 4. | To approve the Amendment to the Company's Second Amended and Restated Certificate of Incorporation to limit the liability of certain officers as permitted by Delaware law. | Management | For | For | ||||||||||
| 5. | To ratify the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending February 3, 2024. | Management | For | For | ||||||||||
| THE KROGER CO. | ||||||||||||||
| Security | 501044101 | Meeting Type | Annual | |||||||||||
| Ticker Symbol | KR | Meeting Date | 22-Jun-2023 | |||||||||||
| ISIN | US5010441013 | Agenda | 935864579 - Management | |||||||||||
| Item | Proposal | Proposed by |
Vote | For/Against Management |
||||||||||
| 1a. | Election of Director: Nora A. Aufreiter | Management | For | For | ||||||||||
| 1b. | Election of Director: Kevin M. Brown | Management | For | For | ||||||||||
| 1c. | Election of Director: Elaine L. Chao | Management | For | For | ||||||||||
| 1d. | Election of Director: Anne Gates | Management | For | For | ||||||||||
| 1e. | Election of Director: Karen M. Hoguet | Management | For | For | ||||||||||
| 1f. | Election of Director: W. Rodney McMullen | Management | For | For | ||||||||||
| 1g. | Election of Director: Clyde R. Moore | Management | For | For | ||||||||||
| 1h. | Election of Director: Ronald L. Sargent | Management | For | For | ||||||||||
| 1i. | Election of Director: J. Amanda Sourry Knox | Management | For | For | ||||||||||
| 1j. | Election of Director: Mark S. Sutton | Management | For | For | ||||||||||
| 1k. | Election of Director: Ashok Vemuri | Management | For | For | ||||||||||
| 2. | Approval, on an advisory basis, of Kroger's executive compensation. | Management | For | For | ||||||||||
| 3. | Advisory Vote on Frequency of Future Votes on Executive Compensation. | Management | 1 Year | For | ||||||||||
| 4. | Ratification of PricewaterhouseCoopers LLP, as auditors. | Management | For | For | ||||||||||
| 5. | Report on Public Health Costs from Sale of Tobacco Products. | Shareholder | Abstain | Against | ||||||||||
| 6. | Listing of Charitable Contributions of $10,000 or More. | Shareholder | Against | For | ||||||||||
| 7. | Report on Recyclability of Packaging. | Shareholder | Abstain | Against | ||||||||||
| 8. | Report on Racial and Gender Pay Gaps. | Shareholder | Abstain | Against | ||||||||||
| 9. | Report on EEO Policy Risks. | Shareholder | Abstain | Against | ||||||||||
| KIKKOMAN CORPORATION | ||||||||||||||
| Security | J32620106 | Meeting Type | Annual General Meeting | |||||||||||
| Ticker Symbol | Meeting Date | 27-Jun-2023 | ||||||||||||
| ISIN | JP3240400006 | Agenda | 717320282 - Management | |||||||||||
| Item | Proposal | Proposed by |
Vote | For/Against Management |
||||||||||
| Please reference meeting materials. | Non-Voting | |||||||||||||
| 1 | Approve Appropriation of Surplus | Management | For | For | ||||||||||
| 2.1 | Appoint a Director Mogi, Yuzaburo | Management | For | For | ||||||||||
| 2.2 | Appoint a Director Horikiri, Noriaki | Management | For | For | ||||||||||
| 2.3 | Appoint a Director Nakano, Shozaburo | Management | For | For | ||||||||||
| 2.4 | Appoint a Director Shimada, Masanao | Management | For | For | ||||||||||
| 2.5 | Appoint a Director Mogi, Osamu | Management | For | For | ||||||||||
| 2.6 | Appoint a Director Matsuyama, Asahi | Management | For | For | ||||||||||
| 2.7 | Appoint a Director Kamiyama, Takao | Management | For | For | ||||||||||
| 2.8 | Appoint a Director Fukui, Toshihiko | Management | For | For | ||||||||||
| 2.9 | Appoint a Director Inokuchi, Takeo | Management | For | For | ||||||||||
| 2.10 | Appoint a Director Iino, Masako | Management | For | For | ||||||||||
| 2.11 | Appoint a Director Sugiyama, Shinsuke | Management | For | For | ||||||||||
| 3 | Appoint a Substitute Corporate Auditor Endo, Kazuyoshi | Management | For | For | ||||||||||
| MEIJI HOLDINGS CO.,LTD. | ||||||||||||||
| Security | J41729104 | Meeting Type | Annual General Meeting | |||||||||||
| Ticker Symbol | Meeting Date | 29-Jun-2023 | ||||||||||||
| ISIN | JP3918000005 | Agenda | 717353685 - Management | |||||||||||
| Item | Proposal | Proposed by |
Vote | For/Against Management |
||||||||||
| Please reference meeting materials. | Non-Voting | |||||||||||||
| 1.1 | Appoint a Director Kawamura, Kazuo | Management | For | For | ||||||||||
| 1.2 | Appoint a Director Kobayashi, Daikichiro | Management | For | For | ||||||||||
| 1.3 | Appoint a Director Matsuda, Katsunari | Management | For | For | ||||||||||
| 1.4 | Appoint a Director Shiozaki, Koichiro | Management | For | For | ||||||||||
| 1.5 | Appoint a Director Furuta, Jun | Management | For | For | ||||||||||
| 1.6 | Appoint a Director Matsumura, Mariko | Management | For | For | ||||||||||
| 1.7 | Appoint a Director Kawata, Masaya | Management | For | For | ||||||||||
| 1.8 | Appoint a Director Kuboyama, Michiko | Management | For | For | ||||||||||
| 1.9 | Appoint a Director Peter D. Pedersen | Management | For | For | ||||||||||
| 2 | Appoint a Substitute Corporate Auditor Komatsu, Masakazu | Management | For | For | ||||||||||
| MORINAGA MILK INDUSTRY CO.,LTD. | ||||||||||||||
| Security | J46410114 | Meeting Type | Annual General Meeting | |||||||||||
| Ticker Symbol | Meeting Date | 29-Jun-2023 | ||||||||||||
| ISIN | JP3926800008 | Agenda | 717378194 - Management | |||||||||||
| Item | Proposal | Proposed by |
Vote | For/Against Management |
||||||||||
| Please reference meeting materials. | Non-Voting | |||||||||||||
| 1 | Approve Appropriation of Surplus | Management | For | For | ||||||||||
| 2.1 | Appoint a Director Miyahara, Michio | Management | For | For | ||||||||||
| 2.2 | Appoint a Director Onuki, Yoichi | Management | For | For | ||||||||||
| 2.3 | Appoint a Director Okawa, Teiichiro | Management | For | For | ||||||||||
| 2.4 | Appoint a Director Minato, Tsuyoshi | Management | For | For | ||||||||||
| 2.5 | Appoint a Director Yanagida, Yasuhiko | Management | For | For | ||||||||||
| 2.6 | Appoint a Director Hyodo, Hitoshi | Management | For | For | ||||||||||
| 2.7 | Appoint a Director Nozaki, Akihiro | Management | For | For | ||||||||||
| 2.8 | Appoint a Director Yanagida, Takahiro | Management | For | For | ||||||||||
| 2.9 | Appoint a Director Tominaga, Yukari | Management | For | For | ||||||||||
| 2.10 | Appoint a Director Nakamura, Hiroshi | Management | For | For | ||||||||||
| 2.11 | Appoint a Director Ikeda, Takayuki | Management | For | For | ||||||||||
| 2.12 | Appoint a Director Yoshinaga, Yasuyuki | Management | For | For | ||||||||||
| 3 | Appoint a Corporate Auditor Yamamoto, Mayumi | Management | For | For | ||||||||||
| 4 | Appoint a Substitute Corporate Auditor Suzuki, Michio | Management | For | For | ||||||||||
| BELLUS HEALTH INC. | ||||||||||||||
| Security | 07987C204 | Meeting Type | Annual and Special Meeting | |||||||||||
| Ticker Symbol | BLU | Meeting Date | 30-Jun-2023 | |||||||||||
| ISIN | CA07987C2040 | Agenda | 935889230 - Management | |||||||||||
| Item | Proposal | Proposed by |
Vote | For/Against Management |
||||||||||
| 1A | Election of Director - Dr. Francesco Bellini, O.C. | Management | For | For | ||||||||||
| 1B | Election of Director - Roberto Bellini | Management | For | For | ||||||||||
| 1C | Election of Director - Dr. Youssef L. Bennani | Management | For | For | ||||||||||
| 1D | Election of Director - Franklin M. Berger, CFA | Management | For | For | ||||||||||
| 1E | Election of Director - Dr. Clarissa Desjardins | Management | For | For | ||||||||||
| 1F | Election of Director - Pierre Larochelle | Management | For | For | ||||||||||
| 1G | Election of Director - Dr. William Mezzanotte | Management | For | For | ||||||||||
| 1H | Election of Director - Joseph Rus | Management | For | For | ||||||||||
| 2 | Appointment of KPMG LLP as Auditors of the Company for the ensuing year and authorizing the Audit Committee to fix their remuneration. | Management | For | For | ||||||||||
| 3 | Ratification and confirmation of a resolution approving the unallocated options under the Stock Option Plan. | Management | Against | Against | ||||||||||
SIGNATURES
Pursuant to the requirements of the Investment Company Act of 1940, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
| Registrant | The Gabelli Healthcare & WellnessRx Trust |
| By (Signature and Title)* | /s/ John C. Ball |
| John C. Ball, President and Principal Executive Officer |
| Date | August 25, 2023 |
*Print the name and title of each signing officer under his or her signature.